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ABSTRACT 
 
Once thought to be an unfortunate consequence of aerobic life, the generation of reactive 
oxygen and nitrogen species (ROS / RNS) is now known to be integral to the proper 
functioning of the cell – utilised for redox signalling. Cysteine (Cys) residues in proteins 
show all the necessary properties to act as a sensor / responder to redox signals. Cys is the 
most redox active of the commonly coded amino acids, reacting directly (non-enzymatically) 
with a wide range of ROS / RNS, and can be post-translationally modified (PTM) to more 
than ten different chemical forms, many of which are enzymatically reversible. The high 
reactivity of Cys however, also makes it a candidate for PTM under conditions of 
dysregulated oxidant handling, i.e., “oxidative stress”, which is contained in most 
pathologies, e.g., neurodegeneration, cardiovascular disease, cancer and obesity. The 
potential role for Cys residues in both the physiological function and pathological 
dysfunction of the cell has lead to much interest in the identification of target proteins / 
cellular processes and sites regulated by Cys PTM. Progress in this area has been hampered 
however, by a relative lack of experimental methods for the study of these sites on a global 
scale. As Cys residues are amongst the least abundant residues in proteins, and Cys PTM may 
occupy as little as a few percent of these sites, enrichment techniques must be applied to 
confidently identify large numbers of sites. Thus, the aims of this thesis were to develop 
enrichment techniques which were robust, sensitive, reproducible and specific in the 
enrichment of Cys PTM sites, and to apply these technique(s) to the study of ischemia / 
reperfusion (IR) injury, which is known to be ameliorated by antioxidant interventions. The 
developed technique to profile reversibly modified Cys sites revolves around; (i) efficient 
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protein extraction, involving free Cys alkylation to limit artefactual oxidation, (ii) thiol-based 
reduction of Cys PTM to thiols, (iii) covalent capture of Cys peptides by a chemistry specific 
to thiols – thiol-disulfide exchange (TDE), and (iv) elution of peptides and analysis by two 
dimensional liquid chromatography tandem mass spectrometry (2D-LC-MS/MS). However, 
the technique is predicated on the ability to reduce Cys PTM, and any modification not 
susceptible to thiol-based reduction will not be captured by TDE. Thus, an additional 
technique was developed to profile any sites forming „irreversible‟ Cys PTM, utilising the 
unique combination of liquid chromatography steps (strong cation exchange and hydrophilic 
interaction liquid chromatography; SCX-HILIC). Various chemical steps were optimised in 
both methods to ensure the most efficient enrichment of the respective Cys PTM including; 
(i) protein extraction / alkylation steps (Chapter 3), (ii) TDE capture efficiency (Chapter 4), 
and (iii) chromatographic resolution of irreversible Cys PTM (Chapter 5). In Chapter 3, the 
alkylation of thiols and other nucleophiles by N-ethylmaleimide (NEM) was examined, to 
determine concentration, time and pH dependence of the reaction, and thus the best reaction 
conditions for thiol alkylation, whilst limiting alkylation of other sites. It was observed that at 
a pH less than neutral, in the presence of a strong denaturant, reactivity at thiols versus other 
sites could be optimised by either concentration or reaction time limitation. In Chapter 4, the 
TDE reaction was examined and, under the optimised conditions, > 90 % enrichment 
specificity for Cys was observed, with approximately equimolar reactions between peptides 
and resin, and reproducibility (by label-free quantitation) in excess of 90 % across six 
replicates. When utilised in „control‟ myocardial tissue, 6559 unique Cys peptides (2694 
proteins) were observed, which constitutes the largest database of Cys PTM sites to date. In 
Chapter 5, a technique to enrich for irreversibly PTM Cys sites is developed, exploiting 
orthogonal retention in SCX and HILIC chemistries, to identify 188 Cys sites (142 proteins) 
which form these PTM under either hydrogen peroxide treatment or IR. This constitutes the 
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largest database of irreversible Cys PTM to date, and the only database incorporating the 
global study of these PTM without exogenous oxidant addition (i.e., IR tissue). These 
techniques however, provide only steady-state analysis of Cys PTM, and for analysis of Cys 
PTM altered in response to interventions (in this case, IR and antioxidant intervention), this 
necessitates the incorporation of quantitative labelling. Utilising a multiplexing technique 
(iTRAQ) and following some alterations of the protocol, we were able to quantify 1372 
reversible Cys PTM sites (642 proteins) which were altered in response to either 15 min 
ischemia (15I), 15I with 15 min reperfusion (IR) or IR with antioxidant intervention (N-2-
mercaptopropionyl glycine; MPG), which increases contractile recovery following IR. 
Interestingly, whilst changes in 15I and IR were largely contributed to by increased Cys PTM 
(i.e., oxidation), the IR + MPG condition constituted a large decrease in reversible Cys PTM. 
To ensure this loss was not due to irreversible PTM formation, we undertook SCX-HILIC of 
the same samples, and revealed that the only condition with substantial increased irreversible 
Cys PTM formation was IR, indicating MPG must reduce the redox state of Cys residues in 
proteins. Overall, these techniques have lead to a substantial increase in the knowledge of 
Cys PTM sites in the literature as well as potential processes affected by redox. The 
generation of large datasets has also allowed for initial studies concerned with elucidating 
reactive linear sequence motifs, revealing the importance of electrostatic interactions and 
proximal thiols in Cys PTM. 
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AA – amino acid 
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LC-MS/MS – liquid chromatography tandem mass spectrometry 
MALDI – matrix-assisted laser desorption ionisation 
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MPG – N-2-mercaptopropionylglycine 
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MS – mass spectrometry 
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PDI – protein disulfide isomerase 
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PTM – post translational modification 
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INTRODUCTION 
 
Cysteine (Cys) is a semi-essential amino acid used sparingly in proteins, representing ~ 1.5 % 
of amino acid residues in proteins across all species – second only to Tryptophan (Trp) in 
rarity (Pe'er, Felder et al., 2004). It is however present in appreciable amounts as small 
molecular weight thiols such as glutathione (GSH) – spanning µM to mM concentrations 
across all cell types (Wendell, 1970; Meister and Anderson, 1983; Ishikawa and Sies, 1984). 
Along with methionine (Met) it constitutes the only common amino acid that exits the realm 
of the ‘classical’ organic atoms (O, N, C, H) with the utilisation of the second row element 
sulfur. The use of this more diffuse ‘soft’ nucleophile over a harder nucleophile such as 
oxygen (as in the structural analogue serine, Ser) leads to interesting chemistries that are 
facilitated not only by the thiol but also via the thiolate anion and sulfenyl radical (discussed 
in section 1.1). In addition, the availability of higher valencies / formal oxidation states 
(O.S.), and the varying bond-strengths of products allows for modifications that are either 
unattainable or highly unstable in oxygen analogues (Whitham, 1995). These properties lead 
to a larger variety of post-translational modification (PTM) than possible for any other amino 
acid (detailed in Section 1.2). 
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It is via these interesting chemical properties and PTM that Cys exerts many of its 
physiological functions. Structural stabilisation by the formation of disulfides is the 
‘classical’ role played by Cys in all biochemical textbooks as exemplified by the pioneering 
experiments on ribonuclease A (Givol, Delorenzo et al., 1965). Cys however, also plays roles 
in catalysis, metal binding (structural and catalytic), antioxidant defence and functional 
modulation of proteins via PTM (i.e., redox signalling; discussed in section 1.3). These 
diverse functions are undoubtedly attributable to the versatility and reactivity of Cys; 
however these same properties may also lead to cellular dysfunction under increased oxidant 
/ electrophile stress. Most pathologies including cancer, cardiovascular (section 1.4) and 
neurological diseases, as well as ageing are known to contain within their aetiology a level of 
oxidant mis-handing and stress. Proteinaceous Cys is frequently implicated as a target for 
these oxidants and the modification of critical Cys residues may hide the key to deciphering 
the molecular events leading to pathological outcomes.  
 
Considering the many functions attributable to Cys in both health and disease, little is known 
about what Cys sites in proteins are modified under physiological or pathological conditions 
or what might make certain sites reactive. Global proteomics studies of Cys are often 
hampered by its high reactivity and poor understanding of oxidant, reductant and electrophile 
reactions with Cys. This means that commonly used practices are often poorly reproducible 
and have low recoveries – a current estimate indicates < 10 % of sites in the same tissue may 
be observed across differing enrichment methods (Chung, Wang et al., 2013). In addition to 
this, few methods are available to give site localisation of Cys residues within proteins, 
making reactivity profiling in proteins containing multiple Cys residues difficult. Cys is truly 
a versatile and reactive chemical handle – however, more work must be undertaken to 
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provide robust methods and large-scale observations of modified / modifiable Cys residues to 
discern chemical patterns that may modulate and direct its activity. 
 
1.1.  Thiols – versatile chemical handles in proteins 
The sulfur moiety may exist in formal O.S. of between -2 and +6, with at least 5 of these 
observed in proteinaceous Cys residues (-2 to +4), making it the most versatile non-metal 
redox participant in biology (Whitham, 1995; Jacob, Giles et al., 2003). These high O.S. and 
an expansion beyond divalent compounds to tri- and tetra-coordinate structures (valencies 4 
and 6) are made possible by the presence of low lying empty d-orbitals (Liu, 1977; Block, 
1978; Whitham, 1995). In the correct geometries, these orbitals may also allow for 
contraction / elongation of bond lengths in some derivatives (e.g. disulfide bond lengths 
between 1.88 and 2.39 Å), potentially altering their reactivity (Block, 1978). 
Thiols are good nucleophiles due to their high polarisablity and low ionisation potential, 
participating avidly in both nucleophilic substitution and addition reactions. In addition, the 
low pKa of thiols – average pKa of ~ 7 in proteins (Grimsley, Scholtz et al., 2009) – and a 
relatively weak S-H bond strength in comparison to other heteroatoms (~ 360 kJ mol
-1
 in 
comparison to O-H ~450 kJ mol
-1
), make deprotonation to the thiolate anion (R-S
-
) or 
homolytic dissociation to the sulfenyl radical (R-S
.
) more likely (Block, 1978; Whitham, 
1995). Both these intermediates are more reactive than the parent thiol and may mediate a 
host of univalent (sulfenyl radical) and divalent (thiolate anion) reactions to give the same 
end products – some of which are given in Figure 1.1. 
Aside from histidine (His), Cys has the next closest pKa to physiological pH and this pKa is 
highly attuned to its microenvironment. Positive / negative charge, and dipole interactions 
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can alter the pKa to span over 7 pH units, with the lowest reported  pKa ~ 3 and the highest ~ 
11 (Grimsley, Scholtz et al., 2009). Whilst thiols don’t hydrogen bond as strongly as 
hydroxyls or amines due to the low electronegativity of sulfur in comparison to hydrogen and 
the diffuse nature of non-bonding electrons (making them poor acceptors), they are good 
proton donors in S-H---O bonding (Crampton, 1974; Liu, 1977; Ferrer-Sueta, Manta et al., 
2011; Roos, Foloppe et al., 2013l). Whether the abovementioned interactions are designed to 
alter pKa or nucleophilicity is a contentious issue, however, changes in dipole interactions 
with Cys thiols during catalysis have been shown to increase the rate of reactions in 
peroxiredoxins (Prx), by altering their nucleophilicity independent of their pKa (Fernandes 
and Ramos, 2004). 
Due to the high reactivity of thiols / thiolates and sulfenyl radicals, they may undergo a 
veritable host of nucleophilic and redox reactions with many biological electrophiles to 
generate PTM Cys residues, each having distinct chemical and physical properties to each 
other and to their parent thiol. The majority of these modifications are known to be 
enzymatically or non-enzymatically reversible, often by thiol-containing proteins and / or 
small molecules to regenerate the free thiol. An overview of some biologically relevant Cys 
PTM and particular chemistries relating to their formation and decay are discussed in Section 
1.2. Both one- and two-electron reaction pathways may theoretically result in the formation 
of many of these Cys PTM, and often the exact mechanism of formation is still unclear, but is 
likely to depend on the identity of the reactive species (often unknown) and the environment 
of the thiol.  
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Figure 1.1. A selection of chemical species that may form PTM of the Cys thiol / thiolate / 
sulfenyl radical. Equilibrium arrows denote modifications that are enzymatically or non-
enzymatically reversible to the thiol (potentially multistep reactions). Square brackets denote 
uncharacterised / theoretical intermediates. 
1.1.1. Alkylation of thiols 
The high nucleophilicity and polarisability of thiols / thiolates makes them excellent reactants 
at ‘soft’ carbon centres that are activated by electron withdrawing groups (Liu, 1977; 
Whitham, 1995). Nucleophilic reactions of Cys at carbon centres usually follow one of two 
paths (i) bimolecular nucleophilic substitution (SN2) or (ii) nucleophilic (Michaels) addition. 
The former involves the concerted attack of the thiol / thiolate on the electrophilic carbon 
with the release of a leaving group, whilst the latter involves the addition of the thiol / thiolate 
to an electrophilic alkene or alkyne, generating an alkane where one substituent is a thioether. 
Induction by electron withdrawing groups ‘activates’ the carbon centre / alkene making it 
more electrophilic, with the most prevalent activating group being the carbonyl (aldehydes, 
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carboxylic acids, esters). Other groups include, but are not limited to; halides (-Cl, -Br, -I), 
sulfo- (-SOnR where R can represent either H [for n >1] or an alkyl group), cyano- (-CN) and 
nitro- (-NO2) substituents. Figure 1.2 shows some common biological and non-biological 
alkylating agents and the site(s) of nucleophilic attack by thiols / thiolates (Rudolph and 
Freeman, 2009). 
 
Figure 1.2. Chemical structures of some biologically (1-5) and non-biologically (6-7) derived 
thiol alkylating agents. An asterisk denotes the reactive carbon centre, whilst a hash denotes the 
activating group. 1) 4-hydroxynonenal (HNE), 2) 15-deoxy-∆12,14-prostaglandin J2, 3) 9-nitro-9-trans-
octadecanoic acid, 4) 15-J2t-isoprostane, 5) acrolein, 6) N-ethylmaleimide (NEM), 7) iodoacetamide 
(IAM), and 8) acrylamide. Note, as NEM is symmetric, only one reactive carbon / activating group 
pair is denoted though either may react. 
1.1.2. Oxidation and nitrosation of thiols 
We live in an oxygen-rich environment with oxygen being either the first or second most 
abundant element in the Earth’s oceans, atmosphere and crust. It is the driving force of the 
aerobic metabolism of all higher organisms, with a 4e
-
 reduction potential of 0.815 V at pH 7 
(Ho, Liebman et al., 1995). Sequential single electron reductions will however, result in 
partially reduced or ‘activated’ oxygen species (Figure 1.3), which are more reactive in many 
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single and divalent chemical reactions than dioxygen (O2) – collectively these are termed 
reactive oxygen species (ROS). A brief discussion of some chemistries of the most relevant 
ROS are given below. Whilst thiols will react directly with the ROS mentioned below to 
generate oxidative Cys PTM, it should be understood that ROS will also react with other 
molecules such as lipids and nitric oxide (NO
.
) to generate electrophilic alkylating species or 
reactive nitrogen species (RNS) which will also modify thiols via secondary reactions 
(Rudolph and Freeman, 2009a; Rudolph and Freeman, 2009b). Thus, the diverse reactivity of 
both ROS and thiols lead to a very complex area of research in which mechanisms are often 
poorly understood. 
 
Figure 1.3. Selected pathways to the formation of ROS from O2. Standard redox potentials (E
o
) for 
the sequential 1 electron (e
-
) reduction of O2 to H2O are given, along with possible reaction schemes 
that may form these ROS (unrelated to electrochemical reduction). 
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1.1.2.1. Dioxygen 
O2 is the most common form of oxygen species and whilst it is theoretically quite 
thermodynamically reactive, there are significant kinetic barriers to concerted reaction with 
most molecules due to its triplet ground state (Ho, Liebman et al., 1995). Autoxidation 
reactions between sensitive groups such as thiols and O2 can occur however, by a poorly 
understood mechanism. In autoxidation reactions (Capozzi and Modena, 1974; Liu, 1977; 
Block, 1978; Walling, 1995; Whitham, 1995; Bagiyan, Koroleva et al., 2003) thiols are 
oxidised to disulfides with the uptake of O2; 
4 R-SH + O2  2 R-S-S-R + 2 H2O   .      (1) 
The reaction is base dependant, and is catalysed by transition metals with two or more O.S. 
(Capozzi and Modena, 1974; Block, 1978; Whitham, 1995). One possibility for the 
mechanism of autoxidation is via the formation of peroxyl radicals (ROO
.
) from either radical 
initiation; 
X
.
 + O2 Ý ROO.   ,        (2) 
(where X
.
 is the radical initiator) or decomposition of contaminating peroxides (Walling, 
1995). In the absence of contaminant peroxides and radical initiators, the reaction will still 
proceed, albeit more slowly – indicating ROS production by O2 itself (possibly by hydrogen 
abstraction). Metal ions also significantly increase the rate of autoxidation presumably by 
increasing generation and redox cycling of peroxides to oxyradicals / peroxyradicals 
(Kirkpatrick and Maclaren, 1973; Capozzi and Modena, 1974; Liu, 1977; Block, 1978; 
Walling, 1995; Whitham, 1995; Bagiyan, Koroleva et al., 2003). 
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1.1.2.2. Singlet dioxygen 
Singlet dioxygen (
1
O2) is the excited state of oxygen where electron spins in the π-
antibonding orbital are antiparallel instead of parallel (Foote and Clennan, 1995). 
Photochemical excitation of triplet O2 to 
1
O2 is possible in the presence of a sensitiser, and 
1
O2 is produced in certain chemical reactions, such as that between hypochlorite (ClO
-
) and 
hydrogen peroxide, H2O2 (Foote and Clennan, 1995; Pryor, Houk et al., 2006). 
1
O2 is much 
more reactive than triplet O2 and is able to directly add to alkenes generating alkyl peroxides 
(Foote and Clennan 1995, Morgan, Dean et al. 2002, Davies 2004), which may then go on to 
react with species such as thiols (see Section 1.1.2.4. for more details). 
1
O2 is also a potent 
direct oxidiser of heteroatoms (S, Se, P, N). For thiols the reaction gives a mixture of 
products including disulfides and sulfoxyacids (potentially sulfenamides also), while for 
thioethers it produces sulfoxides, (Devasagayam, Sundquist et al. 1991, Foote and Clennan 
1995, Morgan, Dean et al. 2002, Davies 2004), with the details of these products found in 
Section 1.2. Reactions with both thiols and thioethers are thought to occur via a peroxy-
intermediate that then reacts to give the final products mentioned above (Davies 2004). 
 
1.1.2.3.  Superoxide 
The superoxide anion radical (O2
.-
) results from the single electron reduction of O2 and will 
disproportionate in protic solvents to give H2O2 and O2; 
2 O2
.-
 + 2 H+  H2O2 + O2   ,      (3) 
with this reaction catalysed by the superoxide dismutase (SOD) enzyme (Bielski and Cabelli, 
1995). O2
.-
 can react as both a single electron oxidant and reductant (Bielski and Cabelli, 
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1995) and is thus particularly related to redox cycling of transition metals, as exemplified in 
the Haber-Weiss cycle (Radi, 2013); 
Fe
3+
 + O2
.-
  .OH + -OH + Fe2+   ,      (4) 
which generates reducing equivalents for the Fenton reaction; 
 Fe
2+
 + H2O2  Fe
3+
 + 
.
OH + 
-
OH   .      (5) 
O2
.-
 reaction with thiols is poorly understood, likely due to experimental limitations due to the 
presence of other oxidants, but theoretical calculations indicate the possibility of a bonded 
radical intermediate followed by breakdown to a sulfinyl radical (RSO
.
) 
 O2
.-
 + RSH Ý RS(OOH).-  RSO. + HO-   ,     (6) 
which will likely react to form a disulfide (Oae, Takata et al., 1981; Winterbourn and 
Metodiewa, 1995; Cardey, Foley et al., 2007). O2
.-
 may also react with unsaturated systems 
(such as unsaturated membrane lipids) to generate peroxidised products, although it is unclear 
if this is by direct addition (as for 
1
O2) or via increased generation of other radical 
intermediates that are better at hydrogen abstraction. 
1.1.2.4.  Hydrogen peroxide 
H2O2 is the first non-radical reduced species of O2, and may be generated by 2e
-
 reduction of 
O2 (unlikely) or by disproportionation / single electron reduction of O2
.-
. H2O2 is a good 2e
-
 
oxidant, which reacts to form either water (E
o
 = 1.77 V) or hydroxide (E
o
 = 0.87 V) 
(Dussault, 1995; Pryor, Houk et al., 2006). Single electron reduction of H2O2 in the presence 
of transition metals such as Fe or Cu may give the hydroxyl radical (
.
OH) via Fenton 
chemistry (Eqn. 5). The weak O-O bond of peroxides also allows for the possibility of 
homolytic dissociation; 
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H2O2  2
.
OH   .        (7) 
This is particularly relevant for alkyl hydroperoxides (ROOH) and dialkylperoxides (ROOR), 
which will dissociate to give alkoxyl radicals (RO
.
) that are potent hydrogen abstractors 
involved in the propagation of radical chains; 
R’O
.
 + R-H  R’OH + R
.
   .       (8) 
Significant chemistry may also occur via the peroxyl radical and hydroperoxyl radicals 
(HOO
.
) following hydrogen abstraction; 
ROOH + X
.
  ROO. + XH   ,      (9) 
where X
.
 is a radical initiator. Hydrogen abstraction from peroxides and alkyl peroxides is 
several orders of magnitude faster than from C-H bonds, making them a likely target for 
radicals. Lastly, peroxides may also undergo nucleophilic chemistries such as addition to 
alkenes and substitution with alcohols and epoxides (Dussault, 1995). Such reactions are 
catalysed by acids, bases or metals and generate ROOH / ROOR which may go on to react 
via the radical chemistries discussed above. 
Analogous to the abovementioned chemistry is the reaction pathway involving the sequential 
nucleophilic attack by thiols / thiolates on H2O2 to generate sequentially the sulfenic (RSOH), 
sulfinic (RSO2H) and sulfonic acid (RSO3H) forms of Cys (Luo, Smith et al., 2005); 
RSH + H2O2  RSOH + H2O   ,      (10) 
RSOH + H2O2  RSO2H + H2O   ,      (11) 
RSO2H + H2O2  RSO3H + H2O   .      (12) 
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Notably, these reactions also occur with alkyl hydroperoxides and may occur at accelerated 
rates in comparison to H2O2 (Morgan, Dean et al. 2002, Morgan, Dean et al. 2004). The 
sequential addition of oxygen atoms to the sulfur centre significantly changes the biochemical 
properties of each of these Cys PTM (further discussed in Section 1.2.3). 
H2O2 also has a role in the formation of more potent hypohalous acids (and their derivatives) 
– which are primarily produced by activated neutrophils during the immune response. 
Hypohalous acids are formed by the addition of halides to H2O2 in a reaction catalysed by the 
enzyme myeloperoxidase (MPO); 
H2O2 + Cl
-
  -OCl + H2O   .       (13) 
-
OCl + H
+
 Ý HOCl   .        (14) 
Hypochlorous acid is a potent oxidant and also participates in halide transfer reactions to 
generate species such as chloramines that are also oxidants, and can cause protein 
degradation (Nagy and Ashby, 2007). Similar reactivity is seen with thiocyanate in the MPO 
catalysed reaction to form hypothiocyanite (OSCN
-
) / hypothiocyanous acid (HOSCN); 
H2O2 + SCN
-
  OSCN- + H2O   ,      (15) 
OSCN
-
 + H
+
 Ý HOSCN   ,       (16) 
which are good thiol oxidants (Nagy and Ashby, 2007). Both of these species are seen to play 
important roles in inflammation and antimicrobial defence. 
1.1.2.5.  Hydroxyl radical 
The hydroxyl radical (
.
OH) is the most powerful oxidant discussed, with a standard reduction 
potential (
.
OH / 
-
OH) of 1.9 V and a derived potential in acidic solutions (H+, .OH / H2O) of 
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2.7 V (Bielski and Cabelli, 1995). It may be formed from water by ionizing radiation, from 
H2O2 by photolysis or Fenton chemistry and is also an intermediate in the breakdown of a 
large number of oxidants and nitrating agents, e.g., peroxynitrous acid, ONOOH (Bielski and 
Cabelli, 1995; Pryor, Houk et al., 2006); 
 ONOOH  NO2
.
 + 
.
OH   ,       (17)  
where it may be a major contributor to the oxidising effect of these species. Once formed, 
.
OH will react with almost diffusion limited rates with virtually any molecule it encounters 
usually via hydrogen abstraction (Eqn. 9). Radical addition, especially to aromatic systems is 
also possible. The nonspecific and reactive nature of 
.
OH means that often a range of 
products are formed even when only one target is present, unlike more mild oxidants that will 
largely form only one or two major products (Hawkins and Davies, 2001). For example, 
direct hydrogen abstraction from thiols to form sulfenyl radicals is a possibility as the S-H 
bond is weaker than the C-H bond (Block, 1978; Whitham, 1995), 
R-S-H + 
.
OH  R-S
.
 +H2O   .      (18) 
Sulfenyl radicals can either undergo radical termination (if another R-S
.
 is close) to form a 
disulfide, addition to O2 to form thioperoxyl / sulfinyl radicals (RSOO
.
 / RSO
.
), or to a 
thiolate to generate the disulfide anion radical (Winterbourn and Metodiewa, 1995; 
Winterbourn, 2008; Hawkins and Davies, 2001), 
R-S
.
 + R-S
-
  [R-S-S-R]
.-
   ,       (19) 
which may be reduced by O2 to form the disulfide and O2
.-
, 
[R-S-S-R]
.-
 + O2  R-S-S-R + O2
.-
   .     (20) 
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This is an important example of non-metal based radical cycling that may be promoted by 
thiols. 
1.1.2.6.  RNS 
Nitric oxide (NO
.
) is a kinetically stable radical species that may traverse biological 
membranes and is used as a signalling molecule. Upon reaction of NO
.
 with ROS or 
coordination to metals however, it may form more reactive RNS or metal nitrosyl species 
(Figure 1.4) allowing for diverse nitrosation /nitrosylation reactions with several biological 
species (Fukuto, Cho et al., 2000; Radi, 2004; Carver, Doctor et al., 2005; Pryor, Houk et al., 
2006; Radi, 2013). 
 
Figure 1.4. Selected pathways for the formation of RNS (and ROS) from 
.
NO. Equilibrium arrows 
denote species that are present in equilibrium. 
 
Activation of NO
.
 by transition metal coordination and the formation of metal nitrosyls is 
most studied for iron-heme groups; 
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heme-Fe
3+
 + NO
.
 Ý heme-Fe3+(NO-) Ý heme-Fe2+(NO+)   .  (21) 
This complex is seen to directly nitrosate thiols in haemoglobin to form S-nitrosothiols, 
RSNO; also referred to as SNOs (Fukuto, Cho et al., 2000; Radi, 2004; Carver, Doctor et al., 
2005; Pryor, Houk et al., 2006; Radi, 2013); 
heme-Fe
2+
(NO
+
) + RS
-
  heme-Fe2+ + RSNO   .    (22) 
This process is termed reductive nitrosation (transfer of NO
+
) and the above reaction will be 
in competition with attack by 
-
OH where nitrate (NO2
-
) is formed. Neither of these products is 
particularly deleterious, however, it highlights a potential role of NO
.
 in radical cycling of 
metals, which may lead indirectly to biological damage. 
The reaction of NO
.
 with O2
.-
 to form peroxynitrite (ONOO
-
) is most frequently used to 
explain NO
.
 mediated toxicity (Radi, 2013); 
NO
.
 + O2
.-
  ONOO-  Ý ONOOH   ,     (23) 
ONOO
-
 / ONOOH is both a one and two electron oxidant (and a nucleophile), and may 
oxidise thiols to sulfenic acid; 
ONOOH + RS
-
  NO2
-
 + RSOH   ,      (24) 
with this reaction being about 10
3
 times faster than the corresponding reaction with H2O2. 
ONOOH may decay via homolytic cleavage to nitrogen dioxide (NO2
.
) and 
.
OH (Eqn. 17), 
the former being a potent oxidising agent. Homolytic cleavage occurs rapidly at 37
o
C pH 7.4 
(phosphate buffer) with an expected half life of 0.8 s, but is still slower than many of the 
competing reactions discussed. NO2
.
 may undergo one electron oxidation of thiols (Radi, 
2013); 
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RSH + NO2
.
  RS
.
 + NO2
-
 + H
+
   ,      (25) 
which may be followed by radical termination with NO
.
 to yield SNOs (Madej, Folkes et al., 
2008; Radi, 2013); 
RS
.
 + NO
.
  RSNO   .       (26) 
Acting as a nucleophile, ONOO
-
 can react with carbon dioxide (CO2) to yield the bicarbonate 
radical, CO3
.-
 (Fukuto, Cho et al., 2000; Radi, 2004; Carver, Doctor et al., 2005; Pryor, Houk 
et al., 2006; Radi, 2013); 
ONOO
-
 + CO2  
.
NO2 + CO3
.-
   ,      (27) 
which is a potent one electron oxidant. This highlights the circular nature of the ROS / RNS 
couple as ROS react to form RNS, which may further react to form new oxidising species. 
Another example of this is the reaction of ONOO
-
 with transition metal centres (Me
n+
), and 
their homolysis to form oxo-complexes (Radi, 2013); 
ONOO
-
 + Me
n+
  ONOO-Men+  
.
NO2 + O=Me
(n+1)+
   ,   (28) 
which are again highly oxidising species. 
 
1.2.  Properties of Post-translationally modified Cys 
Alkylation and oxidation will lead to modified Cys residues with vastly differing properties 
to that of the parent thiol. Their reversibility in particular is of interest as this may determine 
whether they are likely to occur as physiological or pathological events. Some modified Cys 
forms are given in Figure 1.1 along with information on their reversibility. It should be noted 
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that within a biological context the most common reductant of these modifications is a thiol 
itself, whether it be a small molecular weight thiol (e.g., GSH) or a thiol-containing enzyme 
(e.g., Prx). 
1.2.1. Thioethers / thioesters 
Thioethers (R-S-R’) and thioesters (R-C(O)-S-R’) result from nucleophilic attack by thiols / 
thiolates on activated carbon centres and do not result in a formal O.S. change in comparison 
to the thiol. Both are however, considerably less reactive than the parent thiol and also more 
hydrophobic. Blocking of the thiol by an acyl or alkyl group removes any ability for S-H 
proton donation in ‘H-bond like’ interactions and also blocks thiolate formation without 
reversal of the modification. The removal of these interactions makes thioethers such as Met 
considered amongst the most hydrophobic of amino acids. 
Thioesters may be formed via condensation with carboxylic acids or via acyl transfer 
reactions such as thiol-thioester exchange (Rudolph and Freeman, 2009): 
R-C(O)-S-R’ + R”-S- Ý R-C(O)-S-R” + R’-S-   .    (29) 
They may be reversed via hydrolysis or acyl transfer to sulfur (as in Eqn. 29) or other 
nucleophiles to yield the thiol / thiolate. Common biological thioesters include S-palmitoyl 
Cys in proteins (Martin, Wang et al., 2012), and acyl-Coenzyme A (CoA) or derivatives 
thereof (e.g. acyl-CoA, acetoacetyl-CoA). 
The formation of thioethers from Cys, also termed ‘alkylation’, usually occurs via 
nucleophilic addition or substitution to activated (i.e., electrophilic) carbon centres (Figure 
1.2). Common biological electrophiles include α,β-unsaturated aldehydes, prostaglandins 
(PG) and nitro-fatty acids (NO2-Fa). Inflammation, oxidative stress and certain dietary / 
lifestyle conditions (e.g., cigarette smoking) can increase concentrations of these electrophilic 
CHAPTER 1: INTRODUCTION 
 
18 
 
species (Feng, Hu et al., 2006). Once formed, thioethers are much less reactive towards 
nucleophilic attack than thioesters, often making their reversal back to a thiol difficult. A few 
enzymatic systems are known to reverse specific forms of alkylated Cys, e.g., prenylcysteine 
lyase may reverse S-farnesyl Cys to Cys (Digits, Pyun et al., 2002; Rudolph and Freeman, 
2009), and some species such as NO2-Fa-Cys are thought to be thiol-exchangeable with 
protein Cys and / or GSH through an unknown mechanism (Batthyany, Schopfer et al., 
2006). Whilst relatively few studies have been conducted it is likely that, with a few 
exceptions, thioether formation is an irreversible process. Whilst thioethers can be considered 
highly stable to most reactions that thiols will undertake, they are still susceptible to 
oxidation to sulfoxides (R-S(O)-R) and sulfones (R-S(O)2-R’). 
 
1.2.2. Disulfides 
An interesting property of sulfur is the relatively strong S-S bond strength of ~ 270 kJ mol
-1
 
versus the O-O or Se-Se bond strengths which are ~ 170 and 184 kJ mol
-1
, respectively (Kice, 
1971). This means that oxidising agents usually convert thiols to disulfides; unlike oxygen 
which will preferentially form carbonyls over peroxides. This bond strength can be further 
strengthened or weakened by increased / decreased overlap of the empty d-orbitals of sulfur, 
leading to a variable bond length for disulfides – average bond length 2.04 – 2.06 Å, but as 
short as 1.88 Å in FS-SF or as long as 2.39 Å in the dithionite anion; 
–
O2S-SO2
-
 (Kice, 1971; 
Capozzi and Modena, 1974; Whitham, 1995). In addition, torsional strain from restricting the 
dihedral angle of substituents of the S-S bond to less than 90
o
 can make for a high energy 
bond, such as that seen in the five-membered ring disulfide of α-lipoic acid where the 
dihedral angle is ~ 30
o
 (Fluharty, 1974). These properties of the S-S bond make it not only a 
highly stable oxidised from of sulfur but also make it geometrically and chemically tuneable. 
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Classically, disulfides have been associated with roles in structural stabilisation and folding 
(Givol, Delorenzo et al., 1965), due to the high thermal and chemical stability of the disulfide 
bond. There is however, increasing evidence that disulfide formation and cleavage has an 
integral role in protein regulation and oxidant sensing (Hogg, 2003; Wouters, Fan et al., 
2010; Lindahl, Mata-Cabana et al., 2011). Some proteins where formation or cleavage of 
disulfides appears to be integral to their function include; apoptosis signal-regulated kinase-1; 
ASK-1 (Nadeau, Charette et al., 2007), p53 tumour suppressor (Sun, Vinci et al., 2003), von 
Willebrand factor (Dong, Thoma et al., 1994), CD4 (Matthias, Yam et al., 2002), coagulation 
/ tissue factor III (Chen, Ahamed et al., 2006) and prion protein (Tabrett, Harrison et al., 
2010). 
Disulfides may be formed oxidatively via higher energy intermediates such as sulfenic acids  
or sulfenyl radicals, or non-oxidatively by thiol-disulfide exchange (TDE; see below). 
Disulfides may exist intra- or inter-protein as well as between proteins and small molecular 
weight thiols (Figure 1.5) such as Cys, N-acetylCys (NAC), GSH (termed S-thiolation / S-
cysteinylation / S-glutathionylation / S-glutathiolation), and the hydrogen sulfide anion (HS
-
, 
termed S-sulfhydration). 
Reduction and interchange of disulfides is mostly achieved via thiol-containing enzymes, 
often utilising vicinal thiol motifs where two Cys are spaced between 2 and 6 residues apart 
in the protein sequence (CX2-6C) – making them highly reactive in TDE reactions. Common 
enzymes involved in disulfide reduction and interchange are thioredoxin (Trx), glutaredoxin 
(Grx) and protein disulfide isomerase (PDI) (Åslund, Berndt et al., 1997). 
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Figure 1.5. Types of disulfides in proteins. These may exist intra-protein, inter-protein or between a 
protein and a small molecular weight (non-protein) thiol-containing molecule e.g., NAC, GSH and 
HS
-
. Note that S-thiolation can be used to describe both S-glutathionylation and S-cysteinylation. 
 
Disulfides may be further oxidised to thiosulfinates, thiosulfonates and disulfide tetroxides, 
see Figure 1.1 (Maclaren, Savige et al., 1965; Savige and Maclaren, 1966). These disulfide 
oxides have increased bond length in comparison to disulfides composed of only di-
coordinate sulfur – which may be due to contraction of d-orbitals with oxidation and / or 
increased electrostatic repulsion (Savige and Maclaren, 1966; Kice, 1971; Capozzi and 
Modena, 1974; Whitham, 1995). These bonds are still susceptible to nucleophilic attack 
which proceeds in the order sulfenyl (-S-) > sulfinyl (-S(O)-) > sulfonyl (-S(O)2-). For TDE 
reactions where S-S bonds contain a single divalent sulfur and a tri- or tetra-coordinate sulfur 
this leads to unsymmetrical cleavage and production of a divalent disulfide and a sulfoxy 
anion (RSOn
-
) (Kice, 1971; Nagy, Lemma et al., 2007). 
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1.2.2.1.  Thiol-disulfide exchange (TDE) 
TDE is the most common reaction occurring in biological systems where thiols / disulfides 
exist in equilibrium, and allows for their exchange using a biologically innocuous reactant 
rather than ‘de novo’ formation of disulfides by ROS / RNS. TDE involves the direct 
nucleophilic attack (SN2-type mechanism) of a thiolate on a disulfide where it may be 
substituted with the release of a new thiolate, Eqn. 31 (Gilbert, 1990; Gilbert, 1995; 
Fernandes and Ramos, 2004; Ferrer-Sueta, Manta et al., 2011), 
R-SH + H2O Ý R-S- + H3O+   ,      (30) 
R-S
-
 + R’-S-S-R” Ý R-S-S-R’ + R”-S-   ,     (31) 
R”-S- + H3O
+
 Ý R”-S-H + H2O   ,      (30) 
______________________________________________ 
R-S-H + R’-S-S-R” Ý R-S-S-R’ + R”-S-H   .    (32) 
The above mechanism would indicate that the pKa of the thiol is the major factor contributing 
to the rate of reaction, and indeed the reaction rate does increase with pH (Gilbert, 1990; 
Gilbert, 1995; Fernandes and Ramos, 2004; Ferrer-Sueta, Manta et al., 2011; Roos, Foloppe 
et al., 2013). In addition as the transition state involves the distribution of charge across the 
S---S---S bond (more concentrated at the entering and leaving thiolates and neutral / slightly 
positive at the central sulfur) the rate is expected to be increased in hydrophobic 
environments (Fernandes and Ramos, 2004; Ferrer-Sueta, Manta et al., 2011). 
Another mechanism is proposed for the addition of a thiol to the S-S bond which may be 
increased in aqueous environments and at lower pH – preventing the adverse effects of highly 
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polar solvents (especially water) on reaction activation energy (due to ion solvation effects 
and the abovementioned charge distribution in the reactants / products versus transition state) 
(Fernandes and Ramos, 2004). The alternate mechanism involves the recruitment of water 
molecules forming a head-to-tail water ‘chain’, connecting incoming and exiting thiols by 
hydrogen bonds i.e. a concerted mechanism (Eqn. 32), which decreases solvent affects and 
increases charge delocalisation in the transition state (Fernandes and Ramos, 2004). 
1.2.3. Sulfoxyacids 
Oxidation of Cys by ROS / RNS, such as H2O2, ONOOH and hypohalous acids, results in the 
sequential formation of the sulfoxyacids; sulfenic acid (R-S-OH), sulfinic acid (R-S(O)-OH) 
and sulfonic acid (R-S(O2)-OH). These sulfoxyacids may also be formed by the scission of 
oxidised disulfides, hydrolysis of SNOs (to sulfenic acid) and by metal-catalysed air 
oxidation in the absence of proximal thiols (Luo, Smith et al., 2005). Due to the high valency 
of sulfur, several resonance structures exist for these sulfoxides however the above 
connectivity indicates the predominant resonance structure (Whitham, 1995). 
Sulfenic acids are amongst the most unstable of Cys forms and are readily hydrolysed back to 
the thiol or can react with proximal thiols to form disulfides (Luo, Smith et al., 2005) – which 
are the primary means of their reversal. They are one of the few forms of Cys which may 
react as an electrophile as well as a nucleophile (Reddie and Carroll, 2008) which makes 
them a suitable intermediate to other, more stable modifications such as disulfides, 
thiosulfinates, nitrosothiols and sulfenamides (R-S-N-R2). The reactivity of these 
modifications to nucleophiles is exemplified in the active site of protein tyrosine 
phosphatases (PTP) where attack by a backbone amide nitrogen (a characteristically 
unreactive species) generates a cyclic sulfenamide, which reversibly inhibits the enzyme – 
Scheme 1.1 (Salmeen, Andersen et al., 2003).  
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As well as their role as an intermediary, sulfenic acids may in themselves constitute a 
regulatory modification if stabilised in a suitable microenvironment of a protein. Suitable 
microenvironments are assumed to largely exclude water and other thiols (to prevent the 
abovementioned hydrolysis / disulfide formation) and to possibly contain charged and polar 
residues, to help stabilise the sulfenic acid with electrostatic / dynamic interactions (Luo, 
Smith et al., 2005). 
Sulfinic and sulfonic forms of Cys are considerably less reactive and more acidic, with Cys 
sulfonic acid (Cys-SO3H) constituting the most acidic modification of protein residues, pKa ~ 
-3 (Lo Conte and Carroll, 2013). Sequential addition of oxygen to the sulfur centre makes it 
less nucleophilic due to increased electron delocalisation, reducing the reactivity of these 
sites (Whitham, 1995). The most pertinent reactivity for the sulfinic acid form is oxidation 
(Eqn. 12) or disproportionation to give thiosulfinylesters and sulfenic acid; 
R-SO2-H + H
+
 Ý R-SO2-OH2+ Ý R-(SO)+ + H2O   ,   (33) 
R-(SO)
+
 + R-SO2-H  R-SO2-O-S-R + H
+
   ,    (34) 
which will further disproportionate to sulfonic acid and an oxidised disulfide (thiosulfinate 
etc). Sulfonic acids are largely considered to be a terminal oxidation state. 
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The role of Cys sulfinic / sulfonic (Cys-SO2/SO3H) modifications in proteins has largely been 
associated with oxidative stress and protein damage rather than regulation; however this has 
come into question for at least the sulfinic acid modification (Lo Conte and Carroll, 2013). 
Two pieces of evidence indicate sulfinic acids may be involved in protein regulation: (i) a 
reductase of sulfinic acids in the active site of peroxiredoxins (Sulfiredoxin; Srx) has been 
identified (Biteau, Labarre et al., 2003) which reduces Cys-SO2H to Cys-SOH in an ATP 
dependant process (Biteau, Labarre et al., 2003; Findlay, Tapiero et al., 2005; Roussel, 
Bechade et al., 2008); and (ii) proteins have been observed where Cys-SO2H at critical 
residues predicates their physiological function, e.g., human DJ-1 protein (Blackinton, 
Lakshminarasimhan et al., 2009), or alters their localisation / quaternary structure, e.g. Prx-
SO2
-
 (Wood, Poole et al., 2002). As no broad spectrum sulfinic acid reductases have yet been 
discovered, whether this is a general or highly specialised regulatory modification remains to 
be discerned. No sulfonic acid reductases have been discovered and occurrence of this 
modification in proteins is still assumed to indicate protein damage. 
1.2.3.1.   Electrophilic chemistry of sulfenic acids 
Sulfenic acids are good electrophiles and nucleophiles, making their chemsity even more 
varied than that of thiols (Whitham, 1995; Reddie and Carroll, 2008; Lo Conte and Carroll, 
2013). This is best exemplified in the formation of a thiosulfinate from two equivalents of 
sulfenic acid; 
2 RSOH Ý R-S(O)-S-R + H2O   ,      (35) 
where one RSOH molecule reacts as the nucleophile and the other as the electrophile in the 
reaction. The electrophilic nature of sulfenic acids can also be harnessed to give specific 
reactions with 1,3-cyclodiones (e.g., 5,5-dimethyl-1,3-cyclohexanedione [dimedone]), which 
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is the predominant method of probing sulfenic acids in the presence of other sulfur species – 
Scheme 1.2 (Saurin, Neubert et al., 2004; Leonard, Reddie et al., 2009). This is the only 
chemoselective technique currently existing for analysis of any thiol PTM as it produces a 
chemically inert thioether product rather than a thiol (see Section 1.5 for further discussion). 
 
1.2.4. Nitrosothiols 
Unlike the previously discussed PTM, which may be formed by the action of ROS or RNS, 
SNO formation predicates the involvement of RNS. SNOs may be formed via the reaction of 
thiols / thiolates / sulfenyl radicals/sulfenic acids with a variety of RNS and / or their 
degradation products including ONOOH / ONOO
-
 and dinitrogen trioxide (N2O3). 
Conflicting reports also indicate nitric oxide (
.
NO) itself may react to form SNOs, although it 
is unclear whether this is only via radical terminations with the sulfenyl radical or via direct 
nucleophilic attack of the thiolate as well (Fukuto, Cho et al., 2000). In addition, formation of 
SNOs may occur via transnitrosylation / nitrosation from more reactive SNOs (Arnelle and 
Stamler, 1995; Dicks, Beloso et al., 1997; Hu and Chou, 2006) or nitrosamines (Peterson, 
Wagener et al., 2007); 
R-S-NO + R’-S- Ý R-S- + R’-S-NO   ,     (36) 
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or via the action of ferric heme nitrosyl species, Eqn. 22 (Radi, 2004; Pryor, Houk et al., 
2006; Radi, 2013). Due to the many pathways potentially present, it is often unclear how any 
individual SNO may have formed.  
As detailed above, SNOs retain the nitrosation activity of 
.
NO but are considerably more 
stable and may serve as an important reservoir of 
.
NO. SNO reduction may occur via 
nucleophilic attack of the S-N bond by thiolates, amines or hydroxyls. Reaction with thiolates 
will generate disulfides (Dicks, Beloso et al., 1997; Williams, 1999) 
R-S-NO + R’-S- Ý R-S-S-R’ + .NO   ,     (37) 
and this reaction will compete with the transnitrosylation / nitrosation reaction above (Eqn. 
36) for simple SNOs, although in a protein microenvironment one product may be preferred. 
S- to N-transnitrosation of secondary amines generates carcinogenic nitrosamines (Peterson, 
Wagener et al., 2007) 
R-S-NO + R’2-NH Ý R-SH + R’2-N-NO   ,     (38) 
while primary amines are deaminated via the facile loss of N2. Thus it is unlikely that these 
reactions will be predominant biological means of SNO reduction, although potentially may 
occur in pathological circumstances. 
Ascorbate (Asc
-
) reduction is used frequently for in vitro reduction of SNOs and may be 
physiologically relevant as concentrations of ascorbate may reach mM in some tissues 
(Noctor and Foyer, 1998). The reaction involves the transfer of NO
+
 to ascorbate to form O-
nitroso-ascorbate and the thiol / thiolate (Williams, 1999; Holmes and Williams, 2000; Gu 
and Lewis, 2007); 
R-S-NO + Asc
-
 Ý R-SH + NO-Asc-    ,     (39) 
CHAPTER 1: INTRODUCTION 
 
27 
 
followed by decomposition of O-nitroso-ascorbate to dehydroascorbate (DHA) and 
.
NO. This 
common reaction is also often performed with the addition of Cu which will mediate the Cu-
dependant decomposition of SNOs that is initially catalysed by ascorbate (Williams, 1999; 
Holmes and Williams, 2000; Gu and Lewis, 2007); 
Cu
2+
 + Asc-  Cu+ + DHA   ,      (40) 
Cu
+
 + RSNO  RS- + NO + Cu2+   .      (41) 
Thiols however, are better reductants of Cu and as they increase in concentration, the Cu
+
 
producing reaction will be (Williams, 1999; Holmes and Williams, 2000; Bagiyan, Koroleva 
et al., 2004; Gu and Lewis, 2007; Prudent and Girault, 2009); 
2Cu
2+
 + 2RS
-
  2Cu+ + RSSR   .      (42) 
It is important to note that the reaction pathway is different to that of the Cu-independent 
reaction (Eqn. 39) as it will quantitatively generate disulfides instead of non-quantitatively 
generate thiols. Any method seeking to identify the newly reduced thiols must take this into 
account. 
 
1.3.  Cysteine in physiology and pathology 
Cys is one of the least abundant residues in protein sequences as it is a relatively late addition 
to the genetic code (Trifonov, 2004), however, it is shown to accumulate more than any other 
amino acid in present day organisms (Jordan, Kondrashov et al., 2005). Once accrued, the 
majority of Cys residues are characterised by an extreme conservation pattern – with paired / 
buried Cys highly conserved and single, solvent accessible Cys poorly conserved (Marino 
and Gladyshev, 2010). This indicates Cys abundance may be controlled by its function rather 
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than physicochemical properties (i.e. polar amino acid). Indeed, Cys residues appear to 
represent highly functional sites in proteins, and Cys mutations in humans more often lead to 
genetic diseases than would be expected on the basis of its abundance (Wu, Ma et al., 2007). 
This dichotomy of Cys within physiology and pathology is largely mediated by the high 
chemical reactivity and the relative ease of formation of Cys PTM. Whilst high chemical 
reactivity is pertinent to the rapid and sensitive reactions necessary in enzyme active sites, 
signalling / regulatory loci and in environmental sensing, it may also lead to high levels of 
unwanted or damaging reactions. 
1.3.1. Structural disulfides 
Disulfide formation is a common PTM especially in secreted and membrane proteins, 
contributing to high structural stability of these proteins in diverse chemical environments 
that may otherwise lead to protein denaturation (Chakravarthi, Jessop et al., 2009; Hell and 
Neupert, 2009; Marino and Gladyshev, 2010; Depuydt, Messens et al., 2011). Native 
structural disulfide formation is the rate-limiting step in protein maturation in the 
endoplasmic reticulum (ER). The ER is significantly more oxidising than the cytosol, and 
contains the necessary chaperones and calcium concentrations to allow for correct protein 
folding (Chakravarthi, Jessop et al., 2009; Depuydt, Messens et al., 2011). The major redox 
buffer GSH exists on the order of 100:1 reduced GSH to oxidised glutathione disulfide 
(GSSG), but in the ER the ratio is approximately 3:1. This allows for the formation of protein 
disulfides by TDE with either GSSG or PDI, with the latter being significantly faster. 
Notably, oxidative protein folding also occurs in the inter-membrane space (IMS) of 
mitochondria and is important for transport into and capture in this compartment, i.e., 
proteins are transported into the IMS in a reduced state, oxidised upon entry and are then 
unable to leave in this oxidised state (Hell and Neupert, 2009). 
CHAPTER 1: INTRODUCTION 
 
29 
 
1.3.2. Metal coordination 
Cys also plays an important role in catalytic and structural metal or metal-cluster 
coordination in proteins, and may coordinate a range of metals including Fe
2+/3+
, Zn
2+
, Cd
2+
, 
Co
3+
 and Cu
+
 (Hansen, Andersson et al., 1996; Dokmanic, Sikic et al., 2008; Marino and 
Gladyshev, 2011:Salama, 1992 #469). When considering its abundance within metal 
coordination spheres relative to its abundance in proteins, Cys is second only to His at these 
sites (Dokmanic, Sikic et al., 2008). Oxidation to sulfenic and sulfinic forms may cause 
increased / decreased metal binding and metal ion exchange, whilst oxidation to disulfides 
abolishes metal ion binding completely – raising the possibility of redox regulation at these 
sites (Jacob, Giles et al., 2003; Marino and Gladyshev, 2011). In addition, Cys is important in 
the formation and incorporation of Fe-S clusters – catalytic centres which are perhaps best 
known for their role in the redox reactions of the mitochondrial electron transport chain 
(ETC) proteins. Cys coordinates heavy metals such as Hg
+
, Ag
+
, Cd
2+
 and Pb
2+
 more strongly 
than any other protein residue due to the diffuse or ‘soft’ nature of its electrons (hard-soft 
acid base theory) and is often implicated in mechanisms of heavy metal toxicity (Salama, 
Abramson et al., 1992; Zalups, 2000; Mondal, Li et al., 2005; Smiri, Nadhida et al., 2013). 
1.3.3. Catalytic Cys 
Catalytic Cys may exist in a wide range of enzymes including oxidoreductases, transferases, 
hydrolases and isomerases, and may exist as either single residues or as pairs (Nagahara, 
2011). Paired residues often indicate that the formation of a disulfide is contained within the 
catalytic cycle of the enzyme (i.e. redox catalysis), whereas single residues may act as pure 
thiolate nucleophiles, i.e. without a change in O.S., or via oxidised intermediates, most 
frequently sulfenic acids. 
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When catalytic Cys residues are paired, they are generally most reactive as vicinal thiols. The 
most common catalytic vicinal thiols exist as CX2C in oxidoreductases such as in the Trx 
family, which involve the formation of an intra-protein disulfide in their mechanism (Gilbert, 
1990; Grauschopf, Winther et al., 1995; Marino, Li et al., 2010). Several oxidoreductases do 
not contain vicinal thiols, but involve catalytic cycles that require certain structural changes 
to bring Cys residues closer together in the 3D structure of the active site e.g., Prx (Rouhier, 
Gelhaye et al., 2002; Wood, Schroder et al., 2003; Bindoli, Fukuto et al., 2008; Smeets, 
Marchand et al., 2008; Hall, Karplus et al., 2009). 
Unpaired Cys residues are used in the active sites of many hydrolases as strong nucleophiles, 
especially when Cys pKa is low enough to ensure almost complete conversion to the thiolate 
at physiological pH. The high reactivity of these Cys residues often makes them susceptible 
to oxidative inactivation (Ziegler, 1985), which may be a biological means of enzyme 
regulation or a consequence of oxidative stress. The lack of a proximal thiol to resolve these 
oxidised residues via a disulfide (which is then reversible by the Trx / Trx reductase system), 
means their catalytic inactivation / reactivation cycle may involve glutathionylation or 
sulfenamide formation, as in the case of PTPs, Scheme 1.1 (Salmeen, Andersen et al., 2003). 
1.3.4. Redox sensing, signalling and regulation 
Whilst some prior evidence existed for regulatory disulfides and oxidative inactivation of 
enzymes containing active site Cys, it was not until the late 1980s / early 1990s when 
evidence for direct oxidant activation of proteins appeared. The nuclear transcription factor 
kappa-B (Nf-ΚB) was shown to be activated by oxidants and inhibited by the antioxidants 
GSH and NAC (Staal, Roederer et al., 1990; Hayashi, Ueno et al., 1993; Flohe, Brigelius-
Flohe et al., 1997), whilst similar studies showed the role of oxidants in the activation of 
activator protein 1,  tumor necrosis factor and in the proliferation of human 
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immunodeficiency virus (Zimmerman, Marafino et al., 1989; Roederer, Staal et al., 1990; 
Kalebic, Kinter et al., 1991; Mihm, Ennen et al., 1991; Peristeris, Clark et al., 1992). Redox 
regulation, signalling and oxidant sensing by Cys is particularly pertinent as the thiol moiety 
is: (i) sensitive to a wide range of oxidants, (ii) able to form stable yet reversible PTM, and, 
(iii) highly modulated by its microenvironment, which may increase / decrease sensitivity or 
infer selectivity. Since these initial studies, the list of cellular processes regulated by oxidant 
modification of Cys has grown and currently covers almost every facet of cell life including 
proliferation, cell cycle arrest, apoptosis, growth factor and cytokine signalling, ion transport 
and metabolism (Kamata and Hirata, 1999; Pomposiello and Demple, 2001; Hidalgo, 
Aracena et al., 2002; Buchanan and Balmer, 2005; Tonks, 2005; Burhans and Heintz, 2009; 
Jones, 2010; Chiu and Dawes, 2012; Stangherlin and Reddy, 2013; Truong and Carroll, 
2013). 
Activation of these processes may be either via direct reactions between target Cys residues 
and ROS / RNS, or via secondary reactions (especially TDE and trans-nitrosation / 
nitrosylation) between oxidised Cys and thiols / thiolates on other proteins (Fig. 1.6). This 
second system essentially allows propagation of the initial ROS / RNS signal ‘non-
oxidatively’ – i.e., utilising the nucleophilic behaviour of Cys alone. This may have some 
advantages in removing any deleterious effects of ROS / RNS. 
The use of oxidants as second messengers and Cys as their modification sites on proteins also 
lends itself to feedback systems that are essentially enzyme independent after the oxidant 
generating step. The penultimate example here is endothelial growth factor receptor (EGFR) 
signalling, where binding of EGF to EGFR stimulates the production of H2O2 – by 
recruitment of an NADH-dependant oxidase (Rao, 1996; Chen, Vita et al., 2001; Reynolds, 
Tischer et al., 2003; DeYulia and Carcamo, 2005; DeYulia, Carcamo et al., 2005). H2O2 may 
directly inactivate / activate downstream targets – including inactivating PTP which would 
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normally inhibit EGFR signalling (Reynolds, Tischer et al., 2003; Salmeen, Andersen et al., 
2003; DeYulia and Carcamo, 2005) – but it also feeds back to increase EGFR signalling (i.e., 
Tyr phosphorylation, pTyr) by sulfenylation of the active site Cys (C797) – i.e., a positive 
feedback loop (Paulsen, Truong et al., 2012). It is important to note however that ROS / RNS 
may also target non-receptor protein Tyr kinases and these will also affect pTyr levels, e.g., 
Src kinase (Devary, Gottlieb et al., 1992; Abe, Takahashi et al., 1997; Yoshizumi, Abe et al., 
2000; Giannoni, Taddei et al., 2010).  
This example shows how short-lived ROS signals may ‘cross-talk’ with other types of 
signalling (in particular protein phosphorylation) to generate long term effects even in 
proteins containing no redox active Cys residues. There is an increasing body of evidence to 
indicate that phosphorylation and redox signalling are intimately linked as many common 
kinase / phosphatase pathways are sensitive to ROS / RNS e.g., mitogen activated protein 
kinase and AMP-activated protein kinase pathways (Torres, 2003; Torres and Forman, 2003; 
Cardaci, Filomeni et al., 2012). 
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Figure 1.6. Selected examples of redox signalling via ROS / RNS modification of Cys residues in 
proteins. Signalling may be via a direct reaction between ROS / RNS (a), via transfer of these PTM 
from a ‘sensor’ to a ‘target’ protein, i.e., indirect (b), and / or redox signalling may involve cross-talk 
with other PTM systems, e.g., phosphorylation. See text for abbreviations. 
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1.3.5. Cellular sources of ROS and RNS 
Until 50 years ago, the concept that cells produced ROS / RNS was hotly debated. In the 
early to mid 1960s, the ‘respiratory burst’ of neutrophils was correctly attributed to the 
production of reduced oxygen species (Iyer, Islam et al., 1961; Selvaraj and Sbarra, 1966) 
whereas previously it was incorrectly attributed to increased mitochondrial respiration 
following its initial discovery (Baldridge and Gerard, 1932). This was the first evidence that 
cells may utilise ROS at least when killing invading pathogens. The discovery of the 
antioxidant enzyme superoxide dismutase (McCord and Fridovich, 1969), whose sole 
purpose seemed to be the scavenging of intracellular O2
.-
, pointed to the fact that reduced 
oxygen species must be produced in cells. Indeed, cells continuously produce ROS and RNS 
as a product of certain enzymatic reactions, as well as a product of aerobic respiration. 
Several enzymes exist to produce ROS and RNS specifically including NADPH oxidase 
(NOX), MPO and nitric oxide synthase (NOS). In addition, some enzymes can produce ROS 
on a conditional basis, such as upon conversion of xanthine dehydrogenase (XD) to xanthine 
oxidase (XO) by thiol oxidation or proteolysis (Stirpe and Della Corte, 1969; Corte and 
Stirpe, 1972). Lastly, but perhaps most pertinent to the broadest number of cell types, is the 
generation of ROS by mitochondria – where ~ 0.2 % of all O2 consumption is diverted to 
ROS generation basally (St-Pierre, Buckingham et al., 2002), with as high as 4 % observed 
under some conditions (Chance, Sies et al., 1979). All of these systems exist to provide 
steady and / or inducible levels of ROS / RNS for normal physiological function and in 
response to stimuli, and increasingly oxidant generation is observed to underlie stress 
response signalling in many organisms. 
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1.3.5.1.  NADPH Oxidase 
NOX are enzymes present in the plasma membrane which utilise NADPH for the single 
electron reduction of O2 to O2
.-
. Assumed at first to be solely present in the plasma membrane 
of neutrophils and involved in the oxidative burst where they can be activated to produce 
extracellular O2
.-
 (in turn used by other enzymes to produce more potent oxidants), NOX has 
now been found at the plasma membrane of many cell types (Lambeth, 2004; Bedard and 
Krause, 2007). In addition, endocytosis allows NOX to exist in the membrane of endosomes 
where it will produce O2
.-
 in the intra-endoplasmic space, which has also been implicated in 
cell signalling (Li, Zhang et al., 2008). It may also present a system of oxidant production in 
the cytoplasm if SOD is present inside endosomes to reduce O2
.-
 to H2O2 and allow 
membrane permeability (Mumbengegwi, Li et al., 2008). It is assumed that O2
.-
 produced by 
plasma membrane NOX is first reduced to H2O2 by extracellular SOD and this may diffuse 
across the membrane. 
There are several isoforms of NOX that have high expression levels in differing mammalian 
tissues, including NOX1 in the colon, NOX2 in phagocytes (intermediate / low in 
cardiomyocytes), NOX3 in the ear, NOX4 in the kidney and blood vessels, NOX5 in lymph 
tissue and testis and DUOX1 and 2 in the thyroid (Lambeth, 2004; Bedard and Krause, 2007). 
It should be noted that the abovementioned tissues are where highest expression has been 
shown, but NOX enzymes are expressed in almost every tissue type, and often the same 
tissue may express several isoforms e.g., the endothelium expresses NOX1, 2, 4 and 5 
(Bedard and Krause, 2007). Common to all enzymes are a NADPH binding site, a flavin 
adenine dinucleotide (FAD) binding site, a heme binding site and (at least) six 
transmembrane domains. Despite these similarities, NOX isoforms differ widely in their 
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mechanism of activation, with some requiring phosphorylation or the binding of differing 
protein subunits or Ca
2+
 (Lambeth, 2004; Bedard and Krause, 2007). 
1.3.5.2.  Nitric oxide synthase  
NO synthase (NOS) enzymes catalyse the synthesis of NO and citrulline from L-arginine in a 
NADPH dependent reaction. NOS enzymes consist of at least three isoforms, termed 
endothelial (eNOS), neuronal (nNOS) and inducible (iNOS) (Knowles and Moncada, 1994). 
The former two are named for the tissues they were first discovered in, whilst the latter is 
induced in a wide range of immune cells e.g., neutrophils and macrophages (Palmer, Ashton 
et al., 1988; McCall, Boughton-Smith et al., 1989). All enzymes require, along with the 
substrates above, four cofactors; flavin mononucleotide (FMN), FAD, tetrahydrobiopterin 
(BH4), and heme, as well as calmodulin – although iNOS does not require Ca
2+
 bound to 
calmodulin and is therefore Ca
2+
 independent (Knowles and Moncada, 1994). The reaction 
also needs O2 as a substrate and NOS can thus generate O2
.-
 and H2O2 in the absence of 
arginine or BH4, suggesting that the mechanism may involve flavin transfer of electrons to O2 
as part of the catalytic cycle (Vasquez-Vivar, Kalyanaraman et al., 1998). nNOS and iNOS 
appear to exist as cytosolic proteins whilst eNOS may exist as both cytosolic and membrane 
associated proteins, with membrane association dictated by a conserved N-myristoylation site 
(Knowles and Moncada, 1994). 
1.3.5.3.  Oxidant generation in the mitochondria 
It is estimated that ~ 90 % of steady state oxidant generation (i.e., not induced) within the cell 
is by mitochondria during oxidative phosphorylation (Balaban, Nemoto et al., 2005). Indeed, 
a common misconception is that these oxidants are purely a by-product of aerobic respiration 
but growing evidence indicates that mitochondrial oxidant generation is a highly regulated 
process that may be increased in response to cellular stimuli including; immunoreceptor 
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ligation, phosphoinositide 3-kinase, Ca
2+
 and cytokine signalling, and hypoxia (Sena and 
Chandel, 2012). Mitochondria also appear to be sensitive to the redox state of the cell, 
specifically the thiol / disulfide state, with increases in disulfide levels increasing ROS 
production (Go, Park et al., 2010). Alternately, decreases in mitochondrial oxidants may be 
accomplished by decreased mitochondrial membrane potential, increased antioxidant levels 
and mitophagy (Sena and Chandel, 2012). 
There are seven major known sites of mitochondrial oxidant production, with all sites 
producing O2
.-
 from single electron reduction of O2 – primarily at flavin or quinone (Q) sites 
or Fe-S clusters (Brand, 2010). In decreasing order of maximum capacity for oxidant 
production they are the ubiquinone-binding sites of complex I (IQ) and III (IIIQ), 
mitochondrial glycerol 3-phosphate dehydrogenase (GPDH), the flavin of complex I (IF), 
electron-transfer flavoprotein-Q oxidoreductase (EFT-QO), pyruvate dehydrogenase (PDH) 
and 2-oxoglutarate dehydrogenase (OGDH) (Brand, 2010). Only two of these are known to 
produce O2
.-
 into the intermembrane space (IMS) of mitochondria (Figure 1.7); site IIIQ and 
GPDH, with the remainder producing O2
.-
 into the mitochondrial matrix (St-Pierre, 
Buckingham et al., 2002; Brand, 2010). Matrix O2
.-
 must be reduced to H2O2 in order to cross 
the inner mitochondrial membrane, which is assumed to occur rapidly as SOD concentrations 
(isoform SOD2) are high, and its reaction rate is virtually diffusion limited, i.e., > 10
9
 M
-1 
s
-1
 
(Rotilio, Bray et al., 1972). O2
.-
 in the IMS is free to diffuse into the cytosol, however high 
concentrations of SOD in the IMS (isoform SOD1) will likely reduce it to H2O2 anyway. 
It is interesting to note that at least three of the sites indicated above exist within the lipid 
bilayer of the inner mitochondrial membrane; IQ, IIIQ and the flavin of GPDH – assumed to 
be the site of production for GPDH (Brand, 2010). This may indicate that oxidant production 
at these sites involves intermediaries such as lipid radicals (L
.
 / LO
.
), lipid peroxyl radicals 
(LOO
.
) and semiquinone radicals, which may then pass electrons to oxygen. This has 
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important considerations for membrane peroxidation under oxidative stress conditions (see 
section 1.3.7.1). 
 
Figure 1.7. Formation of O2
.-
 by mitochondrial proteins at the mitochondrial inner membrane 
occurs at seven sites. Most sites form O2
.-
 in the mitochondrial matrix where it must be reduced by 
SOD to H2O2 in order to cross the inner mitochondrial membrane, although two sites produce O2
.-
 into 
the IMS. Complex IV (blue) is the only place where 4 e- reduction of O2 to H2O2 is favoured. Roman 
numerals are used to denote mitochondrial ETC components (I, III and IV), see text for all other 
abbreviations. 
 
Maximal rates of oxidant production are often estimated in vitro at many of these sites and it 
is thus unknown which site(s) are responsible for physiological or pathological oxidant 
production. Several other sites have been observed to produce oxidants in vitro, but are 
thought to contribute little if at all to biological oxidant production, at least without certain 
genetic mutations, including complex II (St-Pierre, Buckingham et al., 2002; Brand, 2010). It 
is also important to note that O2
.-
 production is suppressed at complex IV, which is the only 
place four electron reduction is favoured (Brand, 2010). 
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1.3.5.4.  Other sources of ROS / RNS  
Several other oxidant producing systems have been observed, most of which are 
oxidoreductases. Notable examples that show cell specific or non-specific distributions 
include MPO, XO, cytochrome P450 (CYP450) and monoamine oxidase (MAO). MPO is an 
important enzyme in host defence to infection and is present in neutrophils (Schultz and 
Kaminker, 1962) producing hypothiocyanous and hypohalous acids, which are potent 
divalent oxidants (Hampton, Kettle et al., 1998; Davies, 2011). XO may be produced from 
XD following thiol oxidation or proteolysis and will produce O2
.-
 from adenine catabolism 
products (Stirpe and Della Corte, 1969; Corte and Stirpe, 1972). XO activity appears to be 
highest in the liver, although activity has been described in the intestine, spleen, heart, brain 
and skeletal muscle (Al-Khalidi and Chaglassian, 1965; Hashimoto, 1974). CYP450 and 
MAO are enzymes with wide tissue distributions although their levels appear highest in the 
liver and brain, respectively. CYP450 and MAO produce ROS particularly under 
pathological conditions (Sandri, Panfili et al., 1990; Zang and Misra, 1993; Kunduzova, 
Bianchi et al., 2002; Maurel, Hernandez et al., 2003), although the exact species is unknown, 
but is most likely O2
.-
 (Zang and Misra, 1993; Bondy and Naderi, 1994) 
1.3.6. Antioxidant systems 
Oxidants are highly reactive signalling molecules with the potential to cause cellular damage 
if not tightly regulated, and thus the cell has also evolved systems of detoxification – termed 
collectively antioxidants. Antioxidant systems include both proteins and small molecules, 
which react with oxidants or oxidised products at high rates to produce less reactive products 
that may then also be recycled (Figure 1.8). 
The key redox buffer of the cell is GSH and its oxidised form GSSG, with GSH existing in 
0.5 – 10 mM concentrations in all tissues (Wendell, 1970; Meister and Anderson, 1983; 
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Ishikawa and Sies, 1984). Altered GSH : GSSG ratios occur in differing compartments of the 
cell, and in response to oxidant production. The rates of direct reaction of GSH with oxidants 
are variable and it is likely this is a path only for very reactive ROS/RNS (e.g., hypohalous 
acids). Alternately, GSH / GSSG may be used as reducing / oxidising equivalents to aid in the 
function of thiol-based enzymes such as PDI, glutathione S-transferase (GST), Grx and Trx 
via TDE reactions. All of these enzymes may act as reduction systems for oxidised proteins 
or as protective systems under oxidative stress (Chance, Sies et al., 1979; Meister and 
Anderson, 1983; Dhalla, Elmoselhi et al., 2000; Bindoli, Fukuto et al., 2008; Winterbourn, 
2008; Ferrer-Sueta, Manta et al., 2011). For example, transfer of GSH equivalents to S-
glutathionylate a protein will help to protect Cys from over-oxidation to Cys-SO2/SO3H and / 
or may activate stress signalling pathways (Sies, Dafre et al., 1998; Chu, Ward et al., 2001; 
Adachi, Weisbrod et al., 2004; Sadidi, Geddes et al., 2005). GSSG equivalents are recycled 
by GSH reductase (GSR). There also exist separate enzyme systems to reduce antioxidant 
enzymes including Trx reductase (TrxR), which get their reducing equivalents from 
nucleotide reductants (e.g. NADH, NADPH, etc). 
In addition to these enzymes, there are systems that react with ROS / RNS directly, instead of 
oxidised proteins. Small molecule antioxidants include ascorbate (vitamin C) and vitamin E, 
whilst antioxidant enzymes include GSH peroxidase (GPx), Prx, catalase (CAT) and SOD 
(Chance, Sies et al., 1979; Meister and Anderson, 1983; Dhalla, Elmoselhi et al., 2000; 
Bindoli, Fukuto et al., 2008; Winterbourn, 2008; Ferrer-Sueta, Manta et al., 2011). Vitamin E 
is present in high concentrations in membranes and is thought to have important roles in 
detoxifying 
.
OH and lipid radicals to prevent lipid peroxidation (Kornbrust and Mavis, 1980). 
Vitamin C is a soluble antioxidant which may act synergistically with vitamin E and reduce 
vitamin E radicals (Packer, Slater et al., 1979), before being recycled itself by 
oxidoreductases. SOD is the detoxifying enzyme for O2
.-
, reducing it to H2O2, whereby Prx, 
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GPx or CAT can reduce it to H2O / O2. Notably, GPx will also reduce LOOH (Thomas, 
Maiorino et al., 1990). Prx and SOD are abundantly and ubiquitously expressed, have high 
rates of reaction with their substrates (> 10
7
) (Rotilio, Bray et al., 1972; Peskin, Low et al., 
2007) and are the major enzymes determining the fate of biologically derived oxidants. The 
question remains however, if the major fate for oxidants is to react with antioxidant systems 
and not downstream targets, how can they ever be used as signalling molecules? Thus it is 
likely that there are other factors affecting the control and action of ROS / RNS. 
H2O2 is by far the most likely candidate as an oxidant messenger as it is membrane 
permeable. Given the high concentrations of Prx and its high reaction rates, there must be 
another mechanism to allow oxidant levels to reach high enough concentrations to be able to 
encounter and modify other proteins. Part of this conundrum is answered by co-localisation 
of oxidant production with protein effectors, which would allow local oxidant concentrations 
to reach sufficiently high levels to modify regulatory sites before being detoxified by Prx. 
Another hypothesis proposed is the ‘floodgate’ theory (Wood, Poole et al., 2003) which 
eventuates form two observations, (i) Prx enzymes are relatively easily inactivated by their 
substrate H2O2 via formation of a Cys-SO2H at their active site (peroxidatic) Cys which 
cannot be reduced by their resolving Cys (2-Cys Prx – see Figure 1.8), and (ii) there has 
evolved a specific reduction system for Prx-SO2
-
 in Srx (Biteau, Labarre et al., 2003; Findlay, 
Tapiero et al., 2005; Roussel, Bechade et al., 2008). It is hypothesised that Prx is so easily 
inactivated by H2O2 that, following its inactivation, H2O2 levels can rise high enough to 
signal to protein effectors before Srx reactivates Prx, which is then able to remove excess 
H2O2 (Wood, Poole et al., 2003). It is interesting to note also that some studies have found 
multiple Prx-SO2
-
 units may aggregate and form higher level quaternary structures (e.g., 
decamers and dodecamers), which may serve functions as chaperones under stress (Wood, 
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Poole et al., 2002; Deponte and Becker, 2005). Prx-SO3
-
 products are as yet thought of as 
dead end products that are removed by proteolysis. 
 
Figure 1.8. The interrelation of selected antioxidant systems in the cell. See text for all 
abbreviations. Central to the figure is the reduction of O2
.-
 to H2O2 by SOD and its subsequent 
reduction to H2O by Prx, CAT, GSH or GPx (which also recycles LOOH). Recycling systems for 
GSSG and oxidised Prx are given (note singly oxidised Prx is recycled by Trx). Trx and GRX are 
reduction systems for disulfide bonded proteins, indicated as ‘target’ protein. 
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1.3.7. Oxidative Stress 
The term oxidative stress is used to describe conditions where oxidant levels surpass those 
that can be controlled by antioxidant systems, causing deleterious modification to essential 
biomolecules. This can be either due to antioxidant depletion / inactivation or increased 
oxidant generation, or likely both. It is also pertinent to note that localised oxidant 
concentrations need to surpass antioxidant levels for a short period of time at least, for redox 
signalling to occur, i.e., the floodgate hypothesis (Wood, Poole et al., 2003), which would 
technically fall under the definition of oxidative stress if only the first condition were met. 
The secondary condition for ‘deleterious’ effects is added in this case to distinguish the 
temporary, mild increase in oxidising environment necessary for oxidant signalling from the 
prolonged, severe increases that are associated with DNA damage, membrane lipid 
peroxidation, cellular apoptosis and necrosis. This highlights again that the role of oxidants in 
biology is a complicated area, depending not only on concentration and time span but also 
species, localisation and availability of antioxidants versus alternate reactants, which may 
generate more potent oxidants. Thus, oxidative stress is also linked intimately to nitrosative 
and electrophile stress, with the likelihood that, under most conditions of global, prolonged 
oxidative stress there will be a combination of all of these stressors. 
Oxidant stress is linked to almost every pathology in mammals either in the development of 
the pathology or in its progression. A more oxidised redox state is also associated with ageing 
and obesity (Elshorbagy, Smith et al., 2012) and is an independent risk factor for the 
development of cardiovascular disease (Go, Park et al., 2010). ROS / RNS can target all 
biomolecules within the cell, although the nature of the species, particularly its reactivity, 
diffusibility and localisation as well as the concentration of reactants, will dictate the actual 
reactions it will undertake (Winterbourn, 2008; Winterbourn and Hampton, 2008). For 
CHAPTER 1: INTRODUCTION 
 
44 
 
instance, 
.
OH has the capability to react with proteins, DNA, RNA, lipids or small molecules 
and is technically membrane diffusible. Given its high reactivity however, its diffusion 
distance is so low (i.e., it will react on first collision) that the reactions it will undertake are 
actually dictated by the localisation of its production. Alternately, H2O2 has a high diffusion 
distance (greater than 1 cell length) and is membrane permeable so it may react relatively far 
from its site of production. The reactions H2O2 will undergo are primarily dictated by its 
reactivity (only appreciable with thiols), the concentration of reactants and the presence / 
absence of transition metal catalysts – thus the most likely reaction will be with Prx. By 
logical extension of this thought, low reactivity oxidants must be produced in high 
concentrations or high reactivity oxidants must be produced in the right localisations to cause 
severe oxidative damage (alternately, secondary reactions forming high reactivity oxidants 
can be catalysed in the right locations). 
Oxidative damage is usually measured via formation of oxidised products of DNA, proteins 
or lipids (Blumberg, 2004; Kadiiska, Gladen et al., 2005). These markers include 8-hydroxy-
deoxyguanosine for DNA damage (Wu, Chiou et al., 2004; Yao, Mei et al., 2004), protein 
carbonylation for protein damage (Dalle-Donne, Rossi et al., 2003; Dalle-Donne, Aldini et 
al., 2006), and isoprostanes, HNE, malondialdehyde and lipid peroxides for lipid oxidation 
(Gutteridge, 1995; Nielsen, Mikkelsen et al., 1997; Montuschi, Collins et al., 2000). It is 
notable that these markers will result from severe and prolonged oxidative stress, whilst 
modifications to reactive sites such as Cys may form with relatively mild or short term 
oxidation and are thus more sensitive. 
1.3.7.1.  Membrane lipid peroxidation 
Radical species that are produced at, or particularly within, the lipid bilayer of an organelle or 
cell membrane are generated into a hydrophobic environment where radical reactions are 
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favoured. Depending on the radical species, they may undergo H-abstraction from activated 
or non-activated sites on lipids (L); 
HO
.
 + L-H  L
.
 + H2O   ,       (43) 
or radical addition to unsaturated systems; 
 HO
.
 + L(C=C)  L(HO-C-C)
.
   .      (44) 
Both will produce lipid radicals (L
.
) that can react with O2 to produce lipid peroxide radicals, 
LOO
.
, or with O2
.-
 to produce lipid hydroperoxides, LOOH (Rudolph and Freeman, 2009). 
The latter often contain weak O-O bonds, which may homolytically dissociate to lipid 
oxyradicals (LO
.
) and 
.
OH, and are also even better sites for H-atom abstraction than 
unmodified lipids, generating LOO
.
 species. This process generates a radical cycle in the 
membrane leading to membrane peroxidation and ultimately dysfunction and 
permeabilisation of the membrane, followed by cell death (Ceconi, Curello et al., 1988; 
Suzuki, Kaneko et al., 1991; Gutteridge, 1995; Eaton, Hearse et al., 2001). In order to 
prevent oxidant damage, membranes often contain hydrophobic radical scavengers such as 
vitamin E which has high affinities for radical electrons and form stable radical adducts – 
essential for the prevention of radical cycles (Kornbrust and Mavis, 1980). It is noteworthy 
that oxidised lipid electrophiles are also used as signalling molecules with the potential to 
modify certain reactive nucleophiles; but these are almost without exception non-radical 
species, although they may have been produced by radical reactions (Rudolph and Freeman, 
2009a; Rudolph and Freeman, 2009b). 
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1.4.  Myocardial Ischemia / Reperfusion 
The heart generates the hemodynamic force to drive the pulmonary and systemic circulations 
and, as such, requires a rich supply of adequately oxygenated blood, supplied to the 
myocardial tissue by the coronary circulation. The O2 demand of the myocardium is 
significantly higher than that of skeletal muscle and any increases in O2 demand must be 
rapidly matched by increases in blood flow, obtained by localised vasodilation. Impairment 
of blood flow through one or more of the coronary arteries will lead to an O2 supply-demand 
imbalance – termed ischemia – and will have a significant effect on the contractile function 
of the myocardial tissue, even after only a few minutes. Constriction and / or blockage of the 
coronary arteries is most commonly caused by atherosclerotic plaque rupture, which leads to 
thrombus formation and arterial occlusion. If ischemia continues for a prolonged period, 
apoptosis and necrosis of myocytes will occur – with prolonged ischemia termed a 
myocardial infarction. Thus, timely intervention is necessary to salvage the myocardium. 
This involves the re-establishment of blood flow through the coronary vasculature – termed 
reperfusion – which is often accomplished through interventions such as thrombolysis, 
percutaneous transluminal coronary angioplasty and coronary artery bypass surgery.  
Even if reperfusion occurs before the onset of myocardial apoptosis and necrosis, there is a 
prolonged period of depressed contractile function following the restoration of blood flow. 
This myocardial dysfunction is attributable to the events occurring in both ischemia and 
reperfusion and is thus most accurately termed ischemia / reperfusion (IR) injury. The 
severity and extent of IR injury is directly related to the length of the ischemic period and the 
extent of oxygen deprivation. Brief ischemia in an area of high collateral blood flow will 
likely lead to mild and reversible contractile dysfunction which will be rectified in a matter of 
hours or days – this is termed myocardial ‘stunning’ (Bolli, 1990; Bolli and Marban, 1999). 
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1.4.1. Biochemical changes during ischemia and reperfusion 
Partial or complete blockage of the coronary arteries will lead not only to the disruption of O2 
supply, but also the disruption to; (i) metabolic substrate supply, (ii) catabolite and toxin 
removal, and (iii) controlled ion exchange. Ischemia is marked by a rapid switch to anaerobic 
glycolysis which is insufficient to meet the high energy demands of the myocardium (Ferrari, 
1995; Buja, 2005). This leads to the depletion of high-energy phosphates (ATP and creatine 
phosphate), followed by adenosine catabolism. The accumulation of purine catabolism end 
products and glycolytic intermediates leads to increased osmotic loading and severe acidosis 
– causing the intracellular pH to drop to 6.7 within seconds and to as low as 5.8 in the case of 
prolonged ischemia (Fleet, Johnson et al., 1985; Jennings, Schaper et al., 1985; Jennings, 
Reimer et al., 1986; Liu, Clanachan et al., 1996; Askenasy and Navon, 1997). Acidosis along 
with inhibition of Na
+
 / K
+
 ATPase during ischemia causes disruptions in ion transport (Fleet, 
Johnson et al., 1985; Jennings, Schaper et al., 1985; Haddock, Woodward et al., 1995; Fuller, 
Parmar et al., 2003 ). First sodium loading occurs via increased Na
+
 / H
+
 exchanger (NHE) 
activity (Jennings, Schaper et al., 1985; Jennings, Reimer et al., 1986; Scholz and Albus, 
1993; Liu, Clanachan et al., 1996; Iwai, Tanonaka et al., 2002; Murphy and Steenbergen, 
2008). This, in combination with inhibition of the Na
+
 / K
+
 ATPase causes reversal of the Na
+
 
/ Ca
2+
 exchanger (NCX) activity and results in calcium loading (Jennings, Schaper et al., 
1985; Jennings, Reimer et al., 1986; Carrozza, Bentivegna et al., 1992; Gao, Atar et al., 
1995; Iwai, Tanonaka et al., 2002; Murphy and Steenbergen, 2008). These increased Ca
2+
 
concentrations may initiate several cascades leading to cellular damage (e.g., protein 
degradation by Ca
2+
-activated proteases), with myofilament proteolysis thought to be 
particularly pertinent to the impairment of contractile function following IR (Mellgren, 1991; 
Matsumura, Kusuoka et al., 1993; Dilisa, Detullio et al., 1995; Yoshida, Inui et al., 1995; 
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Gao, Atar et al., 1997; McDonough, Arrell et al., 1999; Chen, Won et al., 2002; Maekawa, 
Lee et al., 2003; Barta, Toth et al., 2005).  
Most of the major perturbations occurring during ischemia are rectified upon reperfusion. 
The myocyte reverts back to aerobic metabolism, utilising high concentrations of ADP and 
AMP to rapidly increase ATP concentrations, although resynthesis of catabolised precursors 
is slower (Jennings, Schaper et al., 1985; Bolli, 1990; Ferrari, 1995; Bolli and Marban, 1999). 
Metabolites and toxins accumulated in ischemia are removed into the systemic circulation, 
but myocyte and mitochondrial swelling occurs due to the high osmotic load (Jennings, 
Schaper et al., 1985; Jennings, Reimer et al., 1986; Askenasy and Navon, 1997; Murphy and 
Steenbergen, 2008). Intracellular K
+
 concentration is restored with reactivation of the Na
+
/K
+
 
ATPase, although Na
+
 and Ca
2+
 concentrations are further exacerbated with reduction of 
acidosis and increased activity of the NHE and thereby the NCX (Grinwald, 1982; Jennings, 
Schaper et al., 1985; Jennings, Reimer et al., 1986; Corretti, Koretsune et al., 1991; Scholz 
and Albus, 1993; Ferrari, 1995; Liu, Clanachan et al., 1996; Bolli and Marban, 1999; Iwai, 
Tanonaka et al., 2002; Bak and Ingwall, 2003; Buja, 2005; Kaplan, Matejovicova et al., 
2008). The major reperfusion specific event is the rapid and dramatic production of ROS, 
likely leading to oxidative stress of the tissue and further damage (Bolli, Patel et al., 1988; 
Corretti, Koretsune et al., 1991; Ferrari, Ceconi et al., 1991; Kaneko, Masuda et al., 1993; Li, 
McCay et al., 1993; Bolli, Zughaib et al., 1995; Bolli and Marban, 1999; Kutala, Khan et al., 
2007). 
1.4.2. Oxyradical hypothesis of IR Injury 
This dramatic generation of ROS from the introduction of O2 during early reperfusion is the 
core of the oxyradical hypothesis of IR Injury. Investigations of the direct time course of 
ROS generation during reperfusion, in open-chested models utilising electron paramagnetic 
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resonance (EPR) and spin trapping EPR, indicate a ‘burst’ in ROS generation immediately 
upon reperfusion which peaks within the first few minutes (Bolli, Patel et al., 1988; Zweier, 
Duke et al., 1989; Zweier, Kuppusamy et al., 1989; Li, McCay et al., 1993; Bolli, Zughaib et 
al., 1995). Studies indicate the presence of a wide range of radical ROS and RNS including 
O2
.-
, 
.
OH, ROO
.
, alkyl (R
.
), semiquinone and nitrogen centred radicals (Arroyo, Kramer et al., 
1987; Zweier, Kuppusamy et al., 1989; Sun, Kaur et al., 1993). Many studies also show 
depletion of cellular antioxidants (Dhalla, Elmoselhi et al., 2000) and increased markers 
indicative of  biomolecule oxidation including lipid peroxidation products, protein and DNA 
oxidation products (Suzuki, Kaneko et al., 1991; Eaton, Hearse et al., 2001; Eaton, Wright et 
al., 2002; Sadek, Humphries et al., 2002; Canton, Neverova et al., 2004; Chen, Chen et al., 
2008). Administration of enzymatic (e.g., SOD and CAT) and non-enzymatic 
(dimethylthiourea and N-2-mercaptopropionyl glycine [MPG]) ROS scavengers as well as 
metal ion chelators (e.g. desferrioxamine) during reperfusion improves functional recovery of 
the myocardium (Myers, Bolli et al., 1985; Myers, Bolli et al., 1986; Bolli, Patel et al., 1987; 
Bolli, Zhu et al., 1987; Bolli, Zhu et al., 1988; Farber, Vercellotti et al., 1988; O'Neill, 
Charlat et al., 1989; White, Tchen et al., 2006). This evidence has lead to the hypothesis that 
oxidative damage occurring to the myocardium following this ROS burst is a major 
contributor to IR injury.  
1.4.3. Alterations in oxidant handling during IR 
The increased oxidant generation observed during IR is likely due to both alterations 
occurring to oxidant producers (discussed in Section 1.3.5) and the unique metabolite profile 
generated during ischemia. In addition to oxidant production, antioxidant depletion is also 
often observed in the post-ischemic myocardium and is exacerbated during reperfusion. 
Antioxidant enzymes and small soluble antioxidants such as intracellular thiols (GSH, NAC) 
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and vitamin C are frequently observed to be depleted, but some studies also indicate the 
depletion of vitamin E in membranes (Noctor and Foyer, 1998; Dhalla, Elmoselhi et al., 
2000; Dobashi, Ghosh et al., 2000; Serteser, Koken et al., 2002). Thus, the increased oxidant 
levels observed during ischemia will be a summation of both modifications of oxidant 
generators during ischemia and early reperfusion, and the depletion / inactivation of 
antioxidant systems during ischemia. This may go some way to explaining why ischemic 
duration is directly related to recovery during reperfusion even in cases where no cell death 
occurs, i.e., stunning. 
Following ischemia (especially prolonged ischemia), the metabolite profile is dominated by 
depleted energy and biosynthesis molecules such as ATP, GTP and amino acids, and elevated 
levels of their catabolites including hypoxanthine (HX) and xanthine (X). This will lead to 
both a lack of important cofactors and substrates for enzymes, e.g., tetrahydrobiopterin (BH4) 
and arginine for NOS, which leads to decoupling and O2
.-
 production (Vasquez-Vivar, 
Kalyanaraman et al., 1998; Zweier and Talukder, 2006), and increased substrates for alternate 
reaction pathways e.g., XO reaction with X / HX to produce O2
.-
(Al-Khalidi and Chaglassian, 
1965; Ferrari, Ceconi et al., 1991; Laycock, Mcmurray et al., 1993; Becker, vanden Hoek et 
al., 1999; Zweier and Talukder, 2006). In mitochondria, the fully reduced ETC, high 
membrane potential and increased disulfide levels (Becker, vanden Hoek et al., 1999; 
Matsuzaki, Szweda et al., 2009; Go, Park et al., 2010) following ischemia means they are 
primed for the production of large amounts of O2
.-
 following re-oxygenation (Becker, vanden 
Hoek et al., 1999; Sadek, Humphries et al., 2002; de Groot and Rauen, 2007; Halestrap, 
2009). Neutrophil infiltration and activation during IR will also generate high levels of ROS 
via NOX and MPO (O'Neill, Charlat et al., 1989; Ferrari, Ceconi et al., 1991; Zhao, 
Nakamura et al., 2000; Serteser, Koken et al., 2002; Kutala, Khan et al., 2007). Finally, 
release of redox active metals from metal-binding sites in proteins (potentially due to 
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increased ROS and / or proteolysis) may also play a role in redox cycling and 
.
OH 
production, thus explaining the affects of iron-chelation therapies (Bolli, Patel et al., 1987; 
Farber, Vercellotti et al., 1988) 
1.4.4. Oxidative Cys modification of myocardial proteins 
A large range of proteins are oxidatively modified in the myocardium both under basal 
conditions and during pathologies such as IR injury, however, site-specific information is 
often unknown, and given the extent of redox imbalance during IR, the number of proteins 
identifed as oxidatiely modified is relatively small. Proteins with Cys modifications span a 
large range of functional classes, many of which are dysfunctional following IR. These 
include, but are not limited to, proteins involved in metabolism and excitation-contraction 
coupling (ECC) / ion transport. 
Given the large changes to metabolism that occur during IR, it is pertinent to ask whether 
oxidative modification of these enzymes at sensitive Cys residues may be a contributing 
factor. Indeed, it has been known for some time that several enzymes involved in glycolysis, 
oxidative phosphorylation and glycogenolysis are sensitive to the redox environment of the 
cell, particularly GSSG (Ziegler, 1985). Thus it is somewhat unsurprising that metabolic 
enzymes are some of the most frequently observed oxidised proteins in IR. Some pertinent 
examples include the glycolytic enzymes hexokinase, phosphofructokinase, triosephosphate 
isomerase, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and pyruvate kinase; the 
TCA cycle enzymes, aconitase and malate dehydrogenase as well as many members of the 
ETC and ATP synthase (Eaton, Byers et al., 2002; Eaton, Wright et al., 2002; Sadek, 
Humphries et al., 2002; Brennan, Wait et al., 2004; Saurin, Neubert et al., 2004; Sethuraman, 
McComb et al., 2004; Tatarkova, Kaplan et al., 2005; Brennan and Eaton, 2006; Fu, Hu et 
al., 2008; Fu, Wu et al., 2009; Kohr, Aponte et al., 2011; Kohr, Sun et al., 2011; Murray, 
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Kane et al., 2011; Wang, Foster et al., 2011). Additional proteins in the mitochondria are also 
frequently observed, hinting at the fact that mitochondrial ROS production is altered, 
including the adenosine nucleotide transporter (McStay, Clarke et al., 2002; Brennan, Wait et 
al., 2004; Saurin, Neubert et al., 2004; Fu, Wu et al., 2009; Kohr, Sun et al., 2011; Murray, 
Kane et al., 2011) and the voltage gated anion channel, VDAC (Sethuraman, McComb et al., 
2004; Fu, Hu et al., 2008; Kohr, Sun et al., 2011; Murray, Kane et al., 2011). It is noteworthy 
that both of these proteins have been implicated in production of the mitochondrial 
permeability transition pore (MPTP), which may lead to cell death (Crompton, 1999; 
McStay, Clarke et al., 2002; Halestrap, 2009; Halestrap, 2009). It is thought that MPTP 
opening is redox modulated, and is one of the means of oxidant activation of cell death, with 
other pathways including activation of NF-KB (Hayashi, Ueno et al., 1993) and ASK-1. 
Other ion transporters besides VDAC are also redox modified during IR, including the Na
+
 / 
K
+
 ATPase which is known to play a role in ion imbalances during IR (Haddock, Shattock et 
al., 1995; Haddock, Woodward et al., 1995). Transporters involved in Ca
2+
 handling are also 
often observed as redox modified, which may play an important role in the dysfunction of 
ECC following IR, including the sarcoplasmic / endoplasmic reticulum Ca
2+
 ATPase, 
SERCA (Brennan, Wait et al., 2004; Fu, Hu et al., 2008; Fu, Wu et al., 2009; Kohr, Aponte 
et al., 2011; Kohr, Sun et al., 2011), ryanodine receptor, RyR (Stoyanovsky, Murphy et al., 
1997), and L-type Ca
2+
 channel (Lacampagne, Duittoz et al., 1995). Other effectors of ECC 
that are oxidised include myofilament proteins, e.g., actin, myosin, tropomyosin and troponin 
(Eaton, Byers et al., 2002; Eaton, Wright et al., 2002; Sadek, Humphries et al., 2002; 
Brennan, Wait et al., 2004; Saurin, Neubert et al., 2004; Sethuraman, McComb et al., 2004; 
Tatarkova, Kaplan et al., 2005; Brennan and Eaton, 2006; Fu, Hu et al., 2008; Fu, Wu et al., 
2009; Kohr, Aponte et al., 2011; Kohr, Sun et al., 2011; Murray, Kane et al., 2011; Wang, 
Foster et al., 2011). 
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1.5.  Methods in Redox Proteomics 
Most amino acid residues in proteins are susceptible to some form of oxidative PTM, 
although many will only become relevant under conditions generating high levels of 
extremely reactive ROS / RNS e.g., 
.
OH. Cys residues appear to be one of the few that are 
sensitive to relatively low concentrations of relatively inert ROS / RNS and unlike similarly 
reactive sites (e.g., Met), Cys has a diversity of chemical reactivity and PTM forms 
unparalleled by any other residue. These factors have made Cys residues amongst the most 
studied sites in redox proteomics analyses. 
Several methodologies exist with the potential to study Cys residues in proteins, but can 
largely be divided into those that analyse the modifications, (i) intact, which may be termed 
‘non-reducing methods’, or (ii) following reduction to a lower O.S., which may be referred to 
as ‘reducing methods’. Some of these methods lend themselves to large-scale (i.e., shotgun 
proteomics) data, but often at the sacrifice of selectivity and reproducibility. Alternately, 
some methods may provide more reproducible information about a smaller number of 
proteins but at the sacrifice of site specific information or the ability for discovery-type 
experiments. The ultimate methodology for Cys redox proteomics would be robust, sensitive 
and reproducible, and could generate site-specific information about the oxidation state of 
Cys across a large number of proteins. 
An additional question is whether the methodology should follow a particular modification 
type or general modification occupancy (i.e. oxidised versus reduced) independent of the type 
of modification. The former option relies on methodology being specific enough to target this 
modification in the presence of other types of modification (i.e., specificity) and the potential 
for these related modifications to interconvert between one another (i.e., site ‘loss’). Even 
when these can be assured, there will be a dilution of the signal if many modifications occupy 
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that site simultaneously, and it will likely have to be enriched before the modification can be 
observed (if at all). Alternately, monitoring and / or enriching for these Cys sites in a PTM 
independent manner will avoid many of these issues and generally lead to more reproducible 
results, at the expense of losing the knowledge of the exact PTM that occupies the site. 
1.5.1. Non-reducing methods  
Methods to study Cys PTM intact are generally low throughput techniques, which gain 
information about a small number of proteins. These techniques include western blotting 
(WB), two dimensional gel electrophoresis (2-DE), diagonal gel electrophoresis and native 
disulfide mass spectrometry (MS). A number of antibodies exist to specific forms of modified 
residues, e.g., SNOs (Sun, Xin et al., 2001), electrophile modified thiols, e.g., anti-HNE 
(Sayre, Zelasko et al., 1997), and dimedone modified sulfenic acids (Maller, Schroder et al., 
2011; Seo and Carroll, 2011), whilst non-reducing western blots are often used to confirm 
inter-protein disulfides  and glutathionylation (Savitsky and Finkel, 2002). Changes in 
migration during 2-DE have also been utilised to identify proteins containing modified Cys, 
as many involve charged modifications, e.g., sulfoxyacids (Wagner, Luche et al., 2002), or 
mass deviations (e.g., inter-protein disulfide). Diagonal gel electrophoresis (sequential non-
reducing / reducing SDS-PAGE) can also be used to resolve inter- and intra-protein disulfides 
by changed mobility (Sommer and Traut, 1974; Brennan, Wait et al., 2004; Cumming, 
Andon et al. 2004) . The technique involves a first dimension non-reducing SDS-PAGE 
followed by a second dimension of reducing SDS-PAGE, resolving all proteins not 
containing disulfides along a diagonal line, and modified proteins either above (intra-protein 
disulfide) or below (inter-protein disulfide) the line. Fluorescent tags with reactivity for thiols 
(e.g., iodofluorescein, Cy-dye) may be coupled to these techniques with some increase in 
sensitivity through fluorescence imaging. All of these techniques however, offer limited 
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resolution and sensitivity, largely because of the finite total protein capacity and lack of any 
enrichment steps, and furthermore many do not provide site specific information. 
Finally, if the modification is relatively stable (e.g., disulfides or labile modifications 
stabilised by protein conformation) then it may be possible to assign it directly from a mass 
spectrometry experiment where the enriched protein is analysed intact or following digestion 
(Mormann, Eble et al., 2008; Wang, Liu et al., 2008; Wu, Jiang et al., 2009; Clark, Go et al., 
2011; Zhang, Cui et al., 2012). The obvious limitation here is the requirement of a single 
protein mixture, but also there is a possibility that modifications may be lost or inter-
converted, especially if digestion is included. Analysis of a simple concentrated mixture in a 
high sensitivity instrument does however offer the possibility to monitor low stoichiometry 
modifications. 
1.5.2. Reducing methods  
Reducing methods are by far the more common for redox proteomics analyses as they are 
more easily aligned with standard shotgun proteomic approaches. In these methods, Cys 
modifications are reduced using selective or non-selective reductants back to the thiol, and 
labelled and / or enriched for analysis. The choice of reducing reagent and labelling / 
enrichment chemistry is thus of paramount importance. Some selected methods (Jaffrey and 
Snyder, 2001; Hao, Derakhshan et al., 2006; Leichert, Gehrke et al., 2008; Forrester, 
Thompson et al., 2009; Doulias, Greene et al., 2010; Murray, Uhrigshardt et al., 2012)  are 
described in Figure 1.9, and whilst they have largely been developed for SNOs they are 
applicable to most Cys PTM with minor modifications. A recent review (Chung, Wang et al., 
2013) indicates that enriching for SNOs within the same sample type with different 
methodologies – biotin-switch  technique (BST) (Jaffrey and Snyder, 2001) / SNO site 
identification (SNOSID) (Hao, Derakhshan et al., 2006), Cys tandem mass tags (CysTMT) 
CHAPTER 1: INTRODUCTION 
 
56 
 
(Murray, Uhrigshardt et al., 2012) and SNO resin assisted capture (SNORAC) (Forrester, 
Thompson et al., 2009) – results in fewer than 10 % of shared peptide identifications across 
any two methods, and only 1 peptide observed across all three. This lack of reproducibility 
may be due to several methodological concerns, which are discussed in this section. 
The first step in all of the methods described (Figure 1.9) is a step to modify or ‘block’ thiols 
present in the original sample, which is necessary to differentiate them from reduced Cys 
PTM in subsequent steps. This initial modification may be an alkylation reaction, usually 
with a haloalkane / maleimide, or TDE with the reagent methyl methane thiosulfonate 
(MMTS). The former is an irreversible modification to a thioether, whilst the later forms a 
reversible disulfide. The alkylation reaction is not specific to thiols and will also occur at 
other nucleophilic sites such as amines and hydroxyls with variable efficiency depending on 
the reagent and the intrinsic reactivity of the site, which can lead to problems with subsequent 
peptide identification / quantitation. Whilst the reaction with MMTS is essentially thiol 
specific, it has nonetheless come under increasing scrutiny (Forrester, Foster et al., 2009) as 
its reversible nature allows for the exchange of the thiomethane group between free thiols 
present in the sample as well as those that are reduced in the following step (Figure 1.9). As 
the reduction step is also usually performed under basic pH, especially for reagents such as 
ascorbate, this increases the likelihood that exchange of the thiomethane group will occur. 
The necessity to stabilise thiols following the reduction of Cys PTM is also an important 
issue. From Section 1.1-1.2 it is clear that many Cys PTM will interconvert when thiols are 
generated by reduction, especially at neutral / basic pH, and thus methods seeking to 
specifically reduce one PTM may lead to artefact formation. In addition, incomplete 
reduction of Cys PTM will lead to their loss in subsequent enrichment / analysis steps. Thus 
strong reducing reagents with conditions focused on maximising the extent of the reaction 
should be favoured to reduce any loss in signal. 
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Lastly, Cys peptides are generally in low abundance when compared with non-Cys peptides, 
and Cys PTM may only occur on a certain percentage of peptides, thus almost without 
exception reduction must be coupled to enrichment strategies to increase the amount of Cys 
to non-Cys peptides present in a sample prior to analysis – although some level of complexity 
may be gained without pre-enrichment with long fractionation steps and fast instruments  
(Weerapana, Wang et al., 2010). Enrichment techniques should rely on the chemical 
reactions of the thiol and should once again be highly efficient and specific for the thiol over 
other nucleophiles. Some techniques include alkylation with enrichment tags such as biotin 
(Figure 1.9), TDE chemistry and metal ion chelation. 
One interesting technique is the reductive alkylation of Cys-SOH by dimedone (Saurin, 
Neubert et al., 2004; Charles, Schroder et al., 2007; Reddie and Carroll, 2008; Reddie, Seo et 
al., 2008), which in a single chemical step reduces the sulfenic acid and alkylates it, forming 
a stable modification (Scheme 1.2). This technique may be coupled to enrichment if a 
suitable chemical handle is included in the dimedone moiety (Charles, Schroder et al., 2007; 
Reddie and Carroll, 2008; Reddie, Seo et al., 2008), and is relatively insensitive to other 
residues and Cys PTM. One caveat is that as Cys-SOH are so unstable, protein extraction 
steps must be optimised to avoid loss. Proteins must be extracted under non-denaturing 
conditions as Cys-SOH modifications are intimately reliant on their microenvironment for 
stabilisation and may be hydrolysed to the thiol or oxidised to a disulfide otherwise. This 
often presents the problem of accessibility of chemical modifiers, especially those containing 
a bulky enrichment group (Charles, Schroder et al., 2007), however, the advent of smaller 
chemical handles that are coupled in secondary steps to reactive chemical handles (Reddie 
and Carroll, 2008; Reddie, Seo et al., 2008) has gone some way to solving this problem. 
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1.5.2.1. Reducing Agents  
There are several reducing reagents in use to reduce Cys PTM, perhaps most for the cleavage 
of disulfides, which are the most common Cys PTM. When cleaving disulfides this may be 
done symmetrically, yielding two equivalents of thiol from one disulfide, or asymmetrically, 
yielding one equivalent of thiol and one modified species. Strong nucleophiles such as 
cyanide, sulphite (SO3
-
) and hydroxide cleave disulfides asymmetrically, with the formation 
of one equivalent of RSCN, RSSO3
-
 and RSOH (Kice, 1971; Block, 1978; Whitham, 1995; 
Schaumann, 2007), respectively (and one equivalent of thiol). Whilst this was (and still is) 
used for many spectrophotometric assays for disulfides, reagents that cleave symmetrically 
are used much more commonly. It should be noted that mono-thiol reductants such as β-
mercaptoethanol and GSH may be grouped as similar to these asymmetric reagents as they 
cleave disulfides via TDE to form one equivalent of thiol and one of a mixed disulfide 
between the reagent and the original analyte, with a subsequent reaction necessary to reduce 
this mixed disulfide to a thiol. 
Symmetric reduction of disulfides may be achieved by dithiol reagents, phosphines and 
borohydrides (Kice, 1971; Kirkpatrick and Maclaren, 1973; Block, 1978; Whitham, 1995; 
Schaumann, 2007). The main differing factor is the pH necessary for these reactions with 
dithiols preferring neutral to basic pH, phosphines tolerating most pH conditions and 
borohydrides necessitating acidic pH. In addition, whilst dithiols and phosphines are 
relatively specific reductants for sulfur centres, borohydrides are strong reductants of carbon 
centres as well and conditions must be controlled (although this is likely only a problem in 
complex samples containing various biomolecules not just enriched proteins). Whilst dithiol 
species are specific for sulfur centres, they are not however specific for the modification that 
exists there and will reverse RSOH, SNO, RSC(O)R, RSSH, etc. efficiently. 
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There exist a few ‘specific’ reductants including ascorbate for SNO, arsenite for RSOH 
(Saurin, Neubert et al., 2004) and hydroxylamine for RSC(O)R – although  this will also 
reverse O-acetylation rapidly and N-acetylation slowly (Bach, Konigsberg et al., 1988). 
These reactions are all slower and less efficient than the reducing reagents discussed above 
and require basic pH conditions for reactions to occur with any efficiency. It should be noted 
that these reactions will likely lead to loss of signal following the rationale discussed above 
and may be the reason that current methodologies show poor reproducibility, for example in 
the abovementioned comparison (p. 54) all techniques used ascorbate reduction. 
1.5.3. Methods for the enrichment of free thiols 
Once you have reduced Cys PTM to free thiols, enrichment techniques will revolve around 
the chemistry of the thiol. The advantage to this is that thiols are a better chemical handle 
than PTM Cys, in that they can be more easily stabilised than the ‘unstable’ PTM of Cys, 
(e.g., SNO, SOH) but are more reactive than the ‘stable’ PTM (e.g., disulfide). Methods to 
enrich for thiols wish to simultaneously exploit the reactivity of thiols and form more stable 
products during enrichment. These may be thioethers following alkylation, metal-ligated Cys, 
or disulfides following TDE. 
1.5.3.1. Alkylation-based methods 
Alkyation methods exploit the reactivity of Cys in SN2 and Michael addition reactions 
towards activated alkanes / enes, and couple free thiols as thioethers to ‘tags’ for enrichment, 
detection or visualisation. The thiol reactive moiety of these tags is most commonly a 
haloalkane (e.g., iodoacetamide), but may also be a maleimide or other alkene, whilst the 
enrichment moiety is almost always biotin, although fluorescent tags may be preferred for 
gel-based separations (Fu, Hu et al., 2008; Lui, Lipscombe et al., 2010).  
  
 
Figure 1.9. Selected ‘reducing’ redox proteomic methods available in the literature for the analysis of Cys PTM. Methods are colour coded with 
reference to the chemistry utilised for Cys enrichment; alkylation-based (orange), metal-ion chelation (pink), and TDE (blue). See text for referencing.
5
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Many varieties of technique rely on alkylation chemistry including; differential alkylation 
(Schnaible, Wefing et al., 2002; Schilling, Yoo et al., 2004; Held, Danielson et al., 2010), redox 
differential gel electrophoresis (Fu, Hu et al., 2008; Lui, Lipscombe et al., 2010), isotope coded 
affinity tagging, ICAT (Sethuraman, McComb et al., 2004; Fu, Hu et al., 2008; Hagglund, 
Bunkenborg et al., 2008; Fu, Wu et al., 2009; Lin, Li et al., 2010), oxICAT (Leichert, Gehrke et 
al., 2008) and CysTMT (Murray, Uhrigshardt et al., 2012). The methodological details of some of 
these techniques are given in Figure 1.9, with the differences mainly centring on the choice of 
reducing and alkylating reagents and the sample labelling order, e.g., for isotopically coded tags 
one tag may be used per sample (ICAT and CysTMT) or to designate reduced and oxidised Cys in 
the same sample (oxICAT). 
The advantages of these methods are that they are experimentally simple, with well defined steps 
such as streptavidin chromatography and many are available commercially as kits. The main 
caveat is ensuring all free Cys are modified efficiently to the exclusion of other nucleophilic sites 
(i.e., mis-alkylations), especially amines. Most techniques employ basic pH to increase reaction 
rate and extent of reaction but these conditions will also favour mis-alkylation. Alternately, 
methods that utilise expensive tags such as ICAT will have a limited tag to sample ratio and may 
therefore result in incomplete alkylation of free thiols. This may also occur if alkylation is 
performed on the protein level without efficient denaturation, as Cys sites often exist buried within 
protein structure and chemical tags may be sterically hindered from these sites otherwise. 
1.5.3.2.  Metal ion chelation 
These methods utilise immobilised metals to enrich for Cys by exploiting the excellent ligation 
properties of Cys for many metals (Dokmanic, Sikic et al., 2008). Whilst Cys may ligate several 
transition metals (e.g., Zn, Fe) some of these metals are also well ligated by amines and imidazole 
groups, which will ligate preferentially and are in higher abundance in protein sequence (Hansen, 
Andersson et al., 1996). Cys however does ligate heavy metals such as Hg, Pb, Au and Ag with 
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much higher affinity than do other residues due to the diffuse nature of its electrons. Immobilised 
heavy metal affinity, most often with organo-Hg derivatives, is thus most often used for Cys 
enrichments (Guo, Chen et al., 2008; Raftery, 2008; Doulias, Greene et al., 2010; Doulias, 
Tenopoulou et al., 2013). The bonds formed are strong, verging on almost covalent, and will 
stabilise the thiol from further reactions. Metal clusters can be analysed by MS in situ (Guo, Chen 
et al., 2008) or peptides can be eluted using small molecular weight thiols or performic acid 
oxidation (Doulias, Greene et al., 2010; Doulias, Tenopoulou et al., 2013). The interactions 
between the sulfur centre and Hg are so strong that they will also allow for reductive insertion into 
SNO (Doulias, Tenopoulou et al., 2013), thus removing the necessity for reduction, if this 
modification can be suitably stabilised by the peptide. It should be noted though that as reactions 
are similarly strong for thiol ligation, the presence of any residual thiols will give false positives. 
The main caveats of these techniques are the high toxicity and accumulation properties of the 
reagents necessary to synthesise the resins (as resins are not commercially available) and problems 
with elution off the resin, which may lead to peptide loss. 
1.5.3.3.  TDE-based methods  
TDE is by far the most selective chemistry used for thiol enrichment, as only thiols or higher order 
chalcogens – selenols, tellurols – will undergo these reactions, and of these only thiols are 
abundant in biological samples. The chemistry may be exploited for chemical tagging in cell 
culture e.g., Cys-biotin for assessment of S-thiolation (Eaton, Byers et al., 2002), or post tissue / 
cell lysis e.g., pyridyldithio-biotin (HDPD-biotin) for enrichment or immunoblotting, which is the 
basis of thiol labelling in the BST and SNOSID (Jaffrey and Snyder, 2001; Greco, Hodara et al., 
2006; Hao, Derakhshan et al., 2006; Derakhshan, Wille et al., 2007; McDonagh, Ogueta et al., 
2009; Murray, Kane et al., 2011). 
Additionally, TDE has been utilised for TDE chromatography where the resin is functionalised 
with a protected disulfide, usually either a thiopyridine or thiophenol group. This technique has 
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largely been utilised for protein capture following SNO reduction by ascorbate, e.g., SNORAC 
(Forrester, Thompson et al., 2009; Kohr, Aponte et al., 2011; Kohr, Sun et al., 2011). Most 
techniques then characterise the proteins with the loss of any site-specific information, whilst some 
call for on-resin digestion to attempt to identify Cys sites. In these techniques, the high specificity 
of TDE may be belied by steric hindrance when performing protein capture as most spacer groups 
are only about 5 atoms in length, e.g., thiopropyl (Kerr, Schlosser et al., 2013), and also 
interactions with the carrier resin (usually sepharose) are likely to be increased with protein 
capture as well. In addition, on-resin digestion will likely be more inefficient than in-solution 
digestion especially surrounding the resin bound Cys, due to steric constraints, and will lead to 
increased retention of non-Cys peptides by non-covalent interactions with the resin. 
Despite these considerations, capture of peptides following in-solution digestion onto TDE resins 
such as thiopropyl sepharose is sparse in the literature. The main utilisation of this type of 
technique is observed in studies seeking to increase proteome coverage by analysis of Cys peptides 
rather than in the study of oxidised Cys residues per se (Liu, Qian et al., 2004; Liu, Qian et al., 
2005; Liu, Qian et al., 2007). 
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1.6.  Project Rationale and Aims 
Cys represent highly functional sites in proteins and are increasingly observed to be the sites of 
redox-based regulation and dysfunction of proteins by ROS / RNS via Cys PTM. It would be 
advantageous to characterise sites that may be modified during events known to alter the redox 
environment of the cell, in the anticipation that these sites may be integral to the physiological 
function or pathological dysfunction of the cell during times of increased ROS / RNS 
concentrations. 
Despite the interest in identifying and characterising Cys PTM, the area is hampered by the lack of 
methodologies for their enrichment, which are compatible with high-throughput peptide 
identification and / or quantitation. Additionally, conflicting results from differing methodologies 
– likely due to irreproducible methods and sample loss during preparation and enrichment – will 
lead to a lack of information and unreliable quantitation. Any method of enrichment should seek to 
reproducibly, linearly and robustly enrich for these sites or, alternately, deplete non-PTM Cys 
sites. 
Thus the aims of this project were to; 
1. Define extraction conditions that preserve Cys in their biological state, utilising alkylation 
chemistry to modify biologically free thiols - following optimisation to ensure efficient 
thiol alkylation whilst minimising mis-alkylation of other nucleophiles. 
2. Optimise a global method of Cys peptide enrichment based on the chemistry of TDE and 
assess parameters essential to reproducible and robust capture, including reaction 
efficiency for thiol capture, linearity of capture with loading and relative depletion of non-
Cys peptides. 
CHAPTER 1: INTRODUCTION 
 
65 
 
3. Capture reversibly modified Cys peptides from myocardial tissue and assess both the 
likelihood that these were originally modified in the myocardium, and whether this 
technique represents a significant advantage over alternately available methodologies. 
4. Develop a method to detect irreversibly modified Cys peptides which would not react via 
TDE chemistry and would thus not be profiled by the above technique. 
5. Adapt the technique(s) to a quantitative multiplexed analysis of alterations in Cys PTM 
occurring during brief IR of the myocardium, and during rescue of functional recovery by 
antioxidant therapy in reperfusion. 
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MATERIALS AND METHODS 
 
 
2.1. Reagents and chemicals  
Methanol, chloroform, Tris-HCl, potassium chloride (KCl) and sodium / potassium 
dihydrogen orthophosphate (KH2PO4 / NaH2PO4) were purchased from Ajax Finechem 
(Sydney, Australia). Sequencing grade porcine trypsin was purchased from Promega 
(Madison WI). All other chemicals were purchased from Sigma-Aldrich (St. Louis MO) 
unless otherwise stated. 
 
2.2. Tissue generation and handling 
All animal studies were approved by the Animal Care and Ethics Committee, the University 
of Sydney (reference: K20/4-2011/3/5517). Lewis rats were euthanized with pentobarbital 
(200 mg kg
-1
), the heart rapidly excised and subjected to Langendorff perfusion with non-
recirculating Krebs buffer as previously described (Parker, Palmisano et al., 2011), and 
contractile function was assessed by insertion of a latex balloon attached to a pressure 
transducer into the left ventricle. Following a 20 min stabilisation period (baseline) hearts 
were randomised into one of four protocols (n=3 per protocol): (i) 30 min of perfusion (non-
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ischemic time control, NITC), (ii) 15 min of global no-flow ischemia (15I), (iii) 15I with 15 
min of reperfusion (IR), or (iv) IR with the addition of 1 mM MPG to the reperfusion buffer 
(IR + MPG). At the completion of the protocols, hearts were snap-frozen in liquid nitrogen 
and stored at -80
°
C prior to pulverisation under liquid nitrogen by mortar and pestle. Samples 
were acquired in biological triplicate. 
 
2.3. Myocardial protein extract preparations 
2.3.1. General tissue extraction protocol 
Frozen tissue was homogenized (Omni International, Kennesaw GA) in 100 mM NaH2PO4, 
pH 6, 10 mM NEM, 1% (w/v) sodium dodecyl sulfate (SDS), 1 mM phenylmethylsulfonyl 
fluoride (PMSF), 1 µM aprotinin, 20 µM leupeptin, 1.5 µM pepstatin A and 2 mM 
diethylenetriamine pentaacetic acid (DTPA). The homogenate was centrifuged at 13000 × g 
for 15 min at 4
°
C and the supernatant removed. Additional homogenization buffer was added 
to the pellet, and the pellet underwent 2 × 30 s cycles of tip-probe sonication (Branson, 
Danbury CT), followed by centrifugation at 13000 × g, 15 min, 4
o
C. The supernatants were 
pooled and NEM added to a final concentration of 30 – 40 mM for no more than 10 min, 
25
o
C.  
2.3.2. Soluble / native tissue extraction  
Frozen tissue was homogenized as above in the absence of NEM and SDS. The homogenate 
was centrifuged at 13000 × g for 15 min at 4
°
C and the supernatant removed. No tip-probe 
sonication / alkylation was undertaken. 
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2.3.3. Additional preparative steps for qualitative analysis 
Following Section 2.3.1, samples underwent chloroform / methanol precipitation as 
previously detailed (Wessel and Flugge, 1984), to remove SDS and unreacted NEM. 
2.3.4. Protein derivatisation for quantitative analysis 
Following Section 2.3.1, 25 mM dithiothreitol (DTT) was added to quench the NEM. The pH 
was adjusted to between 7 and 8, and proteins were reduced for 1 hr, 25
o
C. DTT was 
quenched and free thiols were reversibly modified with 60 mM MMTS (diluted 1 : 10 in 
acetonitrile [MeCN]) for 1.5 hr at 30
o
C. Proteins then underwent chloroform / methanol 
precipitation (Wessel and Flugge, 1984). 
 
2.4. Spectrophotometric assay by 4,4’-dithiodipyridine 
4,4’-dithiodipyridine (DTDP) stock solution (for Section 2.4.1) is 8.8 mg DTDP resuspended 
in 300 µl of 400 mM hydrochloric acid (HCl) and then diluted to 12 mM HCl (4 mM DTDP). 
More concentrated solutions can be made utilising the same ratios (for Section 2.4.2). 
2.4.1. Thiol assay following extraction 
Protein samples were resuspended in DTDP sample buffer (100 mM NaH2PO4, 0.2 mM 
ethylenediaminetetraacetic acid [EDTA], 1% (w/v) SDS) and heated at 80
o
C for 15 min and 
then diluted to a final volume of 1.2 ml with DTDP assay buffer (100 mM NaH2PO4, pH 6, 
0.2 mM EDTA). The assay was performed as previously described (Riener, Kada et al., 
2002) with all volumes adjusted for the decreased assay volume.  Briefly, the absorbance at 
324 nm of the diluted protein sample was measured prior to addition of DTDP (A324p), as 
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well as the absorbance of the DTDP stock solution (50 µl in 1.25 ml assay buffer) alone 
(A324r). The absorbance of the protein solution at 280 nm was taken in order to normalise for 
sample loss during precipitation. DTDP stock solution (50 µL) was added to the diluted 
protein sample and the reaction was considered complete when the A324 reading was 
constant over 5 min (A324s). Thiol concentrations were calculated by the subtraction method 
detailed by (Riener, Kada et al., 2002) using an extinction coefficient of 21450 M
-1 
cm
-1
 
determined for 4-thiopyridine (4-TP)  resuspended in SDS (Figure 1.2). 
 
Figure 2.1. Extinction coefficient determination for 4-TP in the presence of SDS (0.2%). 
Determination was in the presence of DTT as a reducing agent. Absorbance is increased from the 
value at 0% SDS – 21069 M-1cm-1 
 
2.4.2. Free thiol / free protein thiol assay during extraction 
Frozen tissue (~ 30 mg) was homogenized (Omni International) in 100 M NaH2PO4, pH 6, 
containing 20 mM DTDP, 1% (w/v) SDS and 2 mM DTPA. The homogenate was centrifuged 
at 13000 × g for 15 min at 4
°
C and the supernatant removed before heating at 80
o
C for 5 min. 
An aliquot of the resultant protein solution was diluted in DTDP assay buffer and the 
absorbance read at 324 nm (dilution such that absorbance < 1 unit) – to assay total free thiol 
in the sample. The remaining protein extract (undiluted) was subject to chloroform / methanol 
precipitation (Wessel and Flugge, 1984), and the resultant pellets were resuspended in DTDP 
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sample buffer, followed by reduction with 20 mM dithiothreitol (DTT) for 0.5 hr at 57
o
C. 
The reduced extract was diluted as above, and the absorbance at 324 nm taken – to assay 
protein free Cys. All absorbance measurements were made in quadruplicate, and all values 
were adjusted for protein concentration following Quant-iT protein assay (Invitrogen, 
Carlsbad CA). Where biological replicates were present, they were assayed separately and the 
reported values are a weighted average of these. 
 
2.5. Protein digestion and solid-phase extraction of peptides 
Protein pellets were resuspended in 50 mM NaH2PO4, pH 7.5 and underwent trypsin 
digestion for 16 hr at 37
o
C with a 1: 25 ratio trypsin : protein sample. The digest was 
acidified to pH < 3 (formic acid [FA]) and 0.1 % trifluoroacetic acid (TFA) added before 
concentration and desalting of peptides by solid phase extraction (SPE) on hydrophilic 
lipophilic balance cartridges (Waters Corp., Milford MA). The eluent was evaporated to 
dryness. For qualitative Cys PTM analysis (i.e., no iTRAQ), tributylphosphine reduction 
(TBP; 10 mM, 30 min room temperature) was conducted prior to acidification and SPE 
cleanup (above). 
 
2.6. iTRAQ labelling reaction 
Peptides were resuspended in 0.5 M triethylammonium bicarbonate, pH 8.5, with 0.1 % (w/v) 
SDS and quantified by Quant-iT assay (Invitrogen). For each sample 180 µg was subject to 
labelling with 4-plex iTRAQ as per the manufacturer’s instructions, for 2 hr at 25oC, ensuring 
the final organic percentage was > 70 % and the reaction pH was > 7.6. The reaction was 
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quenched and any O-acetylation reversed with 0.5 M hydroxylamine for 1.5 hr at 25
o
C. The 
four labelled samples were pooled before drying the combined solution volume by ¾ to 
reduce the organic concentration. The labelled peptides were reduced with 10 mM TBP, 25
o
C 
for 30 min, before acidification and dilution to > 1 mL with 0.1 % TFA for SPE cleanup as 
detailed above. 
 
2.7. Protein / peptide oxidation strategies 
2.7.1. Performic acid oxidation 
Performic acid oxidation was performed on Bovine serum albumin (BSA, 1 mg / ml), or 
peptide digest (following Section 2.5 without TBP reduction). Performic acid was prepared 
by combining 1:19 parts H2O2 to FA and mixing at room temperature for 1 hr. Protein / 
peptide sample was resuspended in FA and 3 volumes of performic acid were added. The 
reaction was incubated on ice for 2.5 hr, before adding 5 volumes of Milli-Q water and 
evaporating to dryness. Protein samples were digested as indicated in Section 2.5., whilst 
peptide samples were resuspended in MQ H2O (low volume) and analysed as detailed in 
Section 2.8.3. 
2.7.2. H2O2 oxidation 
H2O2 was added to the supernatant from Section 2.3.2 to give a final concentration of 100 
nM, 10 µM, 100 µM or 10 mM and incubated at 25
o
C for 1 hr followed by reduction with 
dithiothreitol (DTT) for 1 hr at 25
o
C. Proteins then underwent chloroform / methanol 
precipitation (Wessel and Flugge, 1984) to remove protease inhibitors before resuspension, 
trypsin digestion and SPE cleanup, as detailed above. 
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2.8. Cys PTM peptide enrichment techniques 
2.8.1. TDE chromatography 
Thiopropyl-sepharose 6B beads were rinsed in Milli-Q water (6 ml per 30 mg beads) and 
then with 100 mM NaH2PO4, pH 7.5 (3 ml). Samples were resuspended in TDE loading 
buffer (100 mM NaH2PO4, pH 7.5, 0.5% (w/v) SDS, 1 mM DTPA), applied to the resin and 
allowed to bind at room temperature for 2 hr with gentle tumbling. The resin and captured 
peptides were washed twice with 0.5 ml of TDE loading buffer for 10 min and then 7 times 
with 1 ml 100 mM NaH2PO4, pH 7.5 for 5 min each. Captured peptides were eluted with 5 x 
200 µl of 10 mM DTT in 10 mM NaH2PO4, pH 7.5, each for 15 min. The unbound fraction 
and first two washes were combined, desalted by SPE and either analysed, or applied again to 
the TDE method. Elution fractions were pooled and desalted by SPE. Those samples destined 
for two-dimensional liquid chromatography (2DLC) fractionation underwent additional 
alkylation (with 30 mM iodoacetamide) before SPE desalting. 
2.8.2. TDE chromatography – iTRAQ labelled peptides 
Undertaken as above, on 100 mg of beads, with the [SDS] in the initial binding and first wash 
increased to 0.75 % (w/v), second and third washes were in 0.5 % (w/v) SDS. 
2.8.3. Strong cation exchange (SCX) for the enrichment of Cys-SO2H/SO3H 
Peptide samples (5 µg BSA / 25 µg performic oxidised extract / 75 µg all other samples) 
were diluted in 2 ml SCX loading buffer (5 mM KH2PO4, pH 2.5) and loaded onto an SCX 
cartridge (AB Sciex, Framingham MA) equilibrated with the same buffer (3 ml). The flow-
through (FT) was collected and the cartridge washed with an additional 1 ml SCX loading 
buffer, which was pooled with the FT. The cartridge was then washed with SCX organic 
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wash buffer (5 mM KH2PO4, pH 2.5, 25 % MeCN) and this was collected separately (fraction 
‘MeCN’). Retained peptides were eluted (each 1 ml) with varying concentrations of 100% 
KCl buffer (5 mM KH2PO4, pH 2.5, 25 % MeCN, 500 mM KCl) diluted in organic wash 
buffer to either 4 (10, 25, 40 and 100 % KCl) or 14 (1, 5, 10, 15, 20, 25, 30, 40, 50, 60, 70, 
80, 90 and 100 % KCl) salt steps. All fractions containing MeCN were dried by ~ ½ - ¾ to 
reduce the MeCN concentration and then diluted with 0.1 % TFA to > 1 ml before 
concentration and desalting by SPE as detailed above. Fractions were subject to HILIC 
fractionation. 
 
2.9. Peptide fractionation techniques 
2.9.1. Offline hydrophilic interaction liquid chromatography (HILIC) 
Fractionation was performed on an Agilent 1200 series capillary-LC system (Agilent 
Technologies, Santa Clara CA). Samples were resuspended in HILIC buffer B (90% MeCN, 
0.1% TFA) and separated on a home-packed column (3 µm, 20 cm x 320 µm, 100 Å pore 
size) of TSKgel Amide-80 beads (Tosoh, Tokyo, Japan) using a gradient of 0 – 70 % HILIC 
buffer A (0.1 % TFA) for 29 min at a flow rate of 6 µL min
-1
. 
2.9.2. SCX for iTRAQ-labeled TDE unbound peptides 
TDE unbound peptide samples (90 µg) were diluted in 2ml SCX organic buffer and loaded 
onto an SCX cartridge (AB Sciex) equilibrated with the same buffer (3 ml), the FT was not 
collected. The peptides were washed with an additional 2 ml SCX organic buffer (not 
collected), before retained peptides were eluted (salt steps: 5, 10, 15, 25, 40 and 100 % KCl) 
and cleaned up as detailed in Section 2.8.3. 
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2.10. Liquid chromatography tandem mass spectrometry analysis 
Liquid chromatography tandem mass spectrometry (LC-MS/MS) was performed using either 
(i) a QSTAR Elite (AB Sciex, Foster City CA) mass spectrometer coupled online to an 
Agilent 1100 series nano-LC system (Agilent Technologies), (ii) a LTQ Orbitrap Velos 
(Thermo Scientific, Waltham MA) mass spectrometer coupled online to a Dionex UltiMate 
3000 HPLC system (Dionex, Sunnyvale CA), or (iii) a 5600 Triple TOF (AB Sciex) coupled 
online to an Eksigent nanoLC Ultra (Eksigent, Dublin CA) . 
2.10.1. QSTAR Elite 
Samples were resuspended in buffer A (0.1% FA), trapped on a Zorbax 300SB-C18 trap 
column (5 µm, 5 x 0.3 mm; Agilent Technologies) and separated on a home-packed reversed 
phase (RP) column (3 µm, 15 cm x 75 µm, 120 Å pore size) of ReproSil-Pur C18 AQ beads 
(Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) using the following gradients; (a) 5 – 
40 % buffer B (99.9 % MeCN, 0.1 % FA) for 105 min at 300 nl min
-1
, or (b) 5 – 60 % buffer 
B (99.9% acetonitrile [MeCN], 0.1% FA) for 110 min at a constant flow rate of 300 nl min
-1
. 
The QSTAR Elite was operated in data-dependant positive ion mode with a selected range of 
350 – 1850 m/z. The 5 most intense ions from each MS scan (charge states 2+ to 4+) were 
selected for collision-induced dissociation (CID) fragmentation, with rolling collision energy 
enabled and a dynamic exclusion of 30 secs. Raw data were viewed and scripted to Mascot 
generic format (.mgf) in either Analyst 2.0 (AB Sciex) or Mascot Distiller (Matrix Science, 
London). 
2.10.2. Orbitrap Velos 
Samples were resuspended in buffer A (0.1% FA), trapped on a ChromeXP trap column (3 
µm, 3.5 x 0.5 mm; Eksigent)  and separated on an in-house RP column (3 µm, 150 cm x 75 
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µm, 120 Å pore size) of ReproSil-Pur C18 AQ beads (Dr. Maisch GmbH) using the following 
gradients; (a) 0 – 60 % buffer B (90 % MeCN, 0.1% FA) for 39 min, (b) 0 – 60 % buffer B  
69 min, or (c) 0 – 45 % buffer B for 50 min, at 250 nl min-1. The LTQ Orbitrap Velos was 
operated in data-dependent positive ion mode with a m/z range of 350 – 2000. The 20 most 
intense ions with charge states 2+ to 4+ were selected for CID fragmentation, or alternately 
the 4 most intense ions with charge states 2+ to 4+ were selected for both higher-energy 
collisional dissociation (HCD) and CID fragmentation, in an alternating manner (i.e., 8 
MS/MS per MS for 4 precursors). Settings were as follows: normalised collision energy of 35 
for CID or 45 for HCD, accumulation time 150 ms for CID or 300 ms for HCD and a 
dynamic exclusion window of 30 secs. Raw data were viewed in Xcalibur (Thermo 
Scientific) and scripted to .mgf in Mascot distiller (Matrix Science). 
2.10.3. 5600 Triple TOF 
Samples were resuspended in reverse phase buffer A (0.1% FA), trapped on a ChromeXP 
trap column (3 µm, 3.5 x 0.5 mm; Eksigent) and separated on a home-packed column (3 µm, 
15 cm x 75 µm, 120 Å pore size) of ReproSil-Pur C18 AQ beads (Dr. Maisch GmbH) at 2 – 
35 % reverse phase buffer B (99.9 % MeCN, 0.1% FA) for (a) 45 min (TDE elute and 
unlabeled samples), or (b) 75 min (TDE unbound), at 300 nl min
-1
. The instrument was 
operated in data-dependent positive ion mode with a m/z range of 300 – 2000 with the 12 
most intense precursor ions (top 15 for unlabeled samples) with charge states 2+ to 4+ 
selected for CID fragmentation, with MS/MS transient summing for 250 or 150 ms for 
iTRAQ labelled and unlabeled peptides, respectively (MS sum 50 ms irrespective). Dynamic 
exclusion was enabled with a 6 s window. Raw data were scripted to .mgf in Mascot distiller 
(Matrix Science, London, UK). 
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2.11. Selected reaction monitoring (SRM) 
Proteotypic peptides and transition pairs for each peptide precursor were designed from 
identified MS/MS spectra, and included the most abundant fragment ions. Transition 
verification was performed on a 5500 QTRAP (AB Sciex) mass spectrometer operated in 
unscheduled SRM mode with triggered MS/MS for each targeted precursor mass to verify 
peptide identity (other settings as below). The most intense transitions for each precursor 
were accepted (3 to 4 transitions per precursor, monitoring NEM-modified and unmodified 
peptide pairs). Following transition optimisation, samples were randomised within each 
replicate batch (n=3), resuspended in buffer A (0.1% FA) and injected (approximately 0.5 µg 
of peptide) onto an Eksigent nanoLC (Eksigent, Dublin CA). The sample was trapped on a 
Zorbax 300SB-C18 trap column (5 µm, 5 x 0.3 mm; Agilent Technologies) prior to separation 
on an in-house analytical column (3 µm, 17 cm x 75 µm, 120 Å pore size) packed with 
ReproSil-Pur C18 AQ beads (Dr. Maisch GmbH), coupled to a PicoFrit column Tip (New 
Objective, Woburn MA). Peptides were separated for 10 min on a gradient of 0 – 40% buffer 
B (99.9 % MeCN, 0.1 % FA) at a flow rate of 250 nl min
-1
. Eluted peptides were analysed on 
the 5500 QTRAP equipped with a nanoelectrospray source with an applied voltage of 2200 
V. The mass spectrometer was operated in scheduled SRM mode with the following 
parameters: detection window 2.5 min, curtain gas 20, ion source gas 13, declustering 
potential 80 and unit resolution of Q1 and Q3. Peak integration was performed in Skyline 
(MacLean, Tomazela et al., 2010) and was manually reviewed. The logarithm of the ratio 
between NEM-modified (N) and unmodified (n) peaks was calculated to correct for 
differences in loading and digestion. Absences of the NEM-modified or unmodified peaks 
were denoted as log2(N/N0) ratios of -12 and 12, respectively. Variations in retention time and 
intensity within and between replicate batches were monitored by interspersed injections of a 
50 fmol BSA peptide digest. 
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2.12. Matrix-assisted laser desorption ionization Time-of-flight 
MS (MALDI-TOF MS) 
 BSA tryptic peptides were added to α-cyano-4-hydroxy cinnamic acid matrix (8 mg / ml in 
70% acetonitrile [MeCN] / 1% formic acid [FA]) directly onto a target plate. Peptide maps 
were generated by MALDI-TOF MS using a Voyager DE-STR mass spectrometer (Applied 
Biosystems, Foster City CA). Spectra were examined in Data Explorer (Applied Biosystems) 
and mass calibration performed using external calibration with the Sequazyme™ kit (Applied 
Biosystems). Peak lists were generated by manual interrogation of the spectra. Data were 
compared with a theoretical tryptic digest of the BSA sequence from the UniProt database 
(entry: P02769; ALBU_BOVIN). Identification parameters included peptide mass accuracy 
within 0.08 Da, one possible missed cleavage per peptide, and with the variable modification 
methionine sulfoxide, Met(O). 
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RESULTS 1: 
CHARACTERISATION OF REACTION CONDITIONS PROVIDING 
RAPID AND SPECIFIC CYS ALKYLATION 
 
 
3.1. Background 
Cys alkylation is a common preparative step for samples destined for MS-based proteomics 
analysis. The thioether moiety is less reactive than the free Cys thiol to most oxidative 
reactions, in particular those forming disulfide cross-links, which complicate peptide 
identifications by MS. While alkylation reactions are common in general proteomics 
procedures, they are receiving new scrutiny as a role for redox-based PTM emerges. 
Methodologies for the identification of redox active Cys rely on rapid and specific alkylation 
to prevent common side reactions during sample preparation, such as auto-oxidation 
(Schilling, Yoo et al., 2004; Held, Danielson et al., 2010; Lin, Li et al., 2010; Lui, Lipscombe 
et al., 2010).  
Common alkylation reactions occur via either: i) bimolecular nucleophilic substitution (SN2), 
as for haloalkanes, or; ii) Michael addition, as for maleimides (Mather, Viswanathan et al., 
2006). In both cases, a nucleophile (thiolate anion) attacks an electron deficient site of the 
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alkylating reagent and either substitutes for a leaving group, often a halide ion (SN2), or adds 
to an activated alkene / alkyne (Michael addition). Thus, the regioselectivity of the peptide – 
alkylating reagent reaction depends on the strength and abundance of the nucleophile in 
question. Whilst Cys is the most nucleophilic of the 20 commonly coded amino acids 
(Marino and Gladyshev, 2010), it is one of the least abundant (Pe'er, Felder et al., 2004). 
Other nucleophiles are relatively common in peptide sequences and, given sufficient time and 
the correct conditions, reactions at hydroxyls, thioethers and primary and secondary amines 
are theoretically possible (such reactions, occurring at sites other than the Cys sulphur atom, 
will henceforth be referred to as „non-specific‟ or „mis-alkylations‟). Intertwined with the 
issue of specificity are reaction rate and relative completion. In an attempt to ensure 
„complete‟ reaction of all cysteines to thioethers, protocols often involve high temperatures, 
basic pH, extended reaction times and high molar excess of alkylating reagent. These 
conditions are likely to promote mis-alkylation events.  
The most common alkylating reagents utilized in proteomics studies are haloalkanes, such as 
IAM, which require basic pH (above pH 8) and extended reaction times to provide 
appreciable removal of Cys activity. After incubation for 4-6 hours at basic pH with a large 
molar excess of IAM (1000 times that of protein Cys), reactions to form thioethers are 
incomplete (Galvani, Hamdan et al., 2001; Rogers, Leinweber et al., 2006). Under milder 
conditions however, IAM reacts with primary amines (on N-termini and Lys) at up to two 
equivalents (Boja and Fales, 2001; Yang and Attygalle, 2007; Nielsen, Vermeulen et al., 
2008), and with secondary amines (His) (Boja and Fales, 2001; Yang and Attygalle, 2007), 
hydroxyls (Tyr) (Cotner and Clagett, 1973; Boja and Fales, 2001; Yang and Attygalle, 2007) 
and thioethers (Met) (Lapko, Smith et al., 2000; Kruger, Hung et al., 2005) at one equivalent. 
Under conditions with longer incubation times and lower concentrations (e.g. 18 hours, 2 mM 
IAM) at 37
º
C, IAM also reacts with the carboxyl groups of Glu, Asp and peptide C-termini 
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(Boja and Fales, 2001; Yang and Attygalle, 2007). Mis-alkylation causes at least two 
potential complications to MS analysis: i) dilution of peptide signals over multiple m/z; and 
ii) artefactual mimicry of biologically relevant PTM. This later point has been observed in 
studies of protein phosphorylation (Kruger, Hung et al., 2005) and ubiquitination (Nielsen, 
Vermeulen et al., 2008).  
An alternative to haloalkane Cys alkylation is the use of maleimides, such NEM. Kinetics of 
the reaction between NEM and Cys are rapid in comparison to IAM, with indications that the 
reaction is complete in 1 to 15 minutes at pH close to neutrality (Rogers, Leinweber et al., 
2006; Scotcher, Clarke et al., 2011), and with an appreciable rate even at pH 4.3 (Rogers, 
Leinweber et al., 2006). Lowered pH conditions are desirable as they not only decrease mis-
alkylation events (by decreasing the nucleophilicity), but also decrease the rate of unwanted 
Cys side reactions, such as auto-oxidation (Bagiyan, Koroleva et al., 2003) and β-elimination 
(Volkin and Klibanov, 1987; Lagrain, De Vleeschouwer et al., 2010; Rombouts, Lagrain et 
al., 2010), which will compete with alkylation at higher pH. The rapid reaction afforded by 
NEM also reduces the need to employ large molar excesses. Complete alkylation with NEM 
has been achieved in single protein studies at a mole ratio of approximately 1:15 at pH 7.3 
(Scotcher, Clarke et al., 2011), and 1:125 in isolated myofibril preparations at pH 4.3 
(Rogers, Leinweber et al., 2006). 
Few studies have identified sites of NEM mis-alkylation, and these have largely concentrated 
on single amino acid and peptide reactivity (Smyth, Nagamatsu et al., 1960; Smyth, 
Konigsberg et al., 1964; Brewer and Riehm, 1967). In addition, little information is known 
about the timescale of mis-alkylation versus Cys alkylation, or the effects of NEM 
concentration and pH. In this study we defined sites of NEM mis-alkylation in proteins and 
examined the effects of concentration, time and pH on specific and non-specific NEM 
CHAPTER 3: RESULTS 1 – CHARACTERISATION OF CYS ALKYLATION 
 
 
81 
 
reactions. The knowledge gained was then used to optimize a rapid and specific alkylation 
protocol for complex protein mixtures derived from myocardial tissue for MS-based 
proteomics studies. 
 
3.2. Experimental Section 
3.2.1. Preparation of alkylated protein standards.  
Ovalbumin (0.35 mM) solutions were prepared in 1% (w/v) SDS, 100 mM Tris-HCl, pH 6, 7 
or 7.5 as indicated, and heated at 80
o
C for 15 mins to denature. Protein solutions were 
alkylated with NEM at concentrations ranging from 5 – 100 mM (NEM : Cys molar ratios of 
between 3.4 : 1 and 67.1 : 1) and reaction times from 1 – 60 mins at room temperature 
(25ºC). Following alkylation, samples underwent chloroform / methanol precipitation as 
previously detailed (Wessel and Flugge, 1984), to remove unreacted NEM. Samples destined 
for spectrophotometric measurement of thiol concentration were prepared as detailed below, 
whilst samples destined for MS analysis were resuspended in 25 mM Tris, pH 7.5 and 
digested by trypsin at 37
o
C for 12 – 16 hrs. Peptide samples were concentrated and desalted 
by solid phase extraction C18 columns (Waters Corp., Milford MA) and evaporated to 
dryness. 
3.2.2. Preparation of myocardial tissue protein extracts.  
Protein extract preparation was performed as per Section 2.3.1. but with the exclusion of all 
NEM alkylation steps, i.e., exclusion from buffer etc. A small aliquot (6 – 7 µg protein) of 
extract was taken for Cys spectrophotometric assay as detailed in Section 2.4.1. The 
remaining aliquots (~ 3 mg protein each) were heated at 80
o
C for 15 mins to denature and 
then subjected to either: (i) alkylation (5 – 50 mM NEM (corresponding to molar ratios of 
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NEM : Cys between 2.1 : 1 and 21.2 to 1), 30 mins, room temperature (25ºC)), reduction (10 
mM DTT, 1 hr, 57
o
C) or; (ii) alkylation (40 mM NEM alkylation) / reduction (10 mM DTT) 
with precipitation following each step. For the NEM alkylation time-course, samples were 
alkylated at 40 mM NEM, for 1 – 15 mins. All samples were precipitated and resuspended for 
spectrophotometric assay as detailed in Section 2.4.1.  
3.2.7. LC-MS/MS analysis.  
Initial studies were performed as in Section 2.10.1 on gradient (b). Follow up studies were 
performed as in Section 2.10.2 on gradient (a). 
3.2.7. Data analysis.  
Initial studies were searched against the UniProt database using an in-house Mascot server 
(Pappin, Perkins et al., 1999), with variable modifications of NEM (Cys) and oxidation 
(Met), two possible missed tryptic cleavages and a peptide and protein tolerance of 0.6 Da for 
QSTAR Elite data. Unmatched queries with a mass of +125, +250 or +375 Da (+1, 2 or 3 
NEM additions; ± 2 Da) were manually sequenced to identify mis-alkylation sites. Residue 
side chain sites of modification were considered verified if: (i) the site could be read from 
fragment ions in at least one direction; (ii) the site contained a nucleophile; and (iii) the 
residue was not N-terminal. Mis-alkylation of the N-terminus was considered confirmed if: (i) 
the site could be read from fragment ions in at least one direction; and (ii) identification was 
not dependent on the presence of a nucleophilic residue at the N-terminus. Confirmed sites of 
mis-alkylation were included as variable modifications in the Mascot search and the data 
searched again. Other theoretical (unconfirmed) sites (Met and Tyr) were included as variable 
modifications to verify that these had not been overlooked in manual sequencing strategies. 
Data acquired on the LTQ Orbitrap Velos from concentration, pH and time-course 
experiments were searched against UniProt using an in-house Mascot server and X!Tandem 
CHAPTER 3: RESULTS 1 – CHARACTERISATION OF CYS ALKYLATION 
 
 
83 
 
through Scaffold 3 (Proteome Software, Portland, OR), with all NEM-positive identifications 
manually reviewed. Search parameters were: variable modifications – NEM at Cys, Lys, His 
and the N-terminus and oxidation (Met); 2 possible missed tryptic cleavages, precursor mass 
tolerance of 3 Da and fragment mass tolerance of 0.8 Da. 
2.8. SRM  
Performed as detailed in Section 2.11. 
 
3. 3. Results 
3.3.1. Defining sites of NEM mis-alkylation 
Ovalbumin protein standard was treated with NEM concentrations between 20 and 100 mM 
(pH 6, 30 mins) prior to trypsin digestion and LC-MS/MS to define sites of NEM mis-
alkylation. MS/MS spectra unmatched by Mascot searches that were of high quality and 
deviated from the theoretical mass of a predicted ovalbumin tryptic peptide by +125, +250 or 
+375 Da (± 2 Da) were manually interpreted to locate possible sites of mis-alkylation. Mis-
alkylation at the ε-amine of Lys was observed, but only at one equivalent of NEM (Figure 
S3.1a, Appendix 1). Alkylation at Lys was typically associated with a missed tryptic cleavage 
(although in at least one case this would be expected due to the position of a Pro at the +1 
location; Figure S3.1a). Alkylation at His was observed in the peptide 
H(NEM)IATNAVLFFGR (Figure S3.1b, Appendix 1), which by our definitions was considered 
an ambiguous assignment as alkylation may be at the His imidazole nitrogens or the α-amino 
group (N-terminus of the peptide). We also observed a non-ambiguous identification of His 
imidazole alkylation (Figure S3.1c, Appendix 1). A similar case was observed for the peptide 
Y(NEM)PILPEYLQC(NEM)VK (Figure S3.1d, Appendix 1). No peptides however, could be 
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identified that were alkylated at a non-N-terminal Tyr, thus alkylation was assumed to be at 
the α-amino group and not at the Tyr hydroxyl. Mis-alkylation at the α-amino group of 
peptides was confirmed for a wide range of N-terminal residues, including those that do not 
possess a nucleophilic side chain (representative spectrum Figure S3.1e, Appendix 1). 
Subsequent Mascot searches were performed with the inclusion of NEM alkylation of His, 
Lys and the N-terminus (variable). The manually interpreted sites described above could then 
be confidently identified by Mascot, based on ion scores and expect values (data not shown). 
To confirm that other nucleophilic sites were not overlooked, we also included Met and Tyr 
alkylation, which are previously documented sites of IAM mis-alkylation (Cotner and 
Clagett, 1973; Lapko, Smith et al., 2000; Boja and Fales, 2001; Kruger, Hung et al., 2005; 
Yang and Attygalle, 2007), even though we did not observe them by manual inspection of 
MS/MS spectra. Subsequent Mascot searches did not generate identifications of Met or Tyr 
sites that were not N-terminally located or could not be more accurately attributed to other 
sites (Cys, Lys or His) by manual interpretation of MS/MS spectra or inclusion of these 
modifications in Mascot searches. 
 
3.3.2. Effect of concentration and pH on levels of mis-alkylation 
Ovalbumin alkylation was next performed at a range of NEM concentrations (5 – 100 mM) at 
pH 6 for 30 mins, and the total number of MS/MS spectra that were identified and confirmed 
as containing a mis-alkylation normalised to the total spectral counts (Figure 3.1). Very few 
mis-alkylations were seen at 5 or 10 mM NEM (molar ratio NEM : Cys of 3.5 and 7 : 1, 
respectively), but such events increased with NEM concentration between 20 - 100 mM (Cys 
: NEM between 13 : 1 and 67 : 1). Alkylation reactions are generally performed at or above 
neutral pH, therefore, we performed ovalbumin alkylation at NEM concentrations between 5 
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– 100 mM at both pH 7 and 7.5. It is undesirable to perform alkylation above pH 8, as NEM 
hydrolysis reactions will begin to compete with alkylation (Gregory, 1955; Smyth, 
Nagamatsu et al., 1960). Total mis-alkylation events were again normalised as above (Figure 
3.2). An increase in mis-alkylations occurred with increased pH at all concentrations tested, 
but particularly above 20 mM NEM. At pH 7 and 7.5, the normalised number of mis-
alkylations observed at 20 mM was approximately equal to those occurring at 60 or 100 mM 
at pH 6. For concentrations of 60 mM (NEM : Cys of 40 : 1) and above, spectra attributable 
to mis-alkylated peptides were well in excess of those observed at any concentration at pH 6. 
 
Figure 3.1. Mis-alkylations increase with increasing NEM concentration. Peptides with mis-
alkylations were identified by MS/MS and a relative level of protein-wide mis-alkylation estimated by 
spectral counts, normalised to the total spectral counts of ovalbumin. Data are provided as a box and 
whisker plot to indicate the dispersion of measurements across six replicate MS/MS experiments. The 
upper, lower and center lines of the boxes represent the upper quartile, lower quartile and middle 
quartile values of the data (thus the box is the inter-quartile range), whilst the bars show the maximum 
and minimum values observed. 
 
These data suggested that 5 – 10 mM concentrations of NEM at pH 6 generate low levels of 
mis-alkylation for reactions up to 30 mins. To determine whether these optimized conditions 
were suitable for maximal removal of Cys reactivity in a complex protein mixture, DTDP 
assay of myocardial tissue proteins treated with 5 – 50 mM NEM (NEM : Cys between 2.1 : 
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1 and 22 : 1, pH 6) for 30 mins was undertaken (Figure 3.3). Loss of Cys reactivity was ~ 91 
% at 5 mM NEM and 93 % at 10 mM NEM (Cys : NEM mole ratio of 1 : 2.1 and 1 : 4.4, 
respectively) after 30 mins. Increasing the NEM concentration above 20 mM resulted in ~ 97 
% removal of Cys reactivity (mole ratio 1 : 8.7 at 20 mM and 1 : 13.2 at 50 mM), and 
remained constant within error at higher concentrations. At such high NEM concentrations 
however, mis-alkylation events are far more likely to occur (Figure 3.1).  
 
Figure 3.2. NEM mis-alkylation positively correlates with increased pH. Peptides with mis-
alkylations were identified by MS/MS and a relative level of protein-wide mis-alkylation estimated by 
spectral counts, normalised to the total spectral counts of ovalbumin. Data are provided as a box and 
whisker plot to indicate the dispersion of measurements across six replicate MS/MS experiments. See 
Figure 3.1 for explanation. 
 
3.3.3. Effects of reaction time on specific and non-specific (mis-) alkylation 
The effect of NEM reaction time on specific (Cys) alkylation was measured by 
spectrophotometric (DTDP) assay of ovalbumin treated with varying NEM concentrations for 
1 – 60 mins (data not shown). After one minute at 40 mM NEM (NEM : Cys, 27 : 1), 
absorbance readings reached a plateau at 99.1 ± 0.2% Cys depletion. This trend was 
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replicated in tissue samples at the same NEM concentration with 98.1 ± 0.5% depletion of 
Cys after 1 min. Due to the observed reaction kinetics, an attempt was made to observe 
reactions at 300 nm (the absorbance maximum of NEM), and at lowered concentrations of 
NEM (3 mM) with concurrent DTDP assay. The reaction of ovalbumin Cys with NEM was 
complete in less than 15 s (the time required to mix NEM and ovalbumin solutions) and thus 
a reaction curve could not be measured. In tissue extract samples the reaction proceeds more 
slowly and, in the presence of 10 mM NEM (diluted 1 : 4 for assay), the reaction is  91.4 ± 
0.2 % complete after 5 mins and 94.5 ± 0.1 % after 10 mins (as assayed by DTDP). A 
measurable 4-thiopyridine (4-TP) response was observed for greater than 30 mins after NEM 
alkylation, indicating the reaction is still incomplete in tissue samples. 
 
Figure 3.3. Remaining Cys reactivity in myocardial tissue homogenate under differing 
alkylation and reduction conditions. Cys reactivity was determined spectrophotometrically by 
DTDP assay (measured at 324 nm). The assayed conditions included: untreated homogenate 
(„extract‟), homogenate alkylated with 5 – 50 mM NEM, homogenate alkylated with 40 mM NEM 
and reduced with 10 mM dithiothreitol (DTT), and homogenate reduced with 10 mM DTT. Insert 
shows the homogenate alkylation concentration course. Error bars provide standard error of mean 
(SEM) for three replicate measurements. 
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In order to assess if specific and non-specific alkylations could be temporally isolated, mis-
alkylations were observed via MS/MS in ovalbumin alkylated with 40 mM NEM for 1 – 60 
mins (Figure 3.4).  Mis-alkylation at 1 min was barely discernible, even though Cys 
alkylation was complete (see above), whilst extension to 60 mins approximately doubled the 
number of observed mis-alkylated peptides compared to the 30 mins time-point. 
 
Figure 3.4. Mis-alkylation events at 40 mM NEM increase with increased alkylation reaction 
times. Peptides with mis-alkylations were identified by MS/MS and a relative level of protein-wide 
mis-alkylation estimated by spectral counts, normalised to the total spectral counts of ovalbumin. Data 
are provided as a box and whisker plot to indicate the dispersion of measurements across the six 
replicate experiments. See Figure 3.1 for explanation. 
 
3.3.4. Measurement of peptide mis-alkylation by SRM 
All ovalbumin peptides that were identified as NEM modified, as well as the mildest 
conditions leading to their observation, are shown in Table 3.1. We next selected a 
representative subset of these to determine accurate quantification and unalkylated : alkylated 
(or mis-alkylated) ratio by SRM. To normalize for variations in loading (and protease 
digestion), the ratio of the area of NEM modified (N) to the area of unmodified peptide (N0) 
was monitored (as a logarithm; Figure 3.5). Thus, lower log2 (N/N0) values denoted lower 
levels of mis-alkylated peptide. Coefficient of variance (CV) (n = 6 replicates) was less than 
20% for all ratios with the exception of 2 peptides (TQINKVVR and IKVYLPR; Figure 3.5). 
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Assessing these 2 peptides by the variance of N in comparison to the average replicate ratio 
of all peptides tested, excluding those with a missed tryptic cleavage, allowed for the 
reduction of the CV to below 25%. Note that for comparison, the original CVs are shown in 
Figure 3.5, and the amended CVs are provided in Table S3.1 (Appendix 1). 
 
Table 3.1. Ovalbumin peptides mis-alkylated by NEM and characterised by MS/MS. Mis-
alkylation was identified at the indicated sites (“Site”), with the mildest condition (lowest [NEM] or 
shortest reaction time) for their appearance specified at each pH. Highlighted sequences were selected 
for SRM analysis. 
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Figure 3.5. Log ratio of NEM-modified (N) to unmodified (N0) peptide peak areas measured by 
SRM for differing NEM concentrations and pH. Transitions were designed for 10 ovalbumin 
tryptic peptides with nine containing sites of mis-alkylation. SRM assays were undertaken for samples 
alkylated at pH 6 (dotted line, closed triangle), pH 7 (solid line) and pH 7.5 (dashed line, open 
diamond) for 30 min. Site of mis-alkylation cannot be confirmed by the SRM transitions chosen for 
peptides (b) – (d), (h) and (i), but is defined in peptide (a) as Lys (NEM). The peptide sequence and 
transitions confirm the only site of mis-alkylation for peptides (e) – (g) is the N-terminus. Error bars 
indicate CV for six replicate measurements of each point. 
 
Due to the nature of the chosen SRM transitions, the site of alkylation could only be 
confirmed for five of the nine (six of ten peptides measured) peptides in Figure 3.5 (peptide 
(a) [TQINK(NEM)VVR]; peptides (e) – (g), which were N-terminally modified; and the 
specific alkylation within ADHPFLFC(NEM)IK (data not shown). For peptides (b)-(d) and (h)-
(i), NEM modification may occur at any of the sites specified in Table 1. Mixed alkylation 
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populations (alkylation occurring at each site) are theoretically possible, although a single 
predominant site cannot be ruled out. Of the ten peptides selected for SRM, only 
ADHPFLFCIK (Cys unalkylated) could not be monitored in any of 6 replicates, however the 
modified form of this peptide (ADHPFLFC(NEM)IK) could be monitored in all samples. Thus, 
this was the only peptide pair designated a log2 (N/N0) ratio of 12, and this was consistent for 
all conditions tested. For the remaining peptides, the ratios increased with NEM 
concentration at all pH conditions tested (Figure 3.5). Ratios at pH 6 were consistently lower 
than or equal to those at pH 7 and 7.5 with one exception (5 mM NEM, peptide (i); Figure 
3.5). 
 
Figure 3.6. Log ratio of NEM-modified (N) to unmodified (N0) peptide peak areas measured by 
SRM for differing reaction times. Eight of 10 ovalbumin peptide ratios were monitored after 
alkylation at 40 mM NEM for 1 – 60 min. Error bars indicate coefficient of variance for six replicate 
measurements of each point. 
 
In addition, at pH 6, seven of the nine peptides had at least one NEM concentration where 
levels of the NEM-modified peptide were below background (designated a log2 (N/N0) value 
of -12). The number of these unobserved NEM-modified peptides was halved at pH 7 and 
7.5, and the majority occurred at 5 mM NEM. Similarly high specificity was also seen at 40 
mM NEM (pH 6) when the reaction time was reduced to 1 min (Figure 3.6). Under these 
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conditions, only two of the nine monitored mis-alkylated peptides could be quantified, 
compared to five and eight at 30 and 60 mins, respectively. The only peptide that was not 
observed in a mis-alkylated form at any time point at 40 mM NEM was 
AFKDEDTQAMPFR (data not shown). 
 
3.4. Discussion 
Alkylation of Cys to a thioether simplifies peptide identification in MS and MS/MS by 
narrowing the range of chemical states Cys may inhabit. Following reduction / alkylation, 
Cys may no longer form or re-form disulfides, thiosulfinates / onates, oxyacids or β-
eliminated products. In addition, alkylation increases ionisation efficiency of Cys-containing 
peptides, resulting in improved protein sequence coverage (Zabet-Moghaddam, Kawamura et 
al., 2008). Despite widespread use, analysis of optimal alkylation conditions and reagents has 
been limited. NEM is an attractive reagent for Cys alkylation due to the rapid reaction 
kinetics even at low pH (Lee and Samuels, 1964; Gorin, Matic et al., 1966; Rogers, 
Leinweber et al., 2006). We have defined conditions that provide rapid and specific NEM 
alkylation and characterized factors that increase mis-alkylations.  
Manual interrogation of MS/MS spectra deviating by the mass of NEM revealed that whilst 
Cys alkylation was the most common site (no identified spectrum contained an unmodified 
thiol), NEM also reacted at primary and secondary amines (i.e., N-termini, Lys and His). No 
reactivity at hydroxyls or thioethers was observed that could not be attributed to α-amine 
reactivity, even though these are documented sites of IAM alkylation (Cotner and Clagett, 
1973; Lapko, Smith et al., 2000; Boja and Fales, 2001; Kruger, Hung et al., 2005; Yang and 
Attygalle, 2007) and are more common than Cys and His (Cys, 1.6 %; His, 1.8 %; Met, 4.4 
%; and Tyr, 2.6 %) in ovalbumin. Reactivity at primary amines was also restricted to one 
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equivalent, possibly due to steric hindrance by, or decreased reactivity of, the mono-alkyl 
species. As α-amino groups of peptides will largely be present as amide groups in proteins 
during NEM alkylation, it is likely that these mis-alkylations are occurring either on 
fragmented protein termini (if not all ovalbumin protein is intact in commercial preparations) 
or on newly released peptide termini during digestion. The addition of thiol-containing 
reducing reagents may reduce the occurrence of N-terminal peptide alkylations, but as these 
may have affected our assessment of specific Cys alkylations of peptides they were excluded 
from our analysis. 
A positive correlation between NEM concentration and mis-alkylations was observed above 
10 mM NEM, and pH and mis-alkylations were also positively correlated. At 5 mM NEM 
(NEM : Cys of 3.5 :1), a moderate increase in mis-alkylations was observed at increased pH, 
but this was significantly higher at 20 mM NEM (Cys : NEM 13 : 1) and above (Figure 3.2). 
At 20 mM NEM for pH 7 and 7.5, spectral counts of mis-alkylated species were more 
consistent with 60 or 100 mM NEM at pH 6. Many alkylation protocols utilize neutral or 
basic pH in an attempt to ensure efficient reactivity however, NEM maintains relatively high 
reactivity down to pH 4.3 (Lee and Samuels, 1964; Gorin, Matic et al., 1966; Rogers, 
Leinweber et al., 2006). Our data suggest it is detrimental to the specificity of the NEM 
reaction to utilize neutral or higher pH. At pH above neutrality the rate of Cys side reactions, 
such as auto-oxidation and β-elimination, also increases, as does NEM hydrolysis. Ideally, 
therefore, the reaction should be performed at as low a pH as possible, although considering 
proteomics may involve subsequent pH sensitive reactions, a compromise is to restrict the pH 
to below neutral.  
At 5 and 10 mM NEM (NEM : Cys of 3.5 :1 and 7 : 1, respectively) and pH 6, relatively few 
mis-alkylations were observed in ovalbumin, indicating relative specificity at up to 30 mins 
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reaction time. Theoretically, if maximal Cys removal was achievable in complex protein 
homogenates at these low NEM concentrations then a relatively specific NEM reaction could 
be assumed. At higher NEM concentrations, Cys reactivity was depleted in complex 
myocardial protein mixtures by ~ 97 % and remained constant within error between 20 - 50 
mM (NEM : Cys between 8.8 : 1 and 22 : 1). Reaction specificity at these concentrations 
however, cannot be assumed (Figure 3.1). We next examined reaction times required to 
generate specific and non-specific (mis-) alkylations. This exploited the rapid reactivity of 
NEM with stronger nucleophiles and assumed preferential reactivity with Cys over other 
sites. Cys alkylation was complete upon mixing for ovalbumin and in ~ 1 minute with 
myocardial tissue homogenates at 40 mM NEM. At these reaction times, mis-alkylation 
events were almost indiscernible, and thus temporal selection of site reactivity is possible. At 
low NEM concentrations (3 mM), the reaction was considerably slower (> 30 mins) but mis-
alkylations are presumably lower. The rate of specific alkylation was also dependent on 
protein denaturation, since the reaction was slower in urea, and in SDS without heat 
denaturation (Figure S3.2, Appendix 1), with the former incomplete after 90 min. Thus, to 
increase the rate of specific alkylation without increasing reaction times, samples were 
heavily denatured before alkylation. Denaturation is therefore critical for methods that seek 
optimal levels of Cys depletion (e.g., redox proteomics), as computational analyses have 
indicated that Cys residues are primarily heavily buried within tertiary structures to minimise 
erroneous reactions caused by their high nucleophilicity (Marino and Gladyshev, 2010; 
Marino and Gladyshev, 2011). Under poorly denaturing conditions, the efficiency of Cys 
alkylation varies depending on Cys reactivity in the specific microenvironment (e.g., the pKa 
of E.coli DsbA is 3.5 (Nelson and Creighton, 1994; Grauschopf, Winther et al., 1995) – ~ 5 
pH values lower than the average) and reagent accessibility to the site. In instances where 
denaturation is not undertaken reactions may proceed for greater than 90 mins (Figure S3.2). 
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Thus, methods which include NEM in extraction buffers may wish to consider both the 
restriction of pH to below neutral and the inclusion of strong denaturants (e.g., SDS) to aid 
reaction completeness.  
Seventeen peptides constituting ~ 50 % of the ovalbumin sequence could be confidently 
identified as mis-alkylated (Table 1). Of these, 10 were chosen for quantification by SRM 
and were monitored as NEM-modified to unmodified peptide couples (N and N0, 
respectively). Nine peptides could be monitored in their NEM-modified form under at least 
one test condition. The peptide ADHPFLFCIK could only be monitored in its Cys alkylated 
form, indicating that all conditions were sufficient to provide complete alkylation within the 
detectable limits of the assay. The 9 NEM-modified peptides were mis-alkylated at only a 
single site (+ 125 Da), however absolute definition of the site of mis-alkylation was only 
possible for a subset. The remaining area ratios likely contain contributions from all possible 
mis-alkylation sites (Table 1). All N : N0 ratios increased with increasing NEM concentration 
and ratios obtained at pH 7 and 7.5 were consistently higher than (or approximately equal to) 
those at pH 6. Mis-alkylation of peptide (a) (TQINKVVR; Figure 3.5) was quantified under 
the mildest alkylation conditions (5 mM NEM and 1 min reaction time). Lys alkylation most 
likely results in a missed tryptic cleavage, which occurs infrequently when the Lys is not 
alkylated and resulted in a high CV. By normalising to the average replicate ratio of all 
unmodified peptides (<N0>) not containing a missed cleavage (all peptides with the 
exception of (a) and (b) in Figure 3.5), the CV was reduced to < 25%. The poor conservation 
of the missed cleavage in the unmodified peptide also results in a ratio of greater than 1:1. 
This pattern of NEM mis-alkylation, therefore, most likely reduces protein sequence 
coverage by increasing missed tryptic cleavages. Other target peptides ((c) and (d); Figure 
3.5) containing a possible site of Lys NEM alkylation also contain a possible N-terminal site. 
Peptide (c) showed reactivity at 5 mM NEM but only at or above neutral pH, demonstrating 
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how increased pH leads to decreased specificity even at low NEM concentrations. Additional 
peptides demonstrated this effect at 5 mM NEM, including the N-terminal modified peptides 
(e) and (g). It can be concluded that for the majority of peptides, increased pH leads to 
increased mis-alkylations at lower NEM concentrations. 
Two targeted peptides contained His sites, which from spectral counting were mis-alkylated 
at the majority of NEM concentrations (Table 1). Peptide (h) displayed two mis-alkylations, 
primarily located on two His residues. This peptide also displayed the highest maximal ratio 
for any peptide not containing a missed cleavage (Figure 3.5 and 3.6), most likely because it 
contains three possible sites of mis-alkylation. From our data and the relative abundances of 
amino acids subject to NEM modification in ovalbumin (Cys; 1.6 %, His; 1.8 %, and Lys; 5.2 
%), it is possible to theorise a reactivity series: Cys >> His > Lys / N-terminus. It is likely that 
His shows increased reactivity over Lys and N-termini both because of the increased kinetics 
of secondary amines in Michael reactions (Mather, Viswanathan et al., 2006) and its lower 
pKa. The difference in reactivity of Lys and N-termini could not be determined due to the 
inability to assess the abundance of N-termini in the alkylation reaction. In alternative studies 
of NEM alkylation, the N-terminus was identified as the only primary amine non-specific 
site, likely due to its high concentration under the chosen conditions (Smythe; Smyth, 
Nagamatsu et al.; Smyth, Konigsberg et al.). The average pKa of peptide α-amines is also 
lower than that of Lys, indicating that in peptide alkylation reactions the above reactivity 
series may actually be: Cys >> His ≥ N-terminus > Lys. Cys modification is by far the 
predominant reaction, proceeding to near 100%, whilst other sites are likely to represent no 
more than 10% of the unmodified peptide pool, demonstrating the specificity of this reagent. 
This proportion, however, will be highly plastic across protein structures and affected by the 
reactivity and accessibility of amine sites and the abundance of Cys. Samples with low Cys 
abundance and a highly reactive amine group may show increased preference for NEM 
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alkylation at this site. In this case, determination of Cys concentration and alkylation at low 
mole ratios of NEM : Cys would be optimal. Conversely, samples with high Cys 
concentrations may require higher NEM concentrations that are restricted to short reaction 
times to allow for complete alkylation whilst decreasing the chance of concentration-driven 
mis-alkylations.  
 
3.5. Conclusions 
NEM represents an attractive alkylating reagent due to its rapid kinetics with Cys and the 
compatibility of the reaction with low pH where mis-alkylation is less probable. In this study, 
sites of mis-alkyaltion by NEM were restricted to amines, namely; the imidazole of His, the 
ε-amine of Lys and the α-amine (N-terminus) of peptides. Reaction conditions below 
neutrality decreased mis-alkylation while still providing a rapid reaction in the presence of 
efficient denaturation. Increased specificity may be obtained by restricting the reaction to 
concentrations below 10 mM NEM or reaction times less than 5 min. The preferred method 
will depend on factors such as Cys abundance, sample complexity, denaturation protocols 
and the presence of highly reactive His and Lys residues (e.g., in enzyme active sites). This 
study demonstrated that long reaction times at high pH, temperature and reagent 
concentrations are not necessary for the reaction of Cys and NEM in single protein and 
complex mixtures, and such conditions may be detrimental to reaction specificity. 
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APPENDIX 1: SUPPLEMENTARY FIGURES 
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Figure S3.1. MS/MS spectra of mis-alkylated peptides. Spectra demonstrate confirmed sites of 
mis-alkylation and ambiguous identifications; (a) Lys mis-alkylation, (b) mis-alkylation assignment at 
His or the N-terminus, (c) His mis-alkylation, (d) ambiguous assignment at either Tyr or the N-
terminus, and (e) N-terminal mis-alkylation. Peptide (b) constitutes two populations as His and N-
terminal alkylation were both unambiguously verified, whilst peptide (d) was assumed to be mis-
alkylated at the N-terminus as no Tyr sites independent of the N-terminus were identified in this study. 
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Figure S3.2. Reaction of ovalbumin protein Cys under denaturing and non-denaturing 
conditions. (a) reaction of Cys with DTDP (no NEM reaction) demonstrating the differences in 
accessibility of Cys, (b) remaining Cys reactivity following 45 mM NEM treatment for 90 min at 
room temperature, (c) remaining Cys in SDS denatured ovalbumin with reaction time at 45 mM 
NEM, room temperature (note: SDS / heat time course is given for comparison only and is not a 
reaction curve as at all time points – excepting zero – Cys concentrations were below the detection 
level of the assay and a kinetic graph could not be determined). All error bars indicate SEM of three 
replicate measurements. 
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Supplementary Table S3.1. Coefficient of variance (% CV) values for all conditions tested. 
Asterisk indicates CV which are greater than 25%. For these conditions, an alternate CV was 
calculated utilizing the average replicate ratio of all peptides which did not contain a missed cleavage 
(<N0>) for normalization of loading amount. This decreased CV to < 25 % for all conditions. 
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RESULTS 2: 
CAPTURE OF REVERSIBLY OXIDISED CYS BY TDE APPLIED 
TO THE MYOCARDIAL REDOX PROTEOME 
 
4.1. Background 
 
ROS and RNS are involved in the generation of oxidative stress and physiological redox 
signalling via the oxidation of biomolecules, in particular proteins. There are several oxidant-
sensitive amino acids that can propagate the ROS / RNS signal or be targeted during stress 
(Davies, Fu et al., 1999; Hawkins and Davies, 2001), however foremost amongst these is 
Cys, which demonstrates high reactivity with a large range of oxidants and is targeted by 
numerous oxidative PTM (Jacob, Giles et al., 2003; Lindahl, Mata-Cabana et al., 2011). The 
Cys sulfur atom can exist in oxidation states between -II and +IV. Reactions that mildly 
oxidize the native thiol (R-S
-II
-H) to low oxidation states, such as the disulfide (R-S
-I
-S
-I
-R) 
or sulfenic acid (R-S
0
-OH), are reversible; however, higher oxidation states such as sulfinic 
(R-S
II
-O2H) or sulfonic acid (R-S
IV
-O3H) are generally biologically irreversible, with the 
exception of peroxiredoxins (Biteau, Labarre et al., 2003). Oxidative PTM may ultimately 
facilitate signal propagation, and / or influence the protein structure / function relationship 
leading to dysfunction and targeted degradation during oxidative stress. Since these PTM 
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appear critical in pathophysiological conditions (e.g., cardiovascular diseases, including 
atherosclerosis and ischemia / reperfusion injury (Christians and Benjamin, 2012; Kumar, 
Calamaras et al., 2012; Shao, Oka et al., 2012)) as well as physiological signal propagation, 
there is a need for large-scale and high-resolution identification of reversibly modified Cys at 
the proteome level. Redox proteomics attempts to target these PTM by combining enrichment 
or antibody-based protein purification techniques with the speed and resolution of MS to 
identify sites of potential biological importance (Rudolph and Freeman, 2009; Thamsen and 
Jakob, 2011).  
Classically, disulfides are crucial in the establishment and maintenance of protein tertiary 
structure (Givol, Delorenzo et al., 1965). However, disulfides and other reversible Cys PTM 
are increasingly seen to act as redox ‘switches’, which can influence protein function, sub-
cellular localization and signalling. Reversible oxidative Cys modifications include inter- or 
intra-protein disulfides, S-thiolation (between protein and non-protein Cys), S-sulfhydration 
(between Cys and hydrogen sulphide, H2S), S-nitrosylation (R-SNO) and sulfenic acid 
formation. Sulfenic acid is the most unstable of the reversible Cys PTM (Claiborne, Miller et 
al., 1993) and is unique in the ability to react as both a nucleophile and electrophile (Bindoli, 
Fukuto et al., 2008), often making it the reactive intermediate to other oxidation states (a 
proximal thiol may reduce a sulfenic acid to a disulfide, or H2S may react to from 
sulfhydryated Cys). Disulfides may form in the absence of ROS activation via TDE where a 
thiolate anion (R-S
-
) attacks an intact disulfide and substitutes itself for one of the 
constituents – this allows interchange between thiol and disulfide, which can propagate a 
signal. The formation of nitrosothiols is less straightforward as they may form by either RNS-
mediated oxidative nitrosation / nitrosylation (nitric oxide itself or higher NO oxides; NOx) or 
trans-nitrosylation by reactive / activated nitrosothiols (a process which also generates 
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disulfides) (Hess, Matsumoto et al., 2005). Once these reversible Cys modifications are 
formed, however, they may all be recycled by thiol reductants (e.g., Trx). 
The similar reduction conditions of many Cys PTM and the wide spread of Cys reactivities 
make any selective reduction chemistry problematic. For example, the reaction of ascorbic 
acid with SNO can be utilized for their analysis (Jaffrey and Snyder, 2001; Hao, Derakhshan 
et al., 2006; Murray, Kane et al., 2011), however the reaction conditions and products are 
highly variable across laboratories, likely due to the inefficiency of this reaction (ascorbate is 
a relatively poor reducing agent) and the multiple decomposition pathways that may occur – 
photo-dissociative, thermal, copper-dependant and independent (Williams, 1999; Holmes and 
Williams, 2000; Grossi and Montevecchi, 2002; Veleeparampil, Aravind et al., 2009). 
Inefficient reduction may also generate false positive / negative protein identifications and 
poor reproducibility. Coupling of free thiols by alkylation chemistry (e.g., SN2 with 
haloalkane-based tags) to chemical handles for enrichment and / or immunodetection (Jaffrey 
and Snyder, 2001; Yano, Wong et al., 2001; Sethuraman, McComb et al., 2004; Landar, Oh 
et al., 2006; Fu, Hu et al., 2008; Hagglund, Bunkenborg et al., 2008; Leichert, Gehrke et al., 
2008; Fu, Wu et al., 2009; McDonagh, Ogueta et al., 2009; Lin, Li et al., 2010; Lui, 
Lipscombe et al., 2010; Marino, Li et al., 2010; Song, Suh et al., 2010; Murray, Uhrigshardt 
et al., 2012) may further confound results due to incomplete incorporation (false negatives) 
or over-incorporation (false positives) of the tags at other nucleophilic sites, e.g., primary 
amines (Cotner and Clagett, 1973; Boja and Fales, 2001). Methods to isolate thiols without 
prior chemical labelling include sequential non-reducing / reducing diagonal gel 
electrophoresis (Sommer and Traut, 1974; Brennan, Wait et al., 2004), organomercurial ion 
affinity (Raftery, 2008; Doulias, Greene et al., 2010) and TDE chromatography. 
Chromatographic methods offer vastly improved resolution and site detection over gel-based 
techniques, whilst TDE offers lower reagent toxicity compared to mercury ion procedures. As 
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only Cys may undergo TDE chemistry, the selectivity of this technique is high, as long as 
sufficient steps are taken to prevent non-covalent interactions with the resin. A number of 
studies have applied immobilized mutant Trx resins (Yamazaki, Motohashi et al., 2004) or 
thiopropyl-sepharose 4B (Wang and Reignier, 2001; Wang, Zhang et al., 2002; Lee, Lee et 
al., 2004; Maya-Ampudia and Bernal-Lugo, 2006; Hu, Tedesco et al., 2010; Hu, Tedesco et 
al., 2010; Salih, Siqueira et al., 2010; Kohr, Aponte et al., 2011; Kohr, Sun et al., 2011) to 
isolate proteins via TDE, but in general, better site identifications, sensitivity and selectivity 
can be achieved by employing a peptide-centric TDE approach. Peptide TDE has, thus far 
however, largely been limited to studies concerned with increasing proteome coverage (Liu, 
Qian et al., 2005; Wang, Qian et al., 2006) and has not been applied to a global study of 
reversible Cys modifications. 
Peptide TDE applied to complex biological samples must consider the differentiation of free 
and oxidized thiols, the prevention of artifactual oxidation of thiols and loss of modifications 
during the protocol. Furthermore, for proteomics applications, such methods must be 
compatible with both label-based and label-free approaches to quantitation, and thus 
assessment of the specificity, efficiency and linearity of the chromatography is necessary. We 
optimized a method for the enrichment of reversibly oxidised Cys that utilizes rapid and 
selective Cys alkylation, thiol-based reduction of Cys modifications and TDE capture, and 
which shows the requirements necessary for quantitative enrichment. We utilized this 
technique for the enrichment and identification of reversibly oxidized Cys-containing 
peptides from myocardial tissue. These large-scale data contained a total of 6559 unique Cys 
peptides from over 2500 unique protein groups with > 90 % enrichment efficiency for Cys 
peptides observed by the technique. These data enabled interrogation of the physicochemical 
properties of the sequence space surrounding modified Cys. The method is compatible with 
multiple sample types and both label-free and label-based mass spectrometric quantitation. 
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4.2. Experimental Section 
4.2.1. Preparation of peptide standard 
BSA was resuspended in 25 mM Tris, pH 7.5 and digested with trypsin at 37
°
C for 16 h. 
Peptides were reduced with 10 mM dithiothreitol (DTT) for 30 min followed by 
concentration and desalting by solid phase extraction (SPE) tC18 columns (Waters Corp., 
Milford MA) and solvent evaporation.  
4.2.2. Preparation of myocardial tissue peptides 
NITC tissue was utilised for this study, see Section 2.2. Tissue extract was prepared as 
detailed in Section 2.3.1, followed by 2.3.3 and digested as in Section 2.5 (with 10 mM DTT 
reduction for 1 hr prior to acidification and SPE cleanup). 
4.2.3. Batch-based TDE chromatography 
The TDE enrichment technique was performed as detailed in Section 2.8.1, and the eluent 
fractionated by HILIC as detailed in Section 2.9.1 (sixteen fractions were taken). 
4.2.4. MALDI-TOF MS of BSA peptides 
Performed as detailed in section 2.12. 
4.2.5. LC-MSMS 
Analysis of myocardial peptides was performed as in Section 2.10.2 on gradient (b), whilst 
label free quantitation of BSA peptides was performed on gradient (a). For label free 
quantitation, the instrument was operated in profile MS mode with the same m/z range as 
detailed in section 2.10.2. 
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4.2.6. Data analysis  
BSA peptide data were searched against the UniProt database using an in-house Mascot 
server, with the variable modification Met(O), two possible missed cleavages and peptide and 
fragment tolerances of 10 ppm and 0.8 Da, respectively. Myocardial peptide data were 
searched against the UniProt Rattus norvegicus database (taxonomy number 10116; release 
date 21/09/11) as above with the addition of the variable modifications; carbamidomethyl (C) 
and NEM (C), using an in-house Mascot server and X!Tandem through Scaffold 3 (Proteome 
Software, Portland OR). A reversed R. norvegicus database was generated and used to filter 
identifications to a < 2 % peptide false discovery rate (FDR). The FDR was thus calculated as 
the number of reverse database matches over the total number of matches from forward and 
reversed databases which scored above a certain mascot ion score – a lower stringency of 2 % 
was selected as a more stringent cut off (≤ 1.5 %) disproportionately removed doubly 
modified (NEM and IAM) peptides from the search in comparison to unmodified / singly 
modified matches. 
4.2.7. Label-free quantitation  
Data were scripted to mzXML using msconvert (http://proteowizard.sourceforge.net/), and 
peaks were extracted and integrated using an in-house script (Wolfram Mathematica, 
Champaign IL). A tolerance of 0.05 Da was applied for all m/z ion values to generate 
extracted ion chromatograms (EIC) followed by numerical integration with a tolerance of 30 
s surrounding the maximum intensity value of the EIC (designated as retention time). 
4.2.8. Bioinformatics 
Gene Ontology (GO) terms were obtained via input of gene names into the DAVID 
bioinformatics tool (Huang, Sherman et al., 2009) with a background reference of all GO 
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terms from R. norvegicus. Values were obtained for over-representation and modified Fisher 
Extact calculation (Hosack, Dennis et al., 2003). Sequence annotation features were obtained 
for reversible Cys modifications from the UniProt database and over-representation analysis 
performed as predicated by the DAVID bioinformatics tool, against a background of all R. 
norvegicus UniProt database sequences. Analysis of the amino acid sequences surrounding 
identified reversibly oxidized Cys residues used 13-mer sequences (6 amino acids up and 
down-stream of the Cys) generated from experimentally captured Cys-containing peptides 
and the R. norvegicus database. Frequency of each amino acid was measured at each position 
and compared to the background to generate a ratio representing the relative frequency in 
comparison to background. Kyte-Doolittle hydrophobicity was calculated on the aligned 13-
mers (Kyte and Doolittle, 1982). Motif analysis was performed using the Motif-X tool 
(Schwartz and Gygi, 2005) on all Cys-peptide sequences identified in the elution of TDE 
chromatography, with the search parameters: central character C, width 13, occurrence 20, 
significance 1 x 10
-6
, background and foreground rat proteome. 
 
4.3. Results and Discussion 
The major objective of this study was to develop an efficient TDE chromatography-based 
method for specific large-scale enrichment of peptides containing reversibly oxidized Cys 
(Figure 4.1). The key areas affecting the performance of the method were: (i) TDE capture 
onto the resin; (ii) prevention of non-covalent interactions during binding and washing; and 
(iii) elution of covalently bound peptides. 
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Figure 1. Schematic of TDE chromatography method. In the initial step, thiols are alkylated to 
allow for the differentiation of free and reversibly oxidized thiols. Samples are then reduced to 
convert reversibly oxidized to free thiols. These are immobilized onto resin functionalized with a 
protected disulfide via TDE. Non-covalently bound proteins / peptides are removed by a stringent 
wash protocol and covalently bound peptides eluted by reduction of disulfide bonds. R denotes either 
another protein (inter-disulfide) or non-proteinaceous group (e.g. glutathione) involved in S-thiolation 
of Cys residues, A denotes the addition of an alkylating group to Cys (e.g. maleimide) and P denotes 
the pyridine-based protecting group for which peptide Cys are substituted. 
 
4.3.1. Hydrophobicity largely mediates non-covalent interactions  
A previous approach for peptide TDE by thiopropyl-sepharose chromatography (Liu, Qian et 
al., 2004) involved MeCN and salt washes to aid in the removal of non-covalently bound 
(non-Cys) peptides, and a single, low volume (100-200 µl) elution of Cys-peptides with DTT. 
We assessed this method using tryptic peptides generated from BSA. MALDI-TOF MS 
showed that while Cys-containing peptides were present in the elution (Figure S4.1a, 
Appendix 2), the dominant peaks could be attributed to non-Cys peptides (61 % of assignable 
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peaks; n = 11/18). The use of a detergent (0.5% SDS) at low concentration in the binding and 
wash steps (Figure S4.1b, Appendix 2) reduced the intensity of these contaminant peaks by ~ 
50 % (based on MS peak intensity), and allowed the observation of 16 eluted Cys-containing 
peptides, however specificity remained poor with 20 non-Cys peptides also identified. We 
next employed a batch-based TDE method of binding and washing, in the presence of 0.5 % 
SDS, and increased the volume of the DTT elution (1 mL using 5 x 200 µl elution steps). 
This resulted in greatly improved specificity with Cys-containing peptides accounting for 92 
% of those ionized by MALDI-MS (n = 23/25; Figure S4.1c, Appendix 2). This improvement 
in non-specific binding was not observed when the batch-based method was employed in the 
absence of SDS (42 % non-Cys peptides, Figure S4.1d, Appendix 2). 
These results indicate that previous methods (Liu, Qian et al., 2005) are less efficient at 
removing interfering non-covalent interactions and at elution of covalently bound peptides. 
The modifications made to the method including: (i) the addition of a hydrophobic modifier 
to the aqueous wash steps (replacing a polar organic phase), (ii) the use of a batch-based, 
rather than column-based method which will increase the efficiency of resin washing, and 
(iii) a higher volume elution step; decreased non-specific binding by over 50 %, and led to a 
concurrent increase in observed Cys-containing peptides. This is perhaps less surprising as 
the original method was intended to increase peptide sequence % coverage by inclusion of 
Cys peptides for improved protein identifications, rather than for the specific enrichment and 
identification of reversibly oxidized Cys-containing peptides. 
4.3.2. TDE chromatography efficiently and specifically captures Cys 
peptides 
LC-MS/MS analysis of tryptic BSA peptides eluted from batch-based TDE chromatography 
allowed the identification of all 35 Cys residues in the predicted BSA sequence (Figure S4.2, 
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Appendix 2). Of the 72 non-redundant peptides confidently identified (Table S1), 59 
contained at least 1 Cys residue. In addition, no Cys-containing peptides were identified in 
the unbound fraction (data not shown). To assess the efficiency of capture, 
spectrophotometric measurement of the TDE protecting group (2-thiopyridine, 2-TP) release 
versus Cys loading was undertaken (Figure 4.2a). 
 
Figure 4.2. Efficient capture of Cys peptides assessed by peptide quantitation and 
spectrophotometric assay. (a) Schematic showing TDE between functionalized resin and a Cys-
containing peptide to liberate the 2-thiopyridinone (2-TP) protecting group; (b) spectrophotometric 
measurement (343 nm) of 2-TP release versus Cys concentration, slope = 1.186 ± 0.015, R
2
 = 0.999, 
(c) quantitation of total peptide eluted from TDE resin, R
2
 = 0.998. Symbols as indicated in Figure 
4.1. 
 
A strongly positive linear correlation (r > 0.999) was observed with a low variance (R
2
 = 
0.999) and a slope close to unity (1.186 ± 0.015), indicating an almost equimolar reaction 
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between peptides and resin at all loadings (Figure 4.2b). The slightly higher slope (~ 1 : 1.2 
mole Cys : 2-TP) is likely due to the unbinding / re-binding of peptides containing vicinal 
thiols (Cys residues spaced 2-6 residues apart) as these are known to be highly reactive to 
TDE chemistry. This linear trend was also observed when the total peptide eluted from the 
column was measured, however, in order to assess whether this trend was indicative of linear 
covalent Cys binding or of increased non-covalent binding at higher loadings, label-free 
quantitation of eluted peptides was performed. 
4.3.3. Label-free quantitation of Cys-containing peptide capture by TDE 
Label-free quantitation was performed by MS peak area (PA) integration of 42 distinct m/z 
peaks, representing 33 Cys-containing and 9 non-Cys-containing BSA peptides, at 4 different 
peptide loadings (n = 6 experimental replicates at each loading; 24 experiments in total). The 
experimental variance / reproducibility at the same loading were indicated as either a PA ratio 
(Figure 4.3 and S4.3, Appendix 2) or average percentage (Table S2). Linearity with respect to 
loading amount was expressed as a slope (of a least squares regression, with intercept fixed at 
zero), linear correlation (r) and variance (R
2
 and % - Table S2). Integration over the entire 
retention time series for the 42 distinct m/z values at each loading indicated a high overall 
reproducibility between experiments (91 ± 9%) and high signal linearity (R
2
 = 0.998) with a 
slope of 1.00 ± 0.07. When individual peptide signals were considered (representative shown 
in Figure 4.3b and c, see Table S2 for complete list), it was observed that all 33 Cys-
containing peptides had a positive linear correlation greater than 0.97 (average: 0.99 ± 0.02) 
and an average slope close to unity (0.99 ± 0.05), however only three of nine non-Cys 
peptides fell within these parameters. For non-Cys containing peptides, average values for 
linear correlation (0.89 ± 0.20) and slope (1.03 ± 0.23) indicated a poorer fit to a linear trend 
and greater variability between peptides. In addition, experimental reproducibility was higher 
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for Cys-containing peptide PA replicates (average PA reproducibility: 87 ± 4%) than for non-
Cys peptides (average PA reproducibility; 72 ± 19%), indicating that the major contributors 
to high linearity and reproducibility of the total summed PA (Figure 4.3a) were the Cys-
containing peptides. 
 
Figure 4.3. Label-free quantitation of peptides eluted with increased loading. (a) A representative 
summed MS ion spectrum of two of six experimental replicates ‘A’ and ‘B’ with a replicate PA ratio 
of 0.97 (i.e. 97 % reproducible for n = 2 replicates); to the right, PA of all loadings (6 replicates per 
point) plotted as a ratio to the maximum load (linearity plot), slope = 0.995 ± 0.068, R
2
 = 0.998; (b) 
replicate extracted peak spectra (‘A’ and ‘B’) for the 749.319 m/z ion (Cys-containing, sequence: 
DDPHACYSTVFDK) indicating replicate PA ratios of 0.91, 0.94, 0.90 and 0.96 for sequential 
loadings, and linearity plot for all loadings with slope = 0.999 ± 0.054, R
2
 = 0.985, and; (c) as for (b) 
for the 630.314 m/z ion (non-Cys containing, sequence: HPYFYAPELLYYANK), replicate ratios of 
0.54, 1.88, 0.29 and 1.56, linear regression slope = 0.815 ± 0.316, R
2
 = 0.793. All replicate PA ratios 
are given as A / B, and loading or PA ratios for linearity plot are divided by the maximum loading. 
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The high reproducibility and capture linearity versus loading, summed MS ion integrals and 
individual Cys-peptide MS ion integrals confirmed the accuracy and reproducibility of the 
technique. Decreased or poorly reproducible peak areas of non-covalently bound peptides 
indicated their relative depletion. The accurate relative fold estimation of the technique 
makes it highly applicable to label-free quantitative studies or those that chemically label 
post-enrichment – allowing for the use of increased starting material to profile low abundance 
modifications. 
4.3.4. Reversibly oxidised Cys in rat myocardium 
We next attempted to determine whether the TDE batch-based method was compatible with 
very complex peptide mixtures at high sensitivity and selectivity. We utilised protein 
extraction conditions to ensure: (i) the prevention of artefactual Cys oxidation / TDE; and (ii) 
the efficient removal of free thiols in the absence of (mis-) alkylation at other sites. 
Extractions were performed at pH below neutral and in the presence of a metal ion chelator 
with complete first sphere coordination properties (DTPA) to slow auto-oxidation and TDE 
processes (Graf, Mahoney et al., 1984). The alkylating reagent NEM was utilized under 
previously optimized conditions (Paulech, Solis et al., 2013) to give complete Cys alkylation 
whilst limiting levels of alkylation at other sites. Namely, the alkylation reaction is performed 
under denaturing conditions and at acidic pH during extraction at 5 mM NEM as this 
concentration is shown to lead to few mis-alkylations even after prolonged reaction times (60 
min) followed by a higher concentration for a very short reaction time to alkylate any buried 
or unreactive Cys. To our knowledge few other studies have addressed these issues, which 
likely result in both false positive and negative identifications due to the highly reactive 
nature of Cys. 
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To assess whether the efficiency of capture seen for BSA peptides translated to a complex 
peptide mixture, a sequential binding experiment was performed where the unbound peptides 
from a primary round of TDE were applied to a secondary round of TDE and the resulting 
eluents analysed by LC-MS/MS (Figure 4.4). Both the primary and secondary rounds of TDE 
enrichment showed > 90% selectivity for Cys-containing peptides, however whilst the 
primary round of TDE contained 1988 non-redundant peptides corresponding to 737 proteins, 
the secondary round contained only 85 non-redundant peptides corresponding to 59 predicted 
high abundance proteins (e.g. myosin heavy chain) – with only 7 additional peptides found in 
the secondary round of TDE compared to the primary, but upon further fractionation (see 
below) no peptides were observed to be unique to this TDE round (Table S3). In the 
unbound, 2664 peptides from 555 proteins (data not shown) were observed with 10% 
containing Cys, however, all of these peptides were NEM alkylated at Cys and could not 
therefore have been captured by TDE. 
We next increased fractionation of the peptides eluted from TDE using offline HILIC 
coupled to online reversed phase LC-MS/MS. This approach identified 7110 non-redundant 
peptides from 2727 protein groups with 91% of the peptides containing Cys (Table S3). This 
study was therefore the largest global site-directed profile of reversibly oxidized Cys in the 
myocardium, or any cell / tissue type to-date. It should be noted that as these sites are 
observed in the absence of any exogenous oxidative / nitrosative agent they represent a 
database of sites modified under physiological conditions and thus potential sites of redox 
regulation / signalling independent of pathological stimuli. Bioinformatics was utilised to 
assess the potential function, distribution and common sequence features of these reactive / 
modified Cys. 
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Figure 4.4. Schematic and results of sequential binding and 2DLC-MS/MS studies on 
myocardial proteins by TDE. Schematic shows the process used for sequential binding and values 
for Cys-peptide specificity (% of total peptides) and number of unique proteins and peptides from 
each experiment. Symbols are as indicated in Figure 4.1. 
 
Gene Ontology (GO) assessment of captured proteins compared to a background reference 
(the prevalence of each GO term in the entire rat genome) allowed for the identification of 
over-represented classes of proteins. GO terms were ranked utilizing both a modified Fisher’s 
extract test (DAVID bioinformatics (Hosack, Dennis et al., 2003; Huang, Sherman et al., 
2009)) and a fold over-representation ratio to determine the most over-represented functions 
and sub-cellular locations associated with reversibly modified Cys (Figure S4.4, Appendix 2). 
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Of the 44 over-represented functional classes, 3 clear clusters could be observed: (i) 
oxidoreductases (5 GO terms) and anti-oxidants (peroxiredoxins were the most over-
represented term); (ii) extracellular matrix, receptor and surface proteins (7 GO terms); and 
(iii) structural stabilization (5 GO terms, including cytoskeletal functions). GO analysis of 
over-represented cellular localizations / complexes revealed an association with degradation 
and folding machinery (signalosome and proteasome), organelle / cell membranes 
particularly mitochondria (Figure S4.4b). A similar analysis was performed on sequence 
annotation features utilizing the UniProt database for the terms: ‘disulfide’, ‘S-nitrosylated’, 
‘sulfenic acid’ and ‘redox active’ (Figure S4.4c). As anticipated, these sequence annotation 
features were over-represented within the data set with 179 UniProt annotated disulfide bond-
containing, 16 redox active, 5 sulfenic acid forming and 12 S-nitrosylated proteins observed.  
Literature comparisons were undertaken to compare the enriched Cys sites to those obtained 
from previous analyses (Figure S4.5, Appendix 2), in particular S-nitrosocysteine 
enrichments, performed by BST (Murray, Kane et al., 2011), SNORAC (Kohr, Aponte et al., 
2011), SNOSID (Hao, Derakhshan et al., 2006) and organo-mercurial ion affinity (Doulias, 
Greene et al., 2010) in rat or mouse tissues. Approximately 90 % of the SNO-sites identified 
in studies utilizing rat or mouse myocardial samples (Kohr, Aponte et al., 2011; Murray, 
Kane et al., 2011) were observed here, as well as approximately 37 % of those observed in 
liver (Doulias, Greene et al., 2010) and 55% of those in brain (Hao, Derakhshan et al., 2006), 
Figure S4.5 (Appendix 2). Protein identifications, rather than Cys sites alone, yielded even 
higher levels of consistency between the studies (> 93 % in heart and > 56 % in other tissues) 
indicating these proteins may have multiple oxidatively modified Cys sites. The total overlap 
between previous studies (as based on protein identifications) was poor (< 20 %; Figure 
S4.5), likely due to the use of sub-cellular fractionation (Murray, Kane et al., 2011) to 
examine mitochondria, and tissue-specific protein expression or modification – which also is 
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the most likely reason for reduced overlap between this study and those in brain / liver. Taken 
together, these comparisons indicate that, (i) even without specific enrichment for S-
nitrosocysteine or subcellular fractionation of mitochondria (Murray, Kane et al., 2011) many 
similar sites are observed indicating the sensitivity of the technique and (ii) the overlap in 
Cys reversible PTM between tissues may be higher than previously indicated. 
An additional confounder was also considered as previous methods utilizing TDE for 
isolation of reversible Cys modifications have attempted to isolate SNO by ascorbate 
reduction (Jaffrey and Snyder, 2001, Kohr, 2011 #316; Kohr, Sun et al., 2011). Ascorbate 
however, is a relatively poor reducing reagent and few independently proven SNO sites have 
thus been identified. We identified 14 of the 20 SNO sites annotated in the UniProt database 
for the 12 proteins observed (accessions provided Figure S4.5). Twelve of these sites were 
not previously identified in S-nitrosocysteine proteomics enrichments (Hao, Derakhshan et 
al., 2006; Doulias, Greene et al., 2010; Kohr, Aponte et al., 2011; Murray, Kane et al., 2011). 
Ascorbate may be insufficiently active to reduce these sites or they may be artificially 
oxidised as the reduction is performed at basic pH and occasionally in the presence of copper. 
Extension of this analysis to identified SNO Cys peptides in a study of human pulmonary 
arterial endothelial cells through the use of CysTMT (Murray, Uhrigshardt et al., 2012), in an 
ascorbate / CuSO4 reduction strategy reveals 154/179 (86%) of the proteins identified in that 
study, as well as 67 % (n = 148/220) of the SNO sites. Endothelial cells represent only a 
small fraction of the cells in myocardial tissue (predominantly myocytes), further suggesting 
that our approach is capable of mining into the low abundance proteome. It should be noted 
however, that our technique does not currently distinguish between different reversible Cys 
modifications, and it is therefore not yet possible to unequivocally state the proportion of S-
nitrosylated sites versus other reversible Cys PTM within our dataset.  
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The predictive capability of this technique is shown by examination of the R. norvegicus NF-
ΚB p105 subunit (F1LQH2_RAT). We observe Cys59 to be redox modified (Figure S4.6, 
Appendix 2); this is an unannotated modification in R. norvegicus but a known S-
nitrosylation site in Homo sapiens (NFKB1_HUMAN), which influences DNA binding 
(Matthews, Botting et al., 1996). A second peptide (residues 115-128; Cys116/121) containing a 
vicinal thiol pair (CX4C) was also identified from NF-KB p105, and it is possible that this 
secondary vicinal thiol-containing peptide is involved in disulfide bonding and / or redox 
regulation, which is frequently observed for this motif (Gitler, Zarmi et al., 1997). 
Comparison of 13-mer sequences (-6 to +6 position) surrounding the captured Cys residues to 
a whole genome background by either motif analysis (MoxifX (Schwartz and Gygi, 2005)) or 
single amino acid frequency (Figure 4.5 and Figures S4.7 and S4.8, Appendix 2) revealed an 
over representation of acidic (Asp / Glu) and small, aliphatic (Ala) or polar (Gly) residues up 
or downstream of Cys. Single amino acid frequency also indicated an under representation of 
large / aromatic amino acids (His, Phe, Trp) as well as Cys and Ser. Calculations of the 
hydrophobicity of the local environment of Cys (13-mer sequences) by the Kyte-Doolittle 
scale (Kyte and Doolittle, 1982) revealed a slightly increased hydrophilicity for the captured 
Cys; -0.18 ± 0.68; in comparison to the background; -0.06 ± 0.90, likely due to the increased 
prevalence of Asp and Glu. 
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Figure 4.5. Sequence and motif analysis of residues surrounding reversibly modified Cys 
captured by TDE enrichment. Single amino acid over-representation identified the acidic amino 
acids Asp (a) and Glu (b) as well as the small amino acids Gly (c) and Ala (d) as over-represented, 
and large amino acids such as Phe and Trp (e) as under-represented surrounding reversibly modified 
Cys compared to a whole R. norvegicus background database (UniProt). Motif analysis (MotifX 
(Schwartz and Gygi, 2005)) also indicated an increased propensity for Asp (f), Glu (g), Gly (i) and 
Ala (j) residues surrounding reversibly modified Cys, either alone or in conjunction with each other 
(h) and (i), or with amino acids not identified by single amino acid combinatorial studies, e.g. Tyr (k). 
The zero position of all plots indicates the position of the central Cys, and six amino acids up and 
down-stream are considered. The 15% tolerance used for assigning globally over / under-represented 
amino acids is shown in grey for (a) – (e). Full details of all amino acids and motifs are given in 
Figures S4.7 and S4.8, Appendix 2. 
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These results provide evidence that acidic residues up or downstream of Cys may predicate 
reversible redox modifications. Whilst the acid-base motif was specifically suggested for S-
nitrosylation (Stamler, Lamas et al., 2001), this evidence indicates that an acidic residue at 
least may be relevant to a larger range of reversible Cys modifications (the role of a proximal 
base further than 6 positions from the Cys is also possible). The increased propensity of small 
amino acids and the under representation of large / and other oxidisable amino acids 
(concurrent with a slightly more hydrophilic environment) indicated open sites accessible to 
oxidant species may be preferred. 
 
4.4. Conclusions 
Cys oxidation is an increasingly important regulatory PTM in both health and disease. 
Techniques to qualitatively and quantitatively identify Cys modifications are few and often 
poorly optimised. Cys modifications where sulfur carries a low oxidation state (-I to 0) are 
reversible and are a means of redox regulation and protection from over-oxidation (to higher, 
biologically irreversible oxidation states) under increased oxidant load. Considering (i) the 
interrelation of most biological oxidants (most formed by secondary reactions of another), (ii) 
the reactivity of Cys with a large number of oxidants, and (iii) the sheer number of Cys 
modifications that may be formed; the grouping of these modifications for enrichment by 
their reduction properties (i.e., reversible vs. irreversible) may be the most practical means to 
globally profile the plethora of modified Cys residues present and changing within a complex 
system. This assures that; (i) all interrelated reversible Cys modifications may be profiled at 
once allowing for the use of less material for site discovery, and (ii) no assumptions are made 
as to the reactivity of certain sites which may interfere with quantitative results, i.e., fold 
changes are related to abundance of these modified sites and not due to their incomplete or 
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non-specific reduction and capture. TDE offers the ability to capture reversibly oxidised Cys 
residues following reduction without further derivatisation, by a chemistry that is specific to 
Cys (avoiding reaction with other nucleophilic residues) and that can be coupled to high 
sensitivity and resolution LC-MS/MS. We have shown the parameters of our TDE 
chromatography technique (i.e., specificity, capture efficiency, reproducibility and linearity) 
to be perfectly suited to quantitative relative fold estimation, and have utilised it to gain the 
largest list of reversibly Cys-modified peptides / proteins to date, allowing for the 
determination of functional classes and a particular acidic motif represented in this dataset. 
The scope for regulation of protein function and dysfunction by oxidative modification of 
Cys is growing ever larger as more studies identify proteins regulated by ROS / RNS. Our 
technique was shown to provide excellent profiling of known reactive and modified Cys sites 
– capturing sites not observed by single-modification-based studies whilst being able to 
capture other known reactive motifs (e.g. vicinal thiols), which may prove integral to redox 
regulation.  
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APPENDIX 2: SUPPLEMENTARY FIGURES 
Note: Extended supplementary tables (S1-3) are not provided in text but electronically. 
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Figure S4.1. Reduction of non-covalent interactions by changed binding and wash conditions. 
Non-covalent interactions are designated by an asterisk. (a) Organic as salt washes with a single low 
volume elution, (b) detergent wash with a single low volume elution, (c) batch-based, detergent wash 
with a high volume elution (series), (d) batch-based, aqueous wash and high volume elution. Non-
colvalent (*) peptide percentage of total (a) 61 %, (b) 58 %, (c) 8.3 %, (d) 42 %, number of Cys 
peptides identified (a) 7, (b) 15, (c) 21, (d) 21. 
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Figure S4.2. Amino acid sequence of BSA with Cys residues indicated (boxed). Peptides which 
were observed in the elution fraction and contain Cys are indicated in bold (shortest peptide sequence 
containing this site), whilst co-eluted peptides which do not contain a Cys are indicated in italics and 
underlined. 
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Figure S4.3. Summed MS peak areas (PA) of 42 BA peptides eluted from TDE chromatography 
including six replicate at each of four loadings. A selected retention time (Rt) window (700 – 1300 
s) is shown which contains all of the most intense peptide peaks, loadings are shown from highest (top 
left) to lowest (bottom right) with each replicate shown in a different colour. Individual peptide 
information is shown in Table S2. 
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Figure S4.4. Total terms / features identified as over-represented in TDE eluted proteins. Terms 
(a,b) are ranked in order of modified Fisher test value (modified p-value) from highest (top) to lowest 
(bottom) with bars representing the relative fold over-representation to a background reference (all R. 
norvegicus GO terms) for (a) molecular function and (b) cellular compartment. GO terms have been 
shortened for brevity. Over-representation of sequence annotation features related to reversible Cys 
PTM (c) against the UniProt database (background taxonomy identifier 10116). 
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Figure S4.5. Comparison of sites observed in four studies enriching for S-nitrosocysteine 
residues in rat and mouse tissues. The larger circle in all panels (blue) indicates the current study 
and the details of the UniProt identifiers of known S-nitrosylated proteins observed in the current 
study and not in the compared studies (the only known S-nitrosylated protein / site identified across 
all studies us GAPDH Cys150). Panels (a) and (c) represent studies performed in rat (Hao, 
Derakhshan et al., 2006) (lower circle, green) and mouse (Kohr, Aponte et al., 2011) (upper larger 
circle, red) myocardial tissue and detail the common Cys sites (a) and protein (c) observed. Panels (b) 
and (d) represent studies performed in rat brain (Jaffrey and Snyder, 2001) (lower circle, orange) and 
mouse liver (Doulias, Greene et al., 2010) (upper larger circle, purple) tissue, detailing the common 
Cys sites (b) and proteins (d) observed. 
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Figure S4.6. Tandem MS spectrum of the NF-ΚB p105 subunit (accession F1LQH2_RAT) 
containing Cys59 identified in the TDE eluent. This site is known to be S-nitrosylated in mouse and 
human homologues, and is indicated to be reversibly modified at this site in rat myocardial samples 
by our study. The asterisk within the peptide sequence indicates post-TDE iodoacetamide 
derivatisation at this site. 
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Figure S4.7. Ratios of the frequency of residue occurrence at each position in a 13-mer sequence 
surrounding Cys, in reference to a background of all Cys 13-mer sequences in the database 
(UniProt R. norvegicus). Position zero denotes the central Cys residue as is shown as 0 for all plots 
(including Cys) for clarity of comparison. Average ratios across all positions were utilised to asses 
trends for each amino acid and are; A 1.17. C 0.74, D 1.34, E 1.23, F 0.83, G 1.17, H 0.85, I 1.05, K 
1.03, L 0.87, N 1.12, P 0.90, Q 1.02, R 0.94, S 0.83, T 1.04, V 1.06, W 0.58, Y 1.01. Over and under-
represented amino acids showed a greater than 15 % deviation from background in their average 
position ratio, identifying A, D, E and G as over-represented and C, F, H, S and W as 
underrepresented. A range of amino acids were positionally under or over represented. 
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Figure S4.8. All linear sequence motifs identified in TDE, as reversibly modified in control 
myocardium. Size of letter indicates the prominence of the amino acid in that motif, with Cys located 
at position zero. Letter colouring indicates the chemical properties of amino acids; yellow, sulfur 
containing; red, acidic; green, small polar; black, aliphatic. Motif score, enrichment ratio and number 
of foreground hits and foreground size are given for each motif. 
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RESULTS 3: 
ENRICHMENT OF CYS SULFINIC AND SULFONIC ACID 
MODIFIED PEPTIDES BY MULTIDIMENSIONAL LC 
 
5.1. Background 
 
Cys is emerging as an integral site for protein PTM in response to physiological stimuli and 
pathological oxidative stress. Numerous studies have identified roles for biologically 
reversible Cys PTM including disulfides, S-nitrosothiols and sulfenic acids (Cys-SOH), at 
integral Cys sites in the regulation of protein function during redox signalling, reviewed in 
(Dröge, 2002; Valko, Leibfritz et al., 2007). In addition, a plethora of studies exist indicating 
that Cys sites can be oxidised during pathologies containing an element of oxidative stress 
e.g., neurodegeneration, cancer and cardiovascular disease (Valko, Leibfritz et al., 2007). 
In addition to these reversible Cys PTM, additional oxidative Cys PTM with no known 
means of enzymatic reversal have been identified. These modifications, namely sulfinic (Cys-
SO2H) and sulfonic acid (Cys-SO3H), are regarded as “over-oxidised” or “irreversible” 
modifications, primarily associated with oxidative stress. Despite the term “irreversible”, at 
least one example exists where Cys-SO2H is reversible; in Prx enzymes by the ATP-
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dependant enzyme, Srx (Biteau, Labarre et al., 2003). Srx is currently not thought to be a 
reduction system for Cys-SO2H in other proteins or for Cys-SO3H. Nonetheless, at basal 
levels, ~ 1 - 2 % of Cys sites may exist as Cys-SO2H/SO3H in some tissues (Hamann, Zhang 
et al., 2002) and the RSO2H modification has some functional significance in certain proteins 
e.g., DJ-1 which is activated during Alzheimer‟s disease by Cys-SO2H PTM at C106 
(Blackinton, Lakshminarasimhan et al., 2009).  
Cys-SO2H/SO3H are produced via sequential oxidation of Cys-SOH, which itself is formed 
by oxidation of the Cys thiol by ROS / RNS such as H2O2 and peroxynitrite. This reaction is 
relatively inefficient; requiring three equivalents of oxidant to fully oxidise the thiol, as well 
as the protection of the initial Cys-SOH from nucleophilic attack. Therefore, Cys forming 
these modifications, particularly at biologically relevant concentrations of oxidant, are likely 
to be either quite reactive or located in a unique microenvironment that accommodates the 
formation of such modifications without the reduction of the Cys-SOH first (e.g., by thiol or 
amine attack). These sites may be candidates as redox sensors and regulatory sites, for 
example by Cys-SOH – recently reviewed by (Lo Conte and Carroll, 2013). Whether Cys-
SO2H/SO3H however, are utilised as regulatory PTM physiologically or during times of 
elevated oxidative stress remains unknown. In any case, these PTM are poorly understood 
and better techniques are necessary to identify Cys-SO2H/SO3H-containing peptides from 
cells and tissues to determine their role. 
Most information on the formation of Cys-SO2H/SO3H modifications in complex samples 
comes either from amino acid analysis (hydrolysed protein lysates) (Hamann, Zhang et al., 
2002) or 2D-gel electrophoresis, where these PTM cause an acidic shift (Wagner, Luche et 
al., 2002; Jeong, Jung et al., 2010). The former technique provides no information on the 
proteins containing these PTM, whilst the latter relies on the modified protein population 
being of sufficient intensity to be observed, and / or the availability of specific antibodies to 
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proteins-of-interest.  One recent study was able to identify 44 Cys-SO2H/SO3H modified 
peptides in H2O2 oxidised (440 µM) cells without any enrichment, utilising long column 
ultra-high pressure LC and high resolution MS (Lee, Paull et al., 2013). Despite this, global 
analysis of these PTM would benefit from an efficient enrichment approach considering: (i) 
Cys residues are the second least abundant amino acid in proteins, ~ 1.5 % abundance (Pe'er, 
Felder et al., 2004), and (ii) Cys-SO2H/SO3H are expected to occupy only a minute fraction 
of these Cys. 
PTM peptide enrichment by LC, followed by shotgun proteomics is a common approach used 
successfully in the enrichment of several protein PTM, including phosphorylation 
(Beausoleil, Jedrychowski et al., 2004; Larsen, Thingholm et al., 2005). Relatively few 
studies however, have explored such techniques for Cys-SO2H/SO3H-containing peptides and 
none have performed studies in complex tissue lysates – only in single protein mixtures (Dai, 
Wang et al., 2005; Chang, Huang et al., 2010). Given that these PTM are amongst the most 
acidic protein modifications, with an average pKa of RSO2H < 2 and RSO3H ~ -3, it is 
pertinent to isolate such modified peptides by their unique charge distribution. At acidic pH, 
where non-modified tryptic peptides will have an average charge state between 1 and 2 
(depending on pKa of acidic residues and the C-terminus), Cys-SO2H/SO3H will have an 
added negative charge, and thus have an average charge distribution ≤ 1. Selection can 
therefore be performed on either positively or negatively charged resins with the former 
being a „positive‟ selection as they will be retained by the resin, whilst the latter is a 
„negative‟ selection as they will not be retained by the resin and will flow through. Both 
techniques have been utilised (Dai, Wang et al., 2005; Chang, Huang et al., 2010) in previous 
studies to capture peptides derived from BSA oxidised by performic acid – causing scission 
of disulfide bonds and conversion of Cys to Cys-SO3H, and Met to the sulfone Met(O2). The 
studies gave comparative results, with positive selection (Chang, Huang et al., 2010) 
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increasing site coverage in comparison to negative selection (Dai, Wang et al., 2005) – 60 % 
versus 45 % - at the expense of specificity, with more non-Cys peptides observed in the 
elution. 
Given the common practice of peptide fractionation with strong cation exchange (SCX) as a 
first dimension during shotgun proteomics, we wished to explore its utility in identifying 
Cys-SO2H/SO3H sites in complex samples. We optimised fractionation to allow for increased 
coverage of Cys-SO2H/SO3H sites in complex myocardial protein extracts. Performic 
oxidised BSA and myocardial protein extracts were utilised to study the interactions 
occurring at each step of the method, and then the method was applied to myocardial protein 
extract that had been exposed to a high concentration of a less efficient oxidant (H2O2). 
Finally, the method was used to identify Cys-SO2H/SO3H-containing peptides derived from 
either physiologically relevant concentrations of H2O2 (i.e., ≤ 100µM, an estimate of the 
likely pathological H2O2 levels (Stone and Yang, 2006; Schroder and Eaton, 2008)) or from 
rat myocardial tissue subjected to IR injury by Langendorff perfusion. 
 
5.2. Experimental Section 
5.2.1. Performic oxidation and tryptic digestion of BSA 
Performed as detailed in Section 2.7.1 for BSA. 
5.2.2. Langendorff Perfusion 
NITC and IR tissues were utilised for this analysis, and were generated and handled as 
indicated in Section 2.2. 
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5.2.3. Myocardial native / soluble protein extraction and H2O2 oxidation  
A soluble protein extract was prepared as indicated in Section 2.3.2 and oxidised by H2O2 as 
indicated in Section 2.7.2. 
5.2.4. Denaturing protein extract of myocardial tissue proteins 
Prepared as indicated in Section 2.3.1. 
5.2.5. Performic oxidation of myocardial protein tryptic digest 
 A denatured protein extract was prepared as detailed above in the absence of reducing and 
alkylating steps (i.e., no NEM in extraction buffer and without DTT reduction) to preserve 
disulfides. Samples were digested and cleaned up as described in Section 2.5 prior to 
performic acid oxidation of peptides as detailed in Section 2.7.1. 
5.2.6. Offline multidimensional liquid chromatography (SCX-HILIC) 
SCX fractionation was performed as indicated in Section 2.8.3. Further HILIC fractionation 
was performed as detailed in Section 2.9.1, with three to eight fractions taken depending on 
individual sample complexity, judged by spectrophotometric absorbance. 
5.2.7. LC-MS/MS 
Initial studies in BSA and performic oxidised extract fractionated by SCX were performed as 
detailed in Section 2.10.1 on gradient (a). Follow-up studies (all SCX-HILIC fractionated 
samples) were acquired as described in either: (i) Section 2.10.2 on gradient (c) with 
alternating HCD / CID MS method (top 4 method), or (ii) Section 2.10.3 on gradient (a). 
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5.2.8. Data analysis 
 Performic oxidised peptide data were searched against the UniProt database (BSA) or 
UniProt Rattus norvegicus database (taxonomy number 10116; release 2013_11) using an in-
house Mascot server. Parameters were one missed cleavage, variable modifications: Met(O2), 
and Cys(O3), pyroglutamate (pyroGlu) at Q/E, acetyl (protein N-terminus). The modification 
phospho (ST) was utilised for initial performic oxidised extract searches to the judge levels of 
enrichment of contaminating phosphopeptides on HILIC. Instrument-dependent peptide / 
fragment tolerances of searches were; 0.2 Da / 0.2 Da (QSTAR), 10 ppm / 0.1 Da (Orbitrap), 
and 50 ppm / 0.1 Da (5600 T-TOF). H2O2 oxidised myocardial peptide data were searched 
against the UniProt R. norvegicus database, as above with the addition of the variable 
modifications; Cys(O2), Met(O), and without pyroGlu at E and phospho (ST) as these were 
not major contaminants in the SCX-HILIC fractions. Non-oxidised (denatured protein 
extract) myocardial peptide data were searched as for H2O2-oxidised peptides with the 
addition of the variable modifications; NEM (C) and methylthio (C). All searches were 
performed against a decoy database which was used to filter identifications to a < 2% FDR. 
5.2.9. Bioinformatics 
Gene Ontology (GO) terms were obtained via input of UniProt identifiers into the DAVID 
bioinformatics tool (Huang, Sherman et al., 2009) with a background reference of all GO 
terms from R. norvegicus. Values were obtained for fold over-representation and modified 
Fisher Extact calculation (Hosack, Dennis et al., 2003) and used to rank the results for 
functional clustering. 
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5.3. Results and Discussion 
5.3.1. Modified SCX strategy for the negative selection of performic 
oxidised Cys 
A common SCX strategy is to bind peptides in a low pH aqueous mobile phase containing 
low salt and a percentage of organic solvent, typically MeCN at 20 - 30% (v/v). The latter 
condition is included to limit hydrophobic retention of peptides and thus increase 
orthogonality when coupled to reverse phase separation. A mobile phase pH of ~ pH 2.5 - 3 
(most commonly used) is within the average pKa range of Asp (3.5 ± 1.2) and the C-terminus 
(3.3 ± 0.8) in proteins (Grimsley, Scholtz et al., 2009). It is thus estimated that many more 
peptides which do not contain Cys-SO2H/SO3H will be neutral at this pH than previously 
indicated by (Dai, Wang et al., 2005) – even in the absence of biological PTM (e.g., amine 
acetylation, protein cleavage, etc.).  Retention of neutral peptides by the SCX resin via 
hydrophobic forces would thus be advantageous to increase the negative selection of Cys-
SO3H peptides in the presence of unmodified peptides with a neutral charge (which will 
likely be retained by the resin by hydrophobic forces). 
SCX (pH 2.5) of performic oxidised BSA peptides in the absence of an organic modifier gave 
in the “flow through” (FT) 20 Cys-SO3H sites on 14 peptides, with 67 % of peptides 
containing a Cys-SO3H and the remainder constituting either non-tryptic cleavages or the 
protein C-terminus (Supplementary Table S1). When 25 % (v/v) MeCN was included in the 
mobile phase, only 1 additional Cys-SO3H site was identified but 9 additional unmodified 
peptides were present, only ~ 30 % peptides contain Cys-SO3H in total. This indicates that 
the initial binding of peptides in aqueous buffer to obtain the FT fraction and then performing 
a subsequent wash with buffer containing an organic modifier, is advantageous in depleting 
hydrophobic / neutral peptides from the FT. 
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An additional 9 Cys-SO3H BSA peptides were recovered in the 15 % (w/v) KCl wash with 48 
% of peptides in this fraction containing the modification. All Cys-SO3H peptides observed 
here contained an additional charged residue arising from a His (9 peptides), a missed 
cleavage (1 peptide) or an Arg / Lys followed by Pro, (R/K)-P, which is uncleaved by trypsin 
(4 peptides).  No additional sites were observed at higher concentrations of KCl. Overall, 86 
% of Cys-SO3H sites in BSA were observed, which is an improvement over both previous 
methods that observed 45 % (Dai, Wang et al., 2005) and 60 % (Chang, Huang et al., 2010), 
respectively. 
To investigate the method in a complex biological sample, we performed performic oxidation 
of a myocardial protein digest.  Initially, an extended SCX gradient of 16 steps 
(Supplementary Table S2) was performed to allow for the clustering of similarly charged 
peptides into fractions and thus avoiding dilution of peptide signals (Figure S5.1, Appendix 
3). It was then possible to categorise 6 charge distributions (Figure 5.1a) and these [KCl] 
were used for all further SCX fractionations. The FT distribution was the only fraction 
skewed to the left (negatively charged) indicating electrostatic repulsion of some peptides 
from the resin. The organic wash (MeCN) fraction contained primarily neutral peptides, 
which are most likely retained by non-charge mediated interactions (i.e., dispersive). 
Calculations of the Kyte-Doolitle hydropathy (Kyte and Doolittle, 1982) – estimating the 
value of Cys-SO3H to be equivalent to Arg – showed that peptides in the FT were more 
hydrophilic than those in the MeCN wash (average of -8.3 and -2.3, respectively). Given that 
both fractions appear relatively hydrophilic, we attempted to increase the elution of 
hydrophobic peptides by increasing the organic content to 50 %, however this did not 
increase the number of peptides eluting in this fraction. All SCX elution steps (1 – 100 % 
KCl) could be subdivided into 4 charge distributions (10%, 25%, 40% and 100%, which 
reflect the highest KCl concentrations demonstrating a distribution). The 1 – 10 % KCl 
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distribution contains almost entirely singly charged peptides and the higher fractions contain 
increasingly positively charged peptides. 
 
Figure 5.1. Resolution of Cys-SO3H peptides from performic oxidised myocardial extract by 
SCX. (a) In-solution charge distributions of peptides across the 6 summed SCX fractions, plotted as 
% of PSMs for each fraction; (b) unique peptides as a % of total identifications occurring in all 
fractions, plotted for total peptides and Cys-SO3H peptides, across the 6 SCX fractions; (c) Cys-
SO3H, pyroglutamate and acetyl-modified and unmodified peptides as a % of total identified peptides 
in each fraction. 
 
The complexity of the samples, measured as the percentage of total unique peptide 
identifications found in each fraction (Figure 5.1b), indicated that the most complex fractions 
were the salt elutions with 84 % of identifications arising from these fractions. A similar plot 
however, for unique Cys-SO3H identifications as a percentage of the total identified indicated 
that the initial fractions contain 71 % of the identified Cys-SO3H peptides – indicating good 
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selection of these peptides into the relatively lower complexity FT and MeCN fractions 
(Figure 5.1b and Table S2). Generally we observe that the FT is more enriched in Cys-SO3H 
peptides (Figure 5.1c) with 72 % of identifications containing this modification, in 
comparison to the MeCN fraction with 43 % of identifications. All salt fractions displayed a 
lower percentage of Cys-SO3H peptides, with fewer than 15 % of identifications containing 
the modification and the majority of these (~ 55 %) contained in the 10 % KCl fraction. 
Many of the non-oxidised peptides in the FT and MeCN fractions contained PTM, such as 
amine acetylation (protein N-terminus) and cyclisation of the peptide N-terminus at Glu and 
Gln to form pyroGlu. These PTM reduce the in-solution charge of these peptides and result in 
them not being retained by the resin. It could be argued that these PTM also make the 
peptides more hydrophobic, and this may be why a greater % are observed in the MeCN 
fraction. All salt fractions contained predominantly unmodified tryptic peptides. 
 
5.3.2. Positive selection by HILIC improves Cys-SO3H peptide 
identification 
Given that the predominant contaminating peptides in the FT and MeCN fractions are N-
terminal modifications that are expected to decrease hydrophilic interactions, we explored the 
use of HILIC to further enrich for Cys-SO3H in performic oxidised myocardial extracts 
(Supplementary Table S3). Whilst Cys-SO3H modified peptides fractionated by SCX (FT, 
MeCN) retain well on HILIC, denoted by increased peptide spectral matches (PSMs) to these 
peptides in HILIC fractions containing increased aqueous composition (Figure 5.2a), other 
peptides were relatively depleted. The possible exceptions are phosphopeptides which are 
relatively sparse contaminants in early SCX fractions (< 10 % of PSMs in FT and MeCN) in 
comparison to N-terminally modified and unmodified tryptic peptides (approximately 20 – 30 
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% of PSMs). It was noted that the complete elution of Cys-SO3H peptides in the FT fraction 
required a higher % aqueous phase than the MeCN fraction, necessitating the use of 48 % and 
43 % H2O, respectively. This again highlights the difference in the population of these two 
SCX fractions; even after HILIC fractionation we only observed 15 % of the total and 16 % 
of the Cys-SO3H peptide matches as shared between FT and MeCN (Table S3). 
 
Figure 5.2. Coupling of HILIC to SCX fractionation to positively select for Cys-SO3H (a) % of 
total peptide spectral matches arising from unmodified / modified peptides with increasing aqueous 
phase, (b) percentage of total Cys-SO3H identifications arising from FT, MeCN and 10 % KCl 
fractions following HILIC. Inset shows the subdivision of peptides contained within the 10 % KCl 
fraction by whether they are His-containing or contain a missed cleavage / (R/K)-P site. 
 
The HILIC strategy does not aid in the further enrichment of Cys-SO3H peptides that 
fractionate by SCX into the salt fractions (Figure S5.2a, Appendix 3). These fractions contain 
many basic peptides which, like Cys-SO3H peptides, will retain well on HILIC, and are of 
much higher abundance in the sample. The extra dimension of chromatography however, 
does increase coverage of Cys-SO3H sites in the 10 % KCl fraction, which comprise ~ 10 % 
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of the peptides identified. This fraction contains ~ 15 % of unique Cys-SO3H identifications 
(Figure 5.2b) and this peptide population almost all contain an additional positively charged 
residue in their sequence. This is most commonly His (58 %), but may also be the result of a 
missed cleavage (7 %) or a (R/K)-P site (24 %). Subsequent salt fractions were much less 
informative with < 1% of unique Cys-SO3H peptides observed in these fractions overall. 
Given this lack of additional site information it was decided further analysis would 
concentrate on FT, MeCN and 10 % KCl fractions. A general schematic of the developed 
method is presented in Figure 5.3. 
 
5.3.3. Enrichment of Cys-SO2H/SO3H in H2O2 oxidised myocardial extract  
Performic acid is a much stronger oxidant than proteins will encounter biologically, resulting 
not only in the oxidation of thiols but also the scission of disulfides, which are otherwise 
relatively inert to oxidation, and complete reaction to Cys-SO3H. A more common path to 
Cys-SO3H is sequential oxidation via Cys-SOH and Cys-SO2H, which is the pathway for 
oxidants such as H2O2. This is a much less efficient reaction and will thus result in the 
formation of fewer irreversible modifications and include both Cys-SO2H and Cys-SO3H. 
Therefore, we decided to test the protocol with myocardial protein extract, which had been 
oxidised with a high concentration of H2O2 (10 mM). A native protein sample was chosen for 
oxidation so as to: (i) preserve any Cys reactivity designated by 3D structure (e.g., Prx), 
which is not present once denatured, and (ii) to prevent oxidation of sites that are not 
normally accessible to H2O2. 
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Figure 5.3. Schematic of SCX-HILIC method for the enrichment of irreversibly oxidised Cys 
(oxCys). Initial binding of peptide samples by SCX chromatography in an aqueous buffer allows for 
electrostatic repulsion of peptides containing oxCys and their negative selection into the FT fraction. 
Subsequent washing with an aqueous phase containing an organic modifier will liberate hydrophobic 
and neutral oxCys peptides retained by the resin along with an increasing amount of neutral non-
oxCys peptides (e.g., PTM peptides). Elution with a low salt concentration will elute retained oxCys 
peptides containing basic residues (H/K/R), as well as singly charged tryptic peptides, whilst 
increased salt concentrations will elute increasingly positive tryptic peptides. oxCys peptides from the 
initial fractions may be positively selected by HILIC chromatography where they retain later than 
more hydrophobic PTM peptides. 
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Figure 5.4. Fractionation of peptides generated from myocardial extract oxidised by 10 mM 
H2O2 (a) % of total unique and unique Cys-SO2H/SO3H peptides identified in each fraction; (b) 
enrichment of PSMs corresponding to Cys-SO2H/SO3H peptides with increased aqueous phase by 
HILIC, with the % total representing the % observed over all fractions. 
 
Following SCX-HILIC fractionation and LC-MS/MS (Figure 5.3), we observed 121 oxidised 
Cys sites containing irreversibly oxidised Cys with 14 observed as Cys-SO2H, 80 as Cys-
SO3H and 27 in both forms (Supplementary Table S4). The Cys-SO2H/SO3H peptides 
observed following H2O2 oxidation fractionate similarly to the performic oxidised peptides 
(Figure 5.4a), with 53 % of unique Cys-SO2H/SO3H peptides first observed in the FT (86 
peptides, 64 sites), an additional 39 % observed in the MeCN fraction (63 peptides, 47 sites), 
and only 8 % in the 10 % KCl fraction (13 peptides, 10 sites), despite more extensive 
fractionation of the 10 % KCl fraction (compared to FT and MeCN) in an attempt to increase 
site observation. The 10 % KCl fraction was considerably more complex as we identified 
9761 unique peptides not containing Cys-SO2H/SO3H (68 % of total peptide identifications 
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across the three fractions), with 3454 identified in the MeCN fraction (24 % of total) and 997 
in the FT (8 % of total). 
Cys-SO2H/SO3H peptides from H2O2-treated proteins also retain well on HILIC but, due to 
their low abundance, were never a majority population, representing at most 6 – 8 % of 
unique PSMs (Figure 5.4a). This is not however, a trivial level of enrichment as these PTM 
are estimated to be present at < 2 % of Cys residues (Hamann, Zhang et al., 2002), whilst N-
terminal acetylation for example occurs at many, if not most, protein N-termini. Again, the 
largest contaminants were acetylated protein N-termini, N-terminal pyroGlu and unmodified 
tryptic / non-tryptic peptides (e.g., protein C-termini). It is worth noting that with the 
increased total peptide loading that is necessary to observe Cys-SO2H/SO3H in H2O2-treated 
samples (which is still less than the binding capacity of the resin), decreased retention of 
acidic peptides was observed, particularly in the MeCN fraction, with 51 % of unmodified 
peptides containing two or more acidic residues in their sequence. Reduction of loading and 
wash volumes, to prevent increased hydrophilic partitioning at increased loads, did not reduce 
this. It would therefore be best to utilise a column with a much higher loading capacity (> 
100 µg) as it would likely reduce this effect and allow for the increased observation of low 
abundance sites. 
The biological range for H2O2 concentration ([H2O2]) is a point of considerable conjecture, 
but the general range of physiologically relevant concentrations is 1 – 700 nM (Stone and 
Yang, 2006) with an upper limit of 1 - 15 µM measured in some tissues (Schroder and Eaton, 
2008), whilst the pathological concentrations are not thought to often exceed 200 µM 
(Schroder and Eaton, 2008). Thus, measurements made above these levels may not be 
physiologically relevant and may result in the oxidation of relatively unreactive sites. 
Reflecting the abovementioned ranges, isolation of irreversibly oxidised Cys was undertaken 
in rat myocardial proteins exposed to 100 nM, 10 µM and 100 µM H2O2. At 100 nM, 52 sites 
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were observed (Figure 5.5a and Supplementary Table S4), with 9 Cys-SO2H, 26 Cys-SO3H 
and 17 Cys-SO2H/SO3H sites. At higher [H2O2] this increased, with 73 observed at 10 µM 
H2O2 (10 Cys-SO2H, 35 Cys-SO3H and 28 Cys-SO2H/SO3H) and 97 sites at 100 µM H2O2 
(16 Cys-SO2H, 57 Cys-SO3H and 24 Cys-SO2H/SO3H). In total, 116 sites were observed 
across all concentrations with a large number (39 sites) observed across all three [H2O2] 
(Figure 5.5b and Table S4). Many sites were also observed uniquely to the 100 µM [H2O2] or 
shared between the 10 µM and 100 µM concentrations.  
 
Figure 5.5. Cys-SO2H/SO3H-containing peptide identifications in myocardial extracts oxidised 
by [H2O2] and myocardial tissue subjected to Langendorff perfusion (NITC and IR) (a) Number 
of sites observed in each sample, with total sites, Cys-SO2H and Cys-SO3H sites denoted, (b) overlap 
of Cys-SO2H/SO3H sites identified at 100 nM, 10 µM and 100 µM H2O2. Full site identification 
information available in Supplementary Tables S4A-F. 
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By increasing pre-fractionation steps, we were able to observe an increase in coverage of the 
irreversible Cys proteome even when measuring sites produced at [H2O2] less than a quarter 
of those applied in other studies (Lee, Paull et al., 2013). The main reason for advocating a 
method with no pre-fractionation would be to decrease artefacts, but as all chromatography 
techniques are performed at acidic pH (< 3) and on peptides, artefact generation is much 
more likely to occur during extraction and digestion than during pre-fractionation. To couple 
this method to site determination in tissues that are not to be treated with exogenous oxidants, 
care should be taken to avoid formation of artefacts by performing extractions at low pH, in 
solutions containing strong denaturants (e.g., detergents), low pH alkylating agents and metal 
ion chelators. Protease inhibition is of particular importance as this method is particularly 
sensitive to non-tryptic proteolysis occurring at any stage in the protocol. Conversely, the 
method will also be sensitive to incomplete tryptic cleavage, which will increase the % of 
Cys-SO2H/SO3H sites eluting in the SCX salt fractions. To ensure low levels of missed 
tryptic cleavages, increased trypsin : protein ratios should be utilised for digestion. 
Unfortunately, increasing pH, reaction time and temperature of digestion will also lead to 
increased formation of pyroGlu at N-termini. Any increased contamination of the FT / MeCN 
by pyroGlu peptides should be endured as the chance of resolving correctly cleaved Cys-
SO2H/SO3H from pyroGlu in these fractions by HILIC is much higher than resolving missed 
cleaved Cys-SO2H/SO3H peptides from unmodified tryptic peptides in SCX salt fractions. 
5.3.4. Enrichment of Cys-SO2H/SO3H following myocardial IR injury 
Whilst protein extracts / cells treated with exogenous oxidants are the most common samples 
analysed thus far for irreversible Cys oxidation, they remain a questionable model of 
pathology. Thus, we sought to decipher whether the method could be applied to myocardial 
tissue subject to IR injury by Langendorff perfusion. IR injury is associated with acute 
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oxidative stress during ischemia and particularly reperfusion, and is thought to be associated 
with oxidative protein damage leading to contractile dysfunction and eventually apoptosis 
and necrosis.  
Taking into account the tissue extraction conditions discussed above, we performed 
enrichment of Cys-SO2H/SO3H peptides from tissue subjected to either 30 min of control 
perfusion (NITC) or 15 min no-flow ischemia with 15 min reperfusion (IR). From the 
denatured NITC extract we observed 27 sites; 7 Cys-SO2H, 18 Cys-SO3H and 2 Cys-
SO2H/SO3H sites (Figure 5.5a and Table S4). Following IR, the number of sites observed 
increased 3-fold, with 89 sites observed; 12 Cys-SO2H, 50 Cys-SO3H and 27 Cys-
SO2H/SO3H sites. It was noted that many of the sites observed as oxidised in IR were also 
observed in H2O2-treated extracts (70 %, Table 5.1), indicating that these may be at least 
pathologically relevant oxidation sites, and site identification numbers are very similar to the 
100 µM H2O2 sample (Figure 5.5a). In NITC tissue, the overlap to H2O2-treated extracts was 
similarly high (61 %), with the unique peptides largely representing myofilament / 
cytoskeletal proteins which were unobserved in H2O2 treated samples likely due to their low 
solubility in aqueous solutions without denaturants. 
Irreversible protein oxidation, particularly of the myofilament, has been suggested as a 
potential cause of decreased contractility of the myocardium following IR (Canton, Neverova 
et al., 2004; Duncan, Ravi et al., 2005; Canton, Skyschally et al., 2006; Hertelendi, Toth et 
al., 2008). The myofilament / cytoskeleton does appear to be a site of irreversible Cys 
oxidation, with 7 Cys-SO2H/SO3H sites contained on 6 myofilament / cytoskeletal proteins in 
NITC samples, and increasing to 14 sites on 13 proteins following IR (Table 5.1 and Table 
S4). When functional clustering was performed (Figure S5.3, Appendix 3), several other 
clusters were also observed to be over-represented. The most over-represented cluster 
contains mitochondrial proteins, likely due to both the role of mitochondria in oxidant 
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generation and also their high abundance in myocardial tissue. The second over-represented 
cluster were oxidoreductases, as their role in electron-transport likely makes them susceptible 
to oxidation, particularly those containing metal-centres or those involved in the 
detoxification of oxidants (e.g., Prx). Further sub-clustering indicates energy utilisation 
pathways in particular are over-represented (Table 5.1), including proteins involved in 
glycolysis (5 / 10 enzymes), the citrate cycle (6 / 9 enzymes), electron transport chain (ETC) / 
ATP synthesis (9 proteins), and fatty acid / amino acid metabolism (12 proteins). 
Interestingly, we observed their Cys oxidation state across NITC and IR to be quite distinct. 
Whilst glycolytic enzymes contain Cys-SO2H/SO3H even in NITC tissue, citrate cycle 
enzymes and electron transport / ATP synthesis enzymes are almost only observed to contain 
Cys-SO2H/SO3H following IR (or H2O2 treatment). This may be due to their differing 
subcellular localisation, i.e., cytoplasmic versus mitochondrial, but a similar trend is not 
observed for proteins involved in fatty acid / amino acid metabolism, many of which are also 
located in the mitochondria and are still observed as oxidised in NITC tissue.  
Over all the conditions studied (NITC, IR and H2O2 treatment), 188 Cys-SO2H/SO3H sites 
were observed, which constitutes by far the largest number of irreversibly modified Cys sites 
currently revealed in the literature. Interestingly, ~ 30 - 50 % of total site identifications 
under each condition contained Cys-SO2H, whereas substantially more (70 – 80 %) could be 
monitored in the Cys-SO3H form (Figure 5.5a). This may either be because: (i) Cys-SO2H is 
more efficiently oxidised to Cys-SO3H than Cys-SOH is to Cys-SO2H; or (ii) Cys-SO3H 
gives better spectral characteristics for assignment. The observation that the Cys-SO2H 
peptide % of total Cys-SO2H/SO3H identifications negatively correlated with [H2O2] may 
indicate that the former is a possibility (with IR sitting in between 10 and 100 µ M H2O2 
samples). Although, as the NITC had the lowest Cys-SO2H % of total Cys-SO2H/SO3H 
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identifications (similar to 10 mM H2O2) this may indicate that spectral assignment at low 
intensities may be better for Cys-SO3H. 
To our knowledge, this is the only proteomics study to enrich Cys-SO2H/SO3H from tissue 
which has not been subject to exogenous oxidant addition. The sites observed agree well with 
sites that are known to be reversibly Cys modified under various conditions, indicating that 
multiple PTM occur at these Cys sites, including both reversible and irreversible 
modifications. Comparing the sites we observed with a database of annotated sites (RedoxDB 
(Sun, Wang et al., 2012)) generated from composite studies across multiple organisms, we 
observe that 40 % of the Cys-SO2H/SO3H sites occur at previously identified reversibly 
modified Cys, and an additional 12 % occur on proteins which are identified as redox 
modified at unknown sites (Table S4). Extending this analysis to include our recent study of 
reversibly modified Cys in the myocardium (Paulech, Solis et al., 2013), we see that only 20 
% of Cys-SO2H/SO3H modifications are located at sites which are novel redox sites, i.e., not 
known to be occupied by a reversible Cys PTM (Table S4). 
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Table 5.1. Summary of Cys-SO2H/SO3H peptides observed in Langendorff perfused myocardial 
tissue (NITC, IR protocols) showing the overlap to the H2O2-treated protein samples. Proteins which 
contain Cys-SO2H/SO3H PTM are clustered by biological function. Sites were observed as shown, 
with the numbers indicating observation of: "2" the sulfinic acid, "3" the sulfonic acid, "2,3" both 
forms independently, "(2,3)" both forms on the same peptide, "(2,2)" a doubly modified peptide. ** 
Indicates the site was observed in the 10 mM H2O2 concentration only. 
Protein 
Identifier Protein Description  Peptide Sequence 
Cys-SOnH (n = 2 or 3) 
NITC IR H2O2 
GLYCOLYSIS / GLUCOSE METABOLISM 
ALDOA_RAT 
Fructose-bisphosphate 
aldolase A ALANSLACQGK   2,3 2,3 
TPIS_RAT Triosephosphate isomerase CLGELICTLNAAK 3 
 
2,3 
    IAVAAQNCYK   3 3 
    IIYGGSVTGATCK   3 3 
G3P_RAT 
Glyceraldehyde-3-
phosphate dehydrogenase VPTPNVSVVDLTCR 3 2,3 2,3 
    IVSNASCTTNCLAPLAK 2 2,3 2,3 
F1M3E5_RAT 
Uncharacterized protein 
(GAPDH family) IVSNASGITNCLAPLAK 2,3 2,3 2,3 
M0R4Q0_RAT 
Uncharacterized protein 
(GAPDH family) IIVSNASCTTNCLAPLAK 3   2,3 
ENOB_RAT Beta-enolase VNQIGSVTESIQACK   2,3 2,3 
D4ADU8_RAT Pyruvate kinase KLHATCAEGIDVAK 2 2   
KPYM_RAT Pyruvate kinase PKM AEGSDVANAVLDGADCIMLSGETAK 3 3   
LDHA_RAT L-lactate dehydrogenase A  VIGSGCNLDSAR   2,3 2,3 
    
 
  
 
  
CITRIC ACID CYCLE 
ODPB_RAT 
Pyruvate dehydrogenase 
E1 component subunit beta EGIECEVINLR   3 3 
CISY_RAT Citrate synthase LPCVAAK   2,3 2,3 
ACON_RAT 
Aconitate hydratase, 
mitochondrial VGLIGSCTNSSYEDMGR 3 2,3 2,3 
IDHP_RAT Isocitrate dehydrogenase CATITPDEAR   2,3 2,3 
    VCVQTVESGAMTK   2,3 2,3 
DHSA_RAT 
Succinate dehydrogenase 
[ubiquinone] flavoprotein VGSVLQEGCEK   3 3 
MDHC_RAT 
Malate dehydrogenase, 
cytoplasmic ENFSCLTR   3 3 
    VIVVGNPANTNCLTASK   2,3 2,3 
MDHM_RAT 
Malate dehydrogenase, 
mitochondrial EGVIECSFVQSK   2,3 2,3 
    ETECTYFSTPLLLGK   2,3 2,3 
    GCDVVVIPAGVPR 3 2,3 2,3 
    GYLGPEQLPDCLK   3 2,3 
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ELECTRON TRANSPORT / ATP SYNTHESIS 
ATP5H_RAT ATP synthase subunit d NCAQFVTGSQAR   2,3 2,3 
ATPG_RAT ATP synthase subunit γ GLCGAIHSSVAK   3 3 
ATP5E_RAT ATP synthase subunit ε FSQICAK   3   
ETFA_RAT 
Electron transfer 
flavoprotein subunit α LGGEVSCLVAGTK   3 2,3 
QCR1_RAT 
Cytochrome b-c1 complex 
subunit 1 LCTSATESEVTR   2,3 2,3 
    YFYDQCPAVAGYGPIEQLSDYNR 3   2** 
QCR2_RAT 
Cytochrome b-c1 complex 
subunit 2 NALANPLYCPDYR   3 2,3 
COX5B_RAT 
Cytochrome c oxidase 
subunit 5B, mitochondrial CPNCGTHYK   3   
B2RYW3_RAT 
NADH dehydrogenase 
(Ubiquinone) 1 beta 9 AFCAPPAYLTHR   3 3 
NDUS1_RAT 
NADH-ubiquinone 
oxidoreductase 75 kDa AVTEGAQAVEEPSIC   3 3 
            
FATTY ACID / AMINO ACID METABOLISM 
ACADS_RAT Short-chain specific acyl-
CoA dehydrogenase 
IGCFALSEPGNGSDAGAASTTAR 3   3** 
  IGIASQALGIAQASLDCAVK   3 3 
ACADV_RAT 
Very long-chain specific 
acyl-CoA dehydrogenase SSAVPSPCGK   2,3 2,3 
ACADL_RAT 
Long-chain specific acyl-
CoA dehydrogenase CIGAIAMTEPGAGSDLQGVR   2,3 2,3 
ACADM_RAT 
Medium-chain specific 
acyl-CoA dehydrogenase MTEQPMMCAYCVTEPSAGSDVAGIK 2 
 
  
ECHM_RAT Enoyl-CoA hydratase TFQDCYSGK   3 3 
THIL_RAT 
Acetyl-CoA 
acetyltransferase QATLGAGLPIATPCTTVNK   3 3 
    VCASGMK   2 2,3 
MCAT_RAT 
Carnitine/acylcarnitine 
carrier protein CLLQIQASSGK   3   
AATC_RAT 
Aspartate 
aminotransferase, 
cytoplasmic SCASQLVLGDNSPALR   2,3 2,3 
AATM_RAT 
Aspartate 
aminotransferase, 
mitochondrial TCGFDFSGALEDISK 3 2,3 2,3 
    VGAFTVVCK   3 3 
MMSA_RAT 
Methylmalonate-
semialdehyde 
dehydrogenase CMALSTAVLVGEAK 2 2,3 2,3 
DCMC_RAT 
Malonyl-CoA 
decarboxylase TPAPAEGQCADFVSFYGGLAEAAQR 3     
ALDH2_RAT Aldehyde dehydrogenase LLCGGGAAADR   3 2 
FABP4 _RAT Fatty acid-binding protein CDAFVGTWK   3 2,3 
    
 
  
 
  
MYOFILLAMENT / CYTOSKELETON 
ACTC_RAT Actin, α cardiac muscle 1 CDDEETTALVCDNGSGLVK 2,3 2 2,3 
ACTA_RAT 
Actin, aortic smooth 
muscle 
MCEEEDSTALVCDNGSGLCKAGFAGD
DAPR   
(2/3), 
(2/2)   
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ACTB_RAT Actin, cytoplasmic 1 DDDIAALVVDNGSGMCK   3   
ACTG_RAT Actin, cytoplasmic 2 EEEIAALVIDNGSGMCK   3   
    
MEEEIAALVIDNGSGMCKAGFAGDDA
PR 3     
ACTH_RAT 
Actin, gamma-enteric 
smooth muscle 
CEEETTALVCDNGSGLCKAGFAGDDA
PR   2   
CAPZB_RAT 
F-actin-capping protein 
subunit beta MSDQQLDCALDLMR 3     
MYL3_RAT Myosin light chain 3 ITYGQCGDVLR   3 3 
    LMAGQEDSNGCINYEAFVK 3 3   
MYH10_RAT Myosin-10 KDQSILCTGESGAGK 3 3   
MYH6_RAT Myosin-6 CIIPNER 2     
    CNGVLEGIR 2 3   
MYPC_RAT 
Myosin-binding protein C, 
cardiac-type DQAVFKCEVSDENVR   3   
MYO1E_RAT Unconventional myosin-Ie ENQCVIISGESGAGK   3   
TPM1_RAT Tropomyosin alpha-1 chain CAELEEELK   2,3 3 
F1LTQ2_RAT 
Uncharacterized protein 
(actin family) LLCYVALDFEQEMATAASSSSLEK   2,3   
VIME_RAT Vimentin QVQSLTCEVDALK   3   
    
 
      
ION TRANSPORT 
IRK11_RAT 
ATP-sensitive inward 
rectifier potassium channel 
11 LCFMLR   3   
ADT1_RAT ADP/ATP translocase 1 EFNGLGDCLTK   2,3 2,3 
    GADIMYTGTVDCWR   3 3 
ADT2_RAT ADP/ATP translocase 2 YFAGNLASGGAAGATSLCFVYPLDFAR   3   
AT2A2_RAT 
Sarcoplasmic/endoplasmic 
reticulum calcium ATPase 
2 VGEATETALTCLVEK   3 2,3 
AT2A3_RAT 
Sarcoplasmic/endoplasmic 
reticulum calcium ATPase 
3 CGQFDGLVELATICALCNDSALDYNEAK   3   
MPCP_RAT 
Phosphate carrier protein, 
mitochondrial GWAPTLIGYSMQGLCK   3 3 
            
RESPONSE TO STRESS / HYPOXIA / ROS 
HSPB8_RAT Heat shock protein beta-8 ADGQLPFPCSYPSR   3   
CH60_RAT 
60 kDa heat shock protein, 
mitochondrial AAVEEGIVLGGGCALLR   3 3 
PRDX5_RAT 
Peroxiredoxin-5, 
mitochondrial GVLFGVPGAFTPGCSK 3 3 3 
PRDX6_RAT Peroxiredoxin-6 DFTPVCTTELGR 3 3 2,3 
D4ADD7_RAT 
Glutaredoxin 5 homolog 
(S. cerevisiae) (Predicted), 
isoform CRA GTPEQPQCGFSNAVVQILR   3 2,3 
MYG_RAT Myoglobin HGCTVLTALGTILK   3 2,3 
    
 
      
OTHER 
RS28_RAT 40S ribosomal protein S28 TGSQGQCTQVR   3 2 
KCRM_RAT Creatine kinase M-type FCVGLQK   3 3 
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KCRS_RAT Creatine kinase S-type LGYILTCPSNLGTGLR   2,3 2,3 
CFAI_RAT Complement factor I SGVCIPNQR   3 3 
ES1_RAT ES1 protein homolog KPIGLCCIAPVLAAK   3 3 
MUC2_RAT Mucin-2 GRCVPLSK   2 2 
HBB1_RAT Hemoglobin subunit beta-1 EFTPCAQAAFQK 3 3 2,3 
D3ZA85_RAT 
Histone cell cycle 
regulation defective 
interacting protein 5 LQGSCTSCPSSIITLK   3   
G3V8S8_RAT Oxysterol-binding protein DGFCMSGSITAK   3   
NHRF2_RAT 
Na(+)/H(+) exchange 
regulatory cofactor NHE-
RF2 QLTCTEEMAHR   2 3 
D3ZQW1_RAT Protein Blm CSSMLKDLDDSDK   2   
E9PT83_RAT Protein Cenpf LECMLSECTALCENK   (2/3)   
D3ZSE6_RAT Protein Dfnb59 RETVYGCFQCSVDGVK   3   
D3ZIN5_RAT Protein Vwa8 APTNVTCILKTLVENGEMILADGR 2 2   
E9PU13_RAT Protein Snx4 EYLFYAEALRAVCR   2   
RDH10_RAT Retinol dehydrogenase 10 CMYPFIAQRK   2   
F1LU05_RAT Uncharacterized protein SYEQQCIEELR   2   
ZBT18_RAT 
Zinc finger and BTB 
domain-containing 18 TFSCMYTLKR 3   3 
       
5.4. Conclusions 
Oxidative modifications at Cys residues in proteins are emerging as important PTM in health 
and disease, further widening our knowledge of protein regulatory mechanisms. Cys thiols 
may be oxidised to low O.S., which are enzymatically / non-enzymatically reversed in the 
cell, or may be further oxidised to higher O.S. to form irreversible Cys PTM. Whilst it is 
estimated that only ~ 2 % of Cys residues exist in this state (Hamann, Zhang et al., 2002), 
and in some proteins these modifications are functional (Blackinton, Lakshminarasimhan et 
al., 2009), little is known about what proteins form these modifications and when. Cys-
SO2H/SO3H sites may be of particular interest as they will likely represent Cys residues with 
high reactivity or unique microenvironments facilitating Cys-SOH stabilisation and reaction 
to higher O.S. Few large-scale proteomics experiments have been performed to observe these 
modifications, and none have sought to enrich these low abundance modifications from the 
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bulk peptide / protein mixture – which may be necessary to observe these modifications in 
biologically oxidised tissue. 
We exploited the unique characteristics of tryptic peptides containing Cys-SO2H/SO3H to 
sequentially: (i) negatively select for them by electrostatic repulsion using SCX, which 
separates them from the bulk of tryptic peptides; and then (ii) positively select for them by 
hydrophilic interactions using HILIC, which increases their separation from other PTM 
localised in these fractions. The increased fractionation of samples allows for the observation 
of a greater number of sites, whilst also allowing for increases in starting material – which 
also improves the quality of MS data / spectral assignments and potentially aids in the 
identification of low abundance sites. Utilising this strategy, 188 Cys-SO2H/SO3H sites were 
observed in myocardial tissue samples and protein extracts, which were treated with H2O2, or 
generated by ex vivo Langendorff perfusion. The majority of these modifications were 
located at sites which are known in the literature to be modified by reversible Cys 
modifications, increasing the diversity of Cys PTM at these sites. Furthermore, we showed 
that even brief IR injury induces significant over-oxidation of myocardial proteins, which is 
consistent with the oxidative damage assumed to occur during IR. Oxidative protein damage 
of many targets may be a significant contributor to contractile dysfunction in brief IR and, 
potentially, a major factor in pathways leading to myocyte apoptosis and necrosis. This 
technique is widely applicable to various sample types and biological treatments, allowing for 
the discovery of targets of the Cys-SO2H/SO3H PTM induced by exposure to ROS / RNS. 
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APPENDIX 3: SUPPLEMENTARY FIGURES 
Note: Extended supplementary tables are not provided in text but electronically 
 
 
Figure S5.1. In-solution charge distributions of peptides (as % of total peptides per fraction) 
across 16 SCX fractions with varying compositions. Six distributions could be defined (each 
contained within a red outline) with each designated by the highest composition representing this 
charge; FT, MeCN, 10 %, 25 %, 40 % and 100 % KCl. 
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Figure S5.2. Performic oxidised myocardial peptides fractionating into the 10 % KCL SCX 
fraction. HILIC fractionation of peptides (a) reveals retention of Cys-SO3H peptides, however, basic 
unmodified peptides are retained equally well resulting in lowered enrichment efficiency, (b) Cys-
SO3H peptides fractionating into the 10 % KCl fraction contain primarily His or additional K / R sites 
(from missed cleavage or followed by P), with smaller numbers (< 10 %) containing combinations of 
these or not containing additional basic residues. 
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Figure S5.3. Functional clustering based on GO terms. Fold over-representation is indicated to a 
genome background (R. norvegicus), with terms ranked within each cluster (red box) by modified 
Fishers Extact (EASE). Each cluster is given an overall score and general name. 
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RESULTS 4: 
MULTIPLEXED TDE ANALYSIS OF CYS OXIDATION DURING 
IR AND ANTIOXIDANT INTERVENTION 
 
6.1. Background 
Protein Cys PTM serves several functional roles. Some Cys PTM are stable modifications 
(e.g., structural disulfides), which will exist for the life of the protein, whilst others are 
transient modifications that are influenced by the redox state of the system (i.e., redox-
sensitive). Unlike other PTM (e.g., phosphorylation), Cys modifications do not require the 
action of specific enzymes, and may occur by direct reaction of thiols with ROS / RNS, 
metals and other thiols. Thus, physiologically and even in the absence of stimuli, Cys PTM 
are in constant flux, maintained at a stable non-equilibrium condition by oxidoreductases, 
with ~ 0.5 % of the pool oxidised and reduced every minute (Jones, 2008). Following a 
stimulus, or under pathological conditions, this fluctuation will be exacerbated resulting in 
altered signalling or oxidative damage. Thus, the study of Cys PTM requires the separation of 
„basal‟ and „stimulated‟ Cys oxidation. 
Several quantitative analyses exist for the delineation of Cys PTM sites on a global-scale. 
Direct comparison of PTM abundance is possible (e.g., differential 2D-gel electrophoresis) as 
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many Cys PTM will change the mobility of proteins or alter reactivity with Cys alkylating 
„tags‟ (Wagner, Luche et al., 2002; Baty, Hampton et al., 2005; Fu, Hu et al., 2008; Jeong, 
Jung et al., 2010). As Cys residues however, are low abundance and Cys PTM likely 
constitutes only a small percentage of these sites, enrichment of modified proteins / peptides 
is necessary. Enrichment and relative quantitation may be performed following chemical 
labelling, with the most frequently used labels containing a carbon electrophile (to alkylate 
Cys) and an enrichment handle, for example, ICAT (Sethuraman, McComb et al., 2004; 
Sethuraman, McComb et al., 2004; Hagglund, Bunkenborg et al., 2008; Leichert, Gehrke et 
al., 2008; Kumar, Kleffmann et al., 2013) and CysTMT (Murray, Uhrigshardt et al., 2012). 
As Cys is the least abundant nucleophile in proteins however, this makes mis-alkylation at 
other sites highly likely, and the alkaline pH necessary for these reactions (pH ~ 8) may 
increase both mis-alkylation as well as side-reactions involving the artefactual oxidation of 
Cys residues. Alternately, inefficient labelling at Cys caused by insufficient tag / too much 
sample, sub-optimal pH, or poorly denatured protein, will prevent enrichment, and thus 
observation, of unlabeled sites. 
An alternative method for enrichment of Cys PTM is resin assisted capture by TDE. Only 
thiols will participate in TDE, nullifying the effects of higher abundance nucleophiles, and 
these can be efficiently enriched without pre-labelling. One technique using this chemistry is 
SNORAC (Forrester, Thompson et al., 2009; Forrester, Hess et al., 2011; Kohr, Aponte et 
al., 2011; Kohr, Sun et al., 2011; Guo, Gaffrey et al., 2014) method which involves the 
capture of reduced proteins onto resin by TDE followed by on-resin digestion with trypsin, 
and elution of Cys peptides by disulfide reduction. This method can also been applied 
quantitatively with the addition of on-resin labelling by isobaric tags for relative and absolute 
quantitation (iTRAQ) (Forrester, Thompson et al., 2009). There are several potential steps 
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however, which may increase the variability of quantitation when using this technique – 
broadly categorised into steric and chemical considerations. 
The former consideration includes the steric hindrance of protein capture and digestion on 
resins such as thiopropyl sepharose, which have a short linker-region – as little as five atoms 
between the solid support and the reacting disulfide. This may prevent capture of some 
proteins that are particularly large or contain heavily buried Cys, and / or may decrease on-
resin digestion efficiency, especially at cleavage sites directly up or downstream of the 
captured Cys – thus quantitative ratios may reflect differences in digestion efficiency rather 
than capture onto resin. Secondly, chemical considerations include both the efficiency of the 
TDE capture and amine labelling reactions. Capture efficiency may be reduced for proteins 
containing multiple Cys (particularly if native structure still exists) due to TDE reactions 
between two protein Cys, whilst the efficiency of labelling may be reduced by competing S-
acylation reactions between free thiols and N-hydroxysuccinimide (NHS) esters (Abad, Nolis 
et al., 2012). Any reduction in labelling efficiency is particularly inopportune as only 
correctly labelled peptides (i.e., completely labelled N-termini and Lys) are quantified by 
algorithms following MS/MS analysis. In addition, the fact that quantitative labels are 
incorporated late in the SNORAC protocol (following TDE enrichment) means quantitative 
ratios will be particularly sensitive to changes in protein abundance, protein loading and TDE 
enrichment efficiency. 
An optimal quantitative procedure would: (i) incorporate labels early on in the protocol to 
standardise any sample loss across all channels; (ii) utilise the most efficient chemical 
conditions for protein digestion and chemical labelling to limit incomplete digestion / 
labelling; (iii) reduce steric effects and the affects of multiple Cys residues by capturing 
peptides instead of proteins onto the resin. Given these considerations, we sought to develop 
a quantitative multiplexed enrichment strategy that incorporates TDE enrichment and isobaric 
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(iTRAQ) labelling to monitor changes in Cys PTM in myocardial tissue samples. We apply 
this method to a rat model of IR injury, which contains in its aetiology oxidant generation / 
mis-handling during ischemia that is greatly exacerbated upon reperfusion, and results in the 
damage of the myocardium indicated by decreased contractility (Bolli, Patel et al., 1988; 
Corretti, Koretsune et al., 1991; Ferrari, Ceconi et al., 1991; Kaneko, Masuda et al., 1993; Li, 
McCay et al., 1993; Bolli, Zughaib et al., 1995; Bolli and Marban, 1999; Kutala, Khan et al., 
2007).  We explore changes in the Cys redox proteome in response to both the initial 
ischemic insult, and subsequent reperfusion in the presence and absence of a thiol-containing 
antioxidant (MPG) which is known to reduce contractile dysfunction following IR (Myers, 
Bolli et al., 1986; Canton, Neverova et al., 2004; White, Tchen et al., 2006). This technique 
allows for the identification and quantitation of > 3000 Cys-containing peptides, and the 
observation of > 1300 of these peptides that are altered in response to IR and / or MPG 
intervention. The generation of such large datasets allows for the interrogation of functional 
processes that may be regulated by Cys and the identification of redox-sensitive sequence 
motifs. 
 
6.2. Experimental Methods 
6.2.2. Langendorff Perfusion  
Performed as indicated in Section 2.2, all protocols were utilised for the comparison. 
6.2.3. Free Cys assay of myocardial samples  
Performed as indicated in Section 2.4.2. 
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6.2.4. Myocardial tissue protein extraction, digestion and iTRAQ labelling 
Equal amounts of tissue (~ 100 mg) were taken from each biological replicate and pooled for 
tissue extraction (i.e., ~ 300 mg total), which was performed as indicated in Section 2.3.1. 
Protein derivatisation, digestion and cleanup are described in Sections 2.3.4. and 2.5, 
respectively (peptides were not reduced prior to SPE in this step). iTRAQ labelling, 
quenching and subsequent peptide reduction are detailed in Section 2.6. 
6.2.5. Multiplexed batch-based TDE chromatography  
Performed as described in Section 2.8.2 (amended from Section 2.8.1). Eluted peptides were 
subject to HILIC fractionation as described in Section 2.9.1 (16 fractions taken), whilst 
unbound peptides were subject to SCX cleanup and fractionation, detailed in Section 2.9.2 (6 
fractions taken). 
6.2.6. SCX-HILIC for assignment of irreversibly oxidised Cys  
Performed as detailed in Section 2.8.3 with 70 µg of the peptide digest (unlabeled). 
6.2.7. LC-MS/MS 
Performed as described in Section 2.10.3 on gradient (a) for TDE eluted peptides (or 
unlabelled peptides following SCX-HILIC enrichment), and gradient (b) for TDE unbound 
peptides. iTRAQ-labelled samples were run in MS and experimental replicate, i.e., four runs. 
6.2.8. Data analysis 
Data were searched against the UniProt Rattus norvegicus database (taxonomy number 
10116; release 2013_11) using an in-house Mascot server. Parameters were one missed 
cleavage, variable modifications; Met(O), NEM(C), and carbamidomethyl (C), with 
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quantitation by 4-plex iTRAQ selected. Another search was performed with the iTRAQ 
modifications searched as variable modifications to ensure labelling efficiency was > 90 %. 
Peptide / fragment tolerances were 30 ppm and 0.1 Da, respectively. All searches were 
performed against a decoy database which was used to filter identifications to a < 2% FDR. 
Quantified peptides were saved in tab-delimited (.txt) format and processed utilising an in-
house java script (see below). 
6.2.9. Ratio estimation and Bayesian probability analysis 
We sought to estimate the relative abundances of each peptide, and the relative abundances of 
each reporter tag for that peptide, using each discrete MS/MS spectral measurement as a 
replicate. The MS/MS data for each peptide was treated individually, by processing the 
reporter ion intensities of each spectrum of that peptide. To do so, we assumed that the 
measured intensity (abundance) for a given reporter tag in a discrete spectral measurement 
was the product of the expected intensity for that measurement, and the relative abundance 
(ratio relative to m/z = 114) of that tag. The parameter values (ratios) reported are those that 
achieved the non-linear sum of least squares, between the expected and measured intensities, 
summed across all measurements and reporters for that peptide (Supplementary Table S1 and 
S2). The relative abundance for the analysed peptide was taken to be the summed intensity of 
all measurements for that peptide. Bayesian analysis (Jaynes, 2003; Sivia and Skilling, 2006) 
was then used to determine the uncertainties of these parameters. Furthermore, it was applied 
to determine whether two tags were significantly different in abundance. This was achieved 
by considering two hypotheses: (i) that their corresponding ratios are the same within the 
same error (H1), and (ii) that both have unique ratios, and separate errors (H2). If we found 
that one ratio was r1 = 1 ± 1 and the other ratio was r2 = 2 ± 2, then, after marginalizing 
all other parameters, it was found that,  
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Loge[Prob(H1)/Prob(H2)] = ½ Loge(2) – Loge(1
2
 + 2
2
) – (1 – 2)
2
/[2 (1
2
 + 2
2
)]       . 
This factor was used as an indicator of whether two ratios were significantly different. A 
value of zero corresponds to when H1 and H2 are equally plausible, whereas negative values 
indicate a greater likelihood that the ratios are significantly different. A Loge(Prob) < -2, is 
equivalent to a < 1% probability of H1, and was the significance threshold applied to all 
ratios. 
6.2.10. Bioinformatics 
Gene Ontology (GO) terms and InterPro protein domains were obtained via input of UniProt 
identifiers into the DAVID bioinformatics tool (Huang, Sherman et al., 2009) with a 
background reference of all GO terms from R. norvegicus. Values were obtained for over-
representation and modified Fisher Extract calculation (Hosack, Dennis et al., 2003) and used 
to cluster terms into categories (an overall term reflective of the general members of that 
cluster). Motif analysis was performed using the Motif-X tool (Schwartz and Gygi, 2005) on 
all Cys-peptide sequences identified in the elution of TDE chromatography (altered / 
unaltered) as well as those identified in each condition (15I, IR and MPG; up / down), with 
the search parameters: central character C, width 13, occurrence 20, significance 1 x 10
-6
, 
background and foreground rat proteome. 
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6.3. Results 
6.3.1. Contractile function and thiol status during IR and antioxidant 
treatment 
Langendorff perfusion was undertaken and recovery (IR samples) or maintenance of function 
(NITC) was measured as % rate pressure product (RPP) at baseline recovered / maintained at 
the end of the protocol (Figure 6.1a). The time-matched NITC tissues maintained function for 
the duration of the protocol (~ 100 %), whereas average IR heart recovery was 66 % 
following 15 min reperfusion, with a further recovery to 86 % when 1 mM MPG was 
included in the reperfusion buffer. It was noted that MPG treatment only gave a significant 
change in % RPP following 15 min of reperfusion (Figure S6.1a, Appendix 4). When free 
thiol content of the tissues was assayed (Figure 6.1b), it was observed that in comparison to 
NITC, 15I showed no significant change in thiol content, IR tissue showed a decrease in thiol 
content, whilst IR + MPG tissue showed a slight increase in free thiol content. This was 
mirrored in the protein free thiol content (Figure S6.1b, Appendix 4), which does not contain 
small molecular weight / soluble thiols in the estimate. 
6.3.2. Multiplexed TDE methodology for the enrichment and quantitation 
of Cys PTM 
In order to reduce any variations generated by sample handling, it was elected to perform 
amine labelling with iTRAQ prior to TDE enrichment – facilitating standardisation of any 
sample loss and allowing four samples to be enriched at once. Significant changes were made 
to sample preparation from the previously published conditions (Paulech, Solis et al., 2013) 
in order to prevent S-acylation by the iTRAQ tag during labelling. The complete series of 
derivatisation steps is given in Figure 6.2, and includes: (i) low-pH alkylation during 
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extraction with NEM; (ii) thiol-based reduction of all reversible Cys PTM with DTT; (iii) 
protection of new free thiols as a disulfide with MMTS, followed by; (iv) in-solution 
digestion with trypsin. Protected peptides are then labelled with one of the iTRAQ tags, prior 
to pooling of all samples, allowing that henceforth all steps are performed with the pooled 
sample. Reduction of the protecting disulfides allows for Cys peptide capture by TDE as 
previously published (Paulech, Solis et al., 2012). One alteration to the protocol was 
necessary, as iTRAQ labelling appeared to make the peptide sample more hydrophobic (as 
enrichment selectivity for Cys peptides dropped below 70 %, data not shown) in comparison 
to unlabelled peptides (Cys > 90 %). Thus, higher concentrations of SDS were utilised in 
binding (0.75 % vs. 0.5%) and wash steps (0.5 % vs. 0.1 %) to obtain comparative results. 
 
Figure 6.1. Myocardial tissue samples utilised for multiplexed TDE analysis. (a) Langendorff 
protocols for the samples generated, detailing recovery and / or maintenance of function at the 
termination of the protocols given as a % rate-pressure product (RPP) of baseline, with errors given as 
SEM for n = 3 replicates. (b) Average total free thiol content of the tissues following Langendorff 
protocols, with errors given as SEM, and asterisks denoting samples significantly altered compared 
with the NITC (p-value < 0.05). 
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Figure 6.2. Multiplexed TDE enrichment strategy for the isolation of reversibly PTM Cys. 
Tissue samples are extracted in the presence of a low pH alkylating agent (NEM) to alkylate free 
thiols present in the sample (“A”), reversible Cys PTM are reduced by a strong thiol-based reductant 
(DTT), before their protection as a methyl-disulfide for iTRAQ labelling. In-solution digestion is 
followed by iTRAQ amine labelling, pooling of samples and removal of the protecting group. Cys 
peptides are captured by TDE onto a resin functionalised by a protected disulfide; the unbound 
fraction contains information on protein abundance, whilst the eluted fraction contains the relative 
abundance of Cys PTM in each sample. 
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Following TDE enrichment, two fractions were obtained – „unbound‟ to TDE and „elution‟ 
from TDE. Whilst the elution fraction contains the Cys PTM information, the unbound 
fraction is useful in correcting any bias in sample loading / labelling prior to TDE as the 
overall intensity distribution should be the same for all labelled channels. The unbound 
fraction can also be utilised for protein abundance assignment, with this information used to 
differentiate between changes in Cys PTM versus a change in total protein abundance. In our 
study, we observed two proteins of increased total protein abundance; pyruvate 
dehydrogenase E1 subunit (ODPA_RAT) and NADH dehydrogenase 1 alpha 12 
(F1LXA0_RAT), which were increased in all the conditions relative to the NITC.  
6.3.3. Cys PTM sites altered in response to IR and antioxidant intervention 
Within the elution fraction we were able to identify and quantify 3918 unique Cys peptides 
(Supplementary Table S1) across two experimental and two MS replicates (4 MS runs), of 
which 3147 were measured three or more times (necessary for Bayesian probability 
calculations). The inter-experimental variance was compared to the variance observed across 
two MS runs for all ratios across the channels (> 1 measurement in each replicate). It was 
observed that for MS replicates the average CV was 18.5 % whilst the average CV across any 
two experimental replicates is 21.8 %. When multiple MS replicates are summed together 
however, the inter-experimental CV drops to 14.1 %, indicating that the variance is affected 
by the number of repeated ratio measurements. 
To garner a robust ratio measurement for the four samples, replicate measurements were 
combined to reveal a total of 1372 Cys peptides altered with a Loge(Prob) < -2 (i.e., < 1% 
probability that the reporter distributions are identical) in comparison to NITC 
(Supplementary Table S2). A total of 970 sites were altered in the 15I sample, 737 in 15I/15R 
and 455 in the IR + MPG sample. Overall, 71 % of sites (n = 968) were consistently 
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increased in abundance (i.e., „oxidised‟) across all observations, whilst 21 % (284 sites) were 
decreased in abundance (i.e., „reduced‟) with the remainder (120 sites) varying in state across 
the conditions tested.  
 
Figure 6.3. Sites identified as altered in reference to NITC, with their distribution in each 
condition. Bold numbers denote the total number of Cys peptides identified between each sample, 
with italicised numbers and arrows denoting the number and direction of change of each site in 
comparison to control, respectively. Changes in the 15I, IR and IR + MPG samples are denoted by 
“I”, “R” and “M”, respectively. 
 
15I and IR samples followed the trend of the overall dataset with the majority of sites 
increased in abundance (76 and 78 %, respectively), in these conditions. However, in the IR + 
MPG sample, 61 % of altered sites were decreased in abundance and this sample contributed 
most to the overall „reduced‟ Cys peptide pool, even though it contributed the least to the 
overall altered peptides, with 21 % of altered Cys sites unique to this condition, compared to 
45 and 33 % for 15I and IR. The overlap of all identified sites is shown in Figure 6.3, along 
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with their specific distributions. It is observed that 56 % of all sites are observed as changed 
in only one condition, with the second largest population changed across both 15I and IR 
together, 18 %. 
 
Figure 6.4. Irreversibly oxidised Cys sites present in each sample. Irreversible Cys PTM were 
enriched by sequential SCX and HILIC fractionation allowing for the observation of sulfinic (Cys-
SO2H) and sulfonic (Cys-SO3H) modified Cys sites. 
 
It should be noted that a decrease in capture of a site may be due either to: (i) relative 
reduction of that site, leading to increased thiol formation, or; (ii) over-oxidation of that site 
to Cys-SO2H/SO3H, which do not undergo TDE. Whilst these PTM exist basally, they are 
known to increase in abundance during pathological ROS generation in conditions such as 
IR. Thus, to differentiate these effects, we enriched for these modifications in the original 
unlabeled digests, as described in Chapter 5. Unfortunately, these modifications cannot be 
enriched in iTRAQ labelled samples as the tag changes the charge distribution of these 
peptides, altering their fractionation profile by SCX and HILIC, which results in such 
peptides no longer being resolved from labelled tryptic peptides – with the potential 
exception of peptides containing Cys-SO2H/SO3H ending in Arg (in solution charge +2). 
Note that added positive charges for peptides ending in Lys (and containing Cys-
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SO2H/SO3H) will result in an in-solution charge of +3 and this will be the same charge as 
unmodified/non-Cys-containing peptides ending in Arg. In practice, we observed that the 
HILIC separation was insufficient to resolve these peptides from the contaminating peptides 
to a sufficient level for them to be sequenced following LC-MS/MS – although it is possible 
that changed buffer conditions in SCX or HILIC could improve this partially. 
Enriching for irreversible modifications in unlabelled samples revealed (Figure 6.4 and 
Supplementary Table S3) that NITC, 15I and IR + MPG  tissues all contained similar 
numbers of Cys-SO2H/SO3H sites (27, 30 and 27 sites, respectively) whilst observations were 
increased following IR (84 sites). Thus, for the 15I and IR + MPG conditions, if not for IR, 
decreases in Cys peptide ratios are presumed to occur mainly from reduction of reversible 
Cys PTM and not formation of irreversible Cys PTM. The incorporation of this additional 
fractionation step into the multiplexed TDE workflow is shown in Figure S6.2 (Appendix 4). 
6.3.4. Protein function and motif analysis of peptides altered by Cys PTM 
The generated iTRAQ dataset was utilised for the analysis of over-represented functional 
classes, cellular localisations, protein domains and primary sequence motifs (all compared to 
a whole genome background of R. norvegicus). Over-represented functional classes 
(clustered GO biological process / molecular function terms) and protein domains (Interpro 
designations) from the proteins corresponding to the peptides altered in each condition are 
given in Figure 6.5. Note that for 15I and IR these represent oxidised proteins whilst in IR + 
MPG these represent reduced proteins. In all conditions, the most over-represented GO term 
clusters relate to oxidation-reduction, aerobic respiration, and metal or metal cluster binding. 
The only protein family over-represented in all conditions were the acyl-CoA oxidoreductase 
family.  Overlapping clusters for 15I and IR include GO terms related to energy generation 
(electron transport, fatty acid metabolism, etc), general stress response (e.g., response to 
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corticosteroids, radiation, etc) and in particular ROS stress, as well as terms relating to zinc 
binding (particularly translocase of the inner membrane complexes, TIM) and ATP-
dependant ion transport. 15I and IR also showed the greatest overlap of over-represented 
protein domains, which were also representative of the abovementioned GO term clusters. IR 
+ MPG in general showed less similarity to 15I or IR in GO terms and protein domains, than 
did the conditions to each other. Unique terms / protein domains in each condition reflect; 
apoptosis, inflammation and ion handling in 15I, Ca
2+
 response, Cys peptidase activity and 
ER stress in IR and, ubiquitin-mediated proteolysis, O2 / hypoxia response and cytoskeleton 
arrangement in IR + MPG. A similar analysis of subcellular localisations revealed that 
mitochondrial, sarcolemmal / contractile, and extracellular proteins were over-represented in 
all conditions in comparison to the whole genome background, whilst endoplasmic reticulum 
and proteasome proteins were over-represented in IR and IR+ MPG, respectively. 
Finally, primary sequence motif analysis was undertaken, first on a broad scale – i.e., 
„changing‟ versus „not changing‟ versus „total‟ – and then for each specific condition. 
Overall, 34 motifs were observed across all searches (Table S6.4, Appendix 4), with 
sequences enriched in acidic / basic residues, Gly and vicinal thiols observed. Sequences 
containing vicinal thiols (CXC, CX2C, and CX5C) were increased in only the „changing‟ and 
„total‟ searches, but not in the „unchanged‟ search which only contained single Cys motifs in 
combination with Asp / Glu and Gly. The „changing‟ peptides were relatively enriched in 
comparison to the „total‟ in vicinal thiol motifs with five versus three motifs observed (Figure 
6.6). Fold enrichment however, was further increased by searching only peptides increased in 
either 15I or IR, with three of five of the motifs identified in 15I and four of the five 
identified in IR containing vicinal thiols. 
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Figure 6.5. Over-represented functional classes and protein domains present in each sample in 
reference to a whole genome background. GO biological process and molecular function terms 
were clustered and general reference terms given to each cluster. Protein domains (InterPro 
designations) are given inside boxes outlined by broken lines. Font size is utilised for GO term 
clusters to give information on the prominence / weight of that cluster, with larger / bold text 
indicating a higher cluster score. Italicised entries indicate that the term is present within another 
condition at a differing prominence, e.g., „glycolysis‟ is more prominent in 15I and IR + MPG than in 
IR. Abbreviations; AA; amino acid, ER; endoplasmic reticulum, ETC; electron transport chain, FA; 
fatty acid, TIM; translocase of the inner membrane, VDAC; voltage dependant anion channel. 
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Figure 6.6. Over-represented vicinal thiol motifs. Motifs with conserved vicinal Cys (bold, red) 
highlighted, and other conserved amino acids (acidic, dark orange; small polar, green) indicated. 
Over-representation (fold-change) of each motif in the dataset in comparison to a whole genome 
background is given for each data subset for which it is found; total observations (blue), total changed 
observations (light green), oxidised in 15I (pink) and oxidised in IR (light orange). 
The most enriched motif, present almost exclusively as oxidised in IR was CXDX2EC with > 
30-fold enrichment. In 15I, the two additional motifs identified were DX3C (1.92 fold 
enriched) and PC (1.85 fold enriched), whilst for IR the additional motif was KX5C (2.06 fold 
enriched) – all of which were less enriched than the vicinal thiol motifs identified in these 
fractions. IR + MPG only gave one significant motif (CK, 3.36 fold enriched), and this was 
only significant in the oxidised subset of peptides, even though the reduced dataset contained 
more sequences. Finally, Cys peptides decreased in 15I contained no significant motifs, 
whilst searching sites decreased in IR resulted in one significant motif which was 
palindromic to that seen in IR + MPG (i.e., KC, 3.27 fold enriched). 
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6.4. Discussion 
ROS and RNS are integral to the proper physiological function of the cell, and dysregulation 
of their production or removal is a hallmark of many pathologies. Cys sites on proteins have 
emerged as integral sites for the sensing of ROS / RNS produced by the cell via the formation 
of Cys PTM. These sites will be dynamically changing, as opposed to more static PTM at 
Cys residues (e.g., structural disulfides), and will lend themselves best to quantitative 
measurement. Due to the intrinsic reactivity of Cys residues however, it is vital that robust 
chemistry and methodology be utilised for their quantitation. For example, confounding 
factors such as variable and inefficient chemical derivatisations, inefficient digestion and 
sample loss during enrichment will decrease the number of sites which may be reproducibly 
measured and cloud ratio assignments with methodological artefacts. 
The multiplexed TDE method presented (Figure 6.2) utilises efficient chemical steps based 
on: (i) extraction conditions which limit artefactual oxidation; (ii) strong thiol-based 
reduction (DTT) to ensure complete conversion of all reversible Cys PTM to thiols; (iii) thiol 
protection by a methyl disulfide group; (iv) efficient in-solution trypsin digestion; (v) in-
solution iTRAQ labelling, and (vi) TDE enrichment of the pooled sample. Protein extraction 
and derivatisation steps can occur in a „one-pot‟ reaction as all reactants are terminated by an 
excess addition of the following reactant (which would not be possible with expensive 
affinity tagging approaches, e.g., ICAT), and this will limit sample loss that would otherwise 
occur from multiple precipitation or cleanup steps, e.g., OXICAT (Leichert, Gehrke et al., 
2008). Performing in-solution protein digestion with trypsin under optimal conditions limits 
any confounding affects from missed cleavages. Missed cleavages should routinely be 
maintained < 10 % of all unique identifications (6.5 % in the current study), as otherwise 
ratios may reflect differences in digestion efficiency rather than Cys PTM. Noteworthy, on-
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resin digestion of proteins captured by TDE has been performed in several studies (Forrester, 
Thompson et al., 2009; Forrester, Hess et al., 2011; Kohr, Aponte et al., 2011; Kohr, Sun et 
al., 2011; Guo, Gaffrey et al., 2014) and, with exception of the original reference(Forrester, 
Thompson et al., 2009), all references contain missed cleavage rates well in excess of 10 %, 
ranging from 27 to 57 % for the Cys peptides reported. It is possible that the resin limits 
trypsin access to sites sterically, but there may be other factors that reduce the effectiveness 
of digestion in these studies as well such as buffer conditions (remaining organic solvents or 
acid) and trypsin-protein adherence to beads (disrupting protein structure and/or decrease in 
trypsin enzymatic activity). 
Label incorporation and pooling should occur as soon as is possible (i.e., following 
digestion), in order to standardise any error generation that may occur. In-solution labelling 
facilitates the use of optimal conditions (organic %, etc) and, as all thiols are blocked, the 
reaction efficiency will not be reduced by S-acetylation reactions between thiols and NHS 
esters (Abad, Nolis et al., 2012). TDE capture is an equilibrium process, which will allow for 
the unbinding and re-binding of peptides / proteins with multiple thiols, and thus thiols will 
always be present during the reaction both on peptides / proteins and on the resin. This has 
implications not only for iTRAQ labelling (abovementioned) but also for the capture 
efficiency of proteins versus peptides. Peptide capture by TDE resins will decrease the 
„unbinding‟ reaction by both limiting the number of adjacent Cys residues and destroying any 
tertiary structure, which increases the reactivity of adjacent / non-adjacent Cys residues. In 
general, larger numbers of sites may be observed by peptide-centric TDE and it will increase 
the observation of vicinal thiol-containing proteins that are highly reactive in TDE reactions 
and may otherwise be missed in protein-centric TDE. 
Following peptide capture and elution, the next advantage of pre-enrichment iTRAQ 
labelling is evident as the fraction unbound to TDE can be utilised for ratio correction as well 
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as protein abundance assignment. The later is particularly pertinent to long biological 
protocols which may result in large protein expression changes between samples, and allows 
for the correction of Cys ratios in light of protein abundance changes. Most methodologies do 
not allow for this correction as non-Cys peptides are not quantified. As our protocols were 
relatively short (30 min), widespread changes in protein expression were not observed and no 
altered Cys peptides were assigned in proteins with altered abundance. The overlap between 
proteins monitored in the Cys-peptide faction and those monitored in the flowthrough was 
only 33 % (and 28% for altered Cys-containing proteins) however, meaning that changes in 
protein expression can only be ruled out for these Cys sites. The low overlap is possibly due a 
combination of the increased simplicity of the Cys-enriched fraction and the relative 
uniqueness of Cys-peptide sequences. This second concept has actually been exploited in one 
study to increase proteome coverage (Wang, Qian et al. 2006), where the overall overlap of 
proteins when comparing a Cys-enriched fraction to a global shot-gun analysis was 56 % 
(even without Cys pre-alkylation during digestion, which would lower it further). 
Overall, the enrichment protocol was not observed to vastly increase experimental variance – 
as the average variance of MS replicates and experimental replicates was roughly aligned – 
with a larger contributing factor being the number of measurements used for ratio assignment 
(i.e., combining MS replicates decreased experimental variance from 21.8 to 14.1 %). Thus 
only peptides measured a minimum of three times were included in our analysis, allowing for 
Bayesian probability calculations to determine reporter ion distributions that were 
significantly (Loge(Prob) <-2) different following a pair-wise analysis to NITC. Thus, whilst 
we were able to observe 3918 unique Cys peptides overall, only 3147 could be utilised for 
probability assignment (> 3 observations) and of these 1372 were observed to be significantly 
altered in distribution (Figure 6.3) – i.e., we have chosen to sacrifice quantity of sites 
measured for the increased robustness of quantitative ratios. 
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Of these assigned peptides, the majority were observed as increased in PTM following 15I 
and IR, but following IR + MPG the majority of peptides were decreased in abundance. By 
coupling the multiplexed TDE enrichment to SCX-HILIC in parallel (Figure S6.2), the 
differing contributions of reduction versus over-oxidation can be judged, and it is worthwhile 
incorporating this measurement into all Cys PTM determinations. Our results indicate that 
treatment with MPG during ischemia both results in a more reduced environment in the tissue 
and prevents the over-oxidation of Cys sites during IR. This was also reflected in the free 
thiol Cys assay of the tissue (Figure 6.1) where more free thiols are observed following MPG 
treatment. Thus, MPG is not acting purely as a ROS / RNS scavenger in the myocardium but 
is also having an effect on the protein thiol redox state of the cell. However, whether this 
effect is via direct interaction of MPG with proteins facilitating their reduction, or whether it 
is an affect of MPG on the biological reduction systems of protein Cys PTM in the cell is 
unknown. 
Significant redox modification was observed in ischemic tissue that had not been subjected to 
reperfusion, including both oxidation and reduction of Cys sites. The production of ROS in 
tissues during ischemic insult has been documented before (Vanden Hoek, Li et al., 1997; 
Becker, vanden Hoek et al., 1999), and hypoxia stress response is known to be activated by 
ROS (Chandel, Maltepe et al., 1998). Our study shows that the extent of oxidative Cys PTM 
occurring during ischemia may be quite large, and highly specific to the ischemic period, 
with this condition resulting in both the largest number of total changes profiled and the 
largest number of unique changes profiled. This may be quite surprising, given that 
reperfusion is believed to result in much larger changes in ROS generation. It should be noted 
however, that the time point profiled is after the highest ROS production, which is thought to 
occur at ~ 5 min of reperfusion (Bolli, Zhu et al., 1988; Bolli, Jeroudi et al., 1989). This may 
mean that the redox state of the cell after 15 min is less oxidised than at earlier time points, 
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and indeed other studies have observed relative depletion of protein Cys at earlier time points 
(e.g., 5 min) in reperfusion compared to later time points (30min) (Kumar, Kleffmann et al., 
2013). However, as this was the first time point showing a statistical difference in functional 
recovery between IR and IR + MPG (Figure S6.1) it was chosen for this study, although 
earlier time points may be more relevant for the elucidation of oxidant sensors and initiators 
of redox signalling cascades following reperfusion. 
Interestingly, many of the processes identified by functional analysis as affected by Cys 
oxidation during 15I and IR are known to show dysfunction following IR – indicating that 
Cys PTM may be a contributing factor in this dysfunction. Energy derivatisation is affected 
heavily by I and R and substantial Cys modification to enzymes involved in glucose and fatty 
acid metabolism, electron transport and ATP synthesis have been observed in previous 
studies (Eaton, Byers et al., 2002; Eaton, Wright et al., 2002; Sadek, Humphries et al., 2002; 
Brennan, Wait et al., 2004; Saurin, Neubert et al., 2004; Sethuraman, McComb et al., 2004; 
Tatarkova, Kaplan et al., 2005; Brennan and Eaton, 2006; Fu, Hu et al., 2008; Fu, Wu et al., 
2009; Kohr, Aponte et al., 2011; Kohr, Sun et al., 2011; Murray, Kane et al., 2011; Wang, 
Foster et al., 2011). Given that these steps involve several oxidoreductase enzymes, and Cys 
is involved in direct catalysis or metal binding, it may be that these enzymes act as redox 
sensitive switches to alter metabolism in response to oxidant levels. Unsurprisingly, many 
terms / domains related to stress response and particularly antioxidant / ROS response are 
observed (e.g., Trx-fold), but more surprisingly zinc-binding motifs are observed to be over-
represented in 15I and IR, indicating the potential for oxidative regulation by Zn extrusion in 
these proteins – previously observed in several proteins containing Cys-Zn clusters (Kroncke, 
Fehsel et al., 1994; Maret and Vallee, 1998). 
Many of the processes uniquely altered in each condition are also known to be redox 
sensitive, and to be dysregulated following IR. Apoptosis and cell fate determination are 
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redox regulated processes (reviewed (Jones, 2010)) and 15I results in modification to proteins 
involved in several apoptotic signals including DNA fragmentation and caspase activation – 
indicating that ROS production in ischemia may be important in these decisions. In IR 
alternately, proteins involved in Ca
2+
 response, ER stress (e.g., unfolded protein response, 
UPR) and Cys protease activity are oxidised – which reflect unique changes occurring during 
reperfusion. Ca
2+
 release from the sarcoplasmic / endoplasmic reticulum is a major redox-
regulated factor in the IR pathology (Krause, Jacobus et al., 1989; Salama, Abramson et al., 
1992; Balshaw, Xu et al., 2001; Hidalgo, Aracena et al., 2002), and may result in the 
activation of Ca
2+
 activated proteases, many of which are cysteine-based proteases as well 
e.g., calpain (Mellgren, 1991; Dilisa, Detullio et al., 1995; Yoshida, Inui et al., 1995; Chen, 
Won et al., 2002; Maekawa, Lee et al., 2003; Barta, Toth et al., 2005). Finally, with MPG 
treatment, Cys PTM affects proteins related to protein dimerisation and ubiquitin-mediated 
proteolysis. Notably, these proteins are present with a more reduced Cys state, which may 
reflect either changes in quaternary structure of protein complexes (e.g., disulfide reduction) 
and / or alterations in protein turnover which are not yet sufficient to be observed by the total 
protein iTRAQ in the unbound fraction. 
Motif analysis of sites oxidised during IR reveals a preponderance of vicinal thiol motifs, 
including the known highly reactive motif CX2C, present in many TDE-active proteins in the 
cell, e.g., Trx, protein-disulfide isomerase (Chivers, Laboissiere et al., 1996). Interestingly, 
these motifs are not reflected in unchanged peptides (or in peptides oxidised during IR + 
MPG), which indicates that they are not just artifactually formed during extraction, but are 
specifically represented in samples subjected to IR. Motifs generally present and unchanged 
by the pathology reflect sites enriched in acidic and small polar residues (i.e., Gly) as was 
previously seen in qualitative basal Cys PTM analysis (Paulech, Solis et al., 2013). Alongside 
the CX2C motif, it was observed that the CXC and CXDX2EC motifs were increased, with 
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the latter constituting the most over-represented motif identified, which are less characterised 
in redox-sensitive processes. The increase in observation of some sites when the „total 
changing‟ peptide pool was searched e.g., GX2CX2CX2G, may reflect that some motifs are 
common to both 15I and IR, but not abundant enough to be revealed when searching each 
fraction separately. Finally, sites not containing vicinal thiols but rather Lys / Pro may 
indicate various PTM such as S-nitrosylation which are stabilised in the absence of vicinal 
thiols. Indeed one motif, CX5K, has been implicated previously to be a potential S-
nitrosylation motif (Kohr, Aponte et al., 2011). Overall the motifs reflect that Cys reactivity 
is tuned by electrostatic factors, structural flexibility / constraint (Gly versus Pro) and the 
presence of proximal thiols. 
 
6.5. Conclusion 
Redox sensitive Cys residues in proteins are important in the sensing and response to ROS 
and RNS physiologically and under oxidative stress via Cys PTM. However, in order to 
identify these Cys in the presence of background Cys PTM which are redox insensitive, 
robust quantitative measurements must be made. Pitfalls in current methodologies including, 
non-specific chemistries, inefficient reactions and incomplete labelling and enrichment, may 
lead to under-representation of sites, or inclusion of Cys sites which are not changed in PTM 
state but are present as artefacts of the methodology. By utilising a „one-pot‟ series of protein 
derivatisation steps, coupled to efficient in-solution digestion, iTRAQ labelling and 
multiplexed TDE enrichment, we have reliably quantified 3147 Cys peptides in myocardial 
tissue, constituting the largest quantitative dataset to date. 1372 Cys residues were observed 
to be altered in response to 15I, IR and IR with MPG, with the data revealing a complex 
interplay of Cys PTM on proteins involved in apoptosis, Ca
2+
 response and proteolysis – 
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processes that are dysregulated during IR. Interestingly, a large number of sites were 
observed to be reduced in intensity in comparison to control particularly following MPG 
treatment, which may indicate their reduction to thiols by cellular reducing systems, or 
alternately their over-oxidation to irreversible Cys PTM, which do not participate in TDE. 
We have delineated these effects to observe that MPG tissues contain similar numbers of 
irreversibly oxidised Cys as control tissue, meaning that the Cys present following MPG 
treatment exist in a more reduced state – which may be a means of increased functional 
recovery in the tissue following IR. The generation of a large dataset of reliable observations 
allowed also for the investigation of reactive Cys motifs present in the primary sequence. We 
identified several vicinal thiol motifs (CXC, CX2C and CXDX2EC), which are oxidised 
during I and IR, as well as motifs corresponding to single Cys residues localised near acidic 
and basic residues (Asp / Glu / Lys), as well as Pro and Gly. This technique provides 
increased reliability and coverage of reversibly redox modified Cys sites, whilst also 
delineating information on total protein abundance and irreversible Cys PTM in one 
experiment. This methodology is broadly applicable to the study of Cys PTM in a range of 
biological systems, allowing for a more complete picture of the complexities of redox 
sensing, signalling and damage. 
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APPENDIX 4: SUPPLEMENTARY FIGURES 
Note: Extended supplementary tables (S1-3) are not provided in text but electronically 
 
Figure S6.1. Functional data and protein free-thiol content of the protocols analysed by 
multiplexed TDE. Functional maintenance / recovery is given as % RPP at the end of baseline (a), 
and is the average of three biological replicates, with error bars indicating the SEM of the replicates at 
5 min intervals. Time points where IR and IR + MPG recovery is significantly different from NITC 
only are denoted by a single asterisk (*), whilst time points where all three conditions are significantly 
different (p-value < 0.05) from each other are denoted by a double asterisk (**). (b) Average protein 
free thiol content of the tissues following Langendorff protocols, with errors given as SEM, and 
asterisks denoting samples which are significantly altered from the NITC (p-value < 0.05). 
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Figure S6.2. Alteration of methodology to incorporate the determination of irreversibly PTM 
Cys (Cys-SO2H/SO3H). Following protein derivatisation and in-solution trypsin digestion, the 
resultant digest is divided, with 180 µg continuing to iTRAQ labelling and reversible Cys PTM 
enrichment and 70 µg undergoing sequential SCX and HILIC fractionation, to enrich Cys-
SO2H/SO3H in each sample (label free). Irreversible Cys PTM retain poorly in SCX (flowthrough) 
and well in HILIC (fractionating into the late aqueous fractions) allowing for site identification and 
label-free quantitation. 
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Table S6.4. Over-represented motifs contained within data subsets. For each motif the; 
fold over-representation (un-bracketed), motif score (round brackets) and number of observed 
sites (square brackets) are provided. Double entries are given when the sequence and its 
palindrome was observed in the same search (i.e., searches are directional). Bold face 
indicates a vicinal thiol motif, whilst residues are coloured as follows: Cys, red; acidic, 
orange; basic, blue; small polar, green; other, purple. Note; no significant motifs were 
observed for sites decreased in 15I or IR + MPG. 
Motif  15I 
Increased 
IR 
Increased 
IR 
decreased 
IR + MPG 
Increased 
Total 
Changed 
Un-
changed 
 
Total 
CXC 2.28 
(10.17) 
[76] 
2.28 (7.12) 
[51] 
2.6 (11.83) 
[69] 
2.79 
(12.73) 
[66] 
  1.92 (9.70) 
[109] 
1.81 (6.02) 
[76] 
  
CXXCXC 8.66 (17.4) 
[21] 
   6.23 
(17.51) 
[26] 
  
DXXXC 1.92(7.09) 
[76] 
      
PC 1.85 (6.85) 
[80] 
      
GXXCXX
C 
7.85 
(16.39) 
[24] 
10.33 
(22.37) 
[30] 
  5.80 
(21.42) 
[40] 
 
  
CXDXXE
C 
 30.71 
(31.95) 
[23] 
34.52 
(27.79) 
[21] 
  16.43 
(29.17) 
[26] 
15.99 
(23.67) 
[23] 
 11.85 
(41.7) 
[50] 
10.37 
(37.34) 
[43] 
CXXCXX
G 
 7.6 (15.18) 
[21] 
     
KXXXXX
C 
 2.06 (6.49) 
[57] 
    1.57 (12.4) 
[280] 
KC   3.27 (6.97) 
[26] 
    
CK    3.36 (8.44) 
[31] 
   
GXXCE      *4.14(19.9
2) 
[43]* 
 
DXCXXG      *4.81 
(17.99) 
[32]* 
 
DXXEC      *4.98 
(18.65) 
[37]* 
 
GXXXC      *1.5 (9.00) 
[230]* 
1.54 (6.85) 
[153] 
CXXG      *1.47 
(6.98) 
[190]* 
1.45 
(11.29) 
[353] 
GXXXXX
CXXGY 
      8.67 
(36.07) 
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[40] 
GXXCXC       3.60 
(24.59) 
[61] 
CD       1.55 
(12.74) 
[298] 
GXXCEX
C 
      10.96 
(29.26) 
[24] 
DC       1.57 
(12.52) 
[283] 
CXXD       1.55 (9.62) 
[222] 
DXXXXC       1.61 (9.71) 
[191] 
CE       1.52 (8.86) 
[220] 
CXXE       1.51 (8.68) 
[220] 
CXXXXG       1.49 (8.51) 
[226] 
DXC       1.63 (7.88) 
[144] 
CXG       1.57 (8.08) 
EXC       1.63 (8.57) 
GXC       1.51 (6.38) 
[150] 
CXXXXX
K 
    1.72 (8.02) 
[121] 
  
GXXCXX
CXXG 
    19.80 
(23.67) 
[21] 
  
CXXXXX
D 
    1.72 (6.59) 
[97] 
  
CXXXXE      1.8 (9.13) 
[120] 
 
DXXXXC      1.82 (6.29) 
[78] 
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APPENDIX 5: SUPPLEMENTARY INFORMATION 
ADDITIONAL SPECTROPHOTOMETRIC ASSAYS 
 
Appended Figure 1. Spectrophotometric assay (DTDP) of the concentration dependence of 
additional reactions. Concentration dependence of (a) reduction by DTT and TBP (assayed as in 
Section 2.4.1 following a 1 hr reduction by DTT and a 20 min reduction by TBP at the concentrations 
given, following protein precipitation), and (b) DTPA inhibition of metal catalysed auto-oxidation 
during extraction (analysed as in Section 2.4.2 with extraction buffers containing varying [DTPA]). 
All values are the average of four replicate measurements, with error bars denoting S.E.M. and 
asterisks denoting conditions significantly altered from the highest concentration tested. 
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OVERVIEW 
 
Once thought to be unfortunate by-products of aerobic life, ROS and RNS are now known to 
be actively produced by cells and are integral in the maintenance and perturbation of the 
“redox balance”. Perturbation of the redox balance is necessary for the use of ROS / RNS as 
messengers, with redox sensing and signalling processes occurring at protein residues 
sensitive to the redox state of their surrounding environment, none arguably more so than Cys 
residues. Redox sensing by Cys and the generation of Cys PTM are made possible by the 
ability of Cys to directly interact with a large range of electrophilic small molecular weight 
compounds without enzymatic catalysis. The chemistry of Cys PTM is complex and 
interrelated, with not only addition and removal of PTMs possible, but also the inter-
conversion and cycling of PTM forms. The high reactivity of thiols and some of their PTM is 
integral to their functioning in a physiological setting, but also makes them particularly 
susceptible to unwanted reactions, which will alter the redox state of proteins. These 
unwanted reactions may occur biologically under conditions of oxidative stress – where they 
constitute interesting examples of macromolecular protein damage / dysregulation – or they 
may occur as the result of methodologies designed to study redox systems – where they 
constitute artefacts. 
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The global study of proteins, and even more so protein PTM, is fraught with methodological 
pitfalls and chemical side products that may obscure actual biological information with 
artefacts. This is a factor not only of the inherent complexity of biology (which cannot be 
avoided), but also due to the large number of preparative steps that are necessary to go from 
“biological system” to “analysable sample”. Preparative steps should be robust, utilising 
efficient and specific chemistries under optimal conditions, which at once promote good 
reaction kinetics and prevent / limit side reactions. The reactivity of Cys is both an advantage 
and disadvantage here as it will react with good kinetics in a range of reactions, some of 
which are desirable and others which are not.  
The methodological concepts derived in this thesis revolve around the optimisation and 
exploitation of several chemistries at Cys / PTM Cys including covalent modifications; 
alkylation and TDE; and non-covalent interactions; electrostatic and polar interactions. 
Overall, we define the conditions and chemical steps necessary for the use of these 
techniques and chemistries in the enrichment, identification and quantitation of Cys PTM in 
proteins (Ch 3 – 5) – and then utilise the lessons learnt to the quantitative study of Cys PTM 
in the myocardium during IR and antioxidant intervention (Ch 6). This contributes both a 
significant increase to; i) methodological knowledge / choice in the area of Cys redox 
proteomics, and ii) the current identified sites of Cys PTM in the myocardium basally and 
during pathological oxidant generation. 
 
7.1. Methodological Developments 
A general overview of the flow of the developed methods is given in Figure 7.1. summarising 
the generic steps of the protocols, including; (i) protein extraction / alkylation / free thiol 
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protection, (ii) digestion and reduction, (iii) Cys (or Cys-SO2/SO3H) enrichment, and (iv) 
identification / quantitation by LC-MS/MS. 
 
Figure 7.1. Overview of the general methodological steps of the protocols developed. All 
necessary generic steps are given, with optional steps (for iTRAQ-based quantitation given in 
brackets). Protein extraction / alkylation steps were optimised to minimise artefact generation, in-
solution digestion / reduction / iTRAQ labelling reactions were then carried out to allow for peptide-
centric enrichment of reversible or irreversible Cys PTM, before LC-MSMS identification and 
quantitation. 
 
Alkylation chemistry is used in the initial stages of most Cys enrichment protocols to allow 
for the differentiation of free and PTM thiols in biological samples, and to remove highly 
reactive free thiols by forming less reactive thioethers. However, as this chemistry is not 
specific to Cys, given the right (or wrong) conditions, alkylation will happen at most 
nucleophiles, and due to their higher abundance in proteins, may constitute a considerable 
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artefact even if kinetics are slower than at Cys. These side reactions are relatively well 
characterised for high pH alkylating agents such as iodoacetamide (see Ch. 3 Background) 
but less characterised for reagents such as NEM, which do not require a high pH for 
alkylation. In Chapter 3, it was observed that several nucleophilic residues in the protein 
ovalbumin were alkylated at low concentrations of NEM (5 mM), particularly when pH was 
above neutral, including His, Lys and N-terminal sites (Table 3.1). Previous literature tended 
to indicate that all concentrations less than 20 mM were „specific‟ for thiols over other 
nucleophiles – although this was not referenced to any pH dependence (Hansen and Winther, 
2009). Thus, care was taken to elaborate on the conditions – pH, time and [NEM] – which 
would exploit the high reactivity of Cys whilst decreasing reactivity at other nucleophilic 
sites. It was observed that thiol and amine reactions could not only be separated by restricting 
[NEM], but also by lowering pH and shortening reaction times – essentially limiting the 
kinetics of the alkylation reaction to the most reactive sites. Thus, alkylation conditions can 
be either: (i) concentration limited for steps involving long waiting times, or (ii) time limited 
for complete alkylation of low reactivity thiols. There is clear advantage however, in 
performing this reaction with efficient protein denaturation (SDS, and potentially heating) 
and at a pH below neutrality, and these should be contained in any alkylation procedure 
seeking to limit artefact generation. As tissue extraction protocols can be prolonged, it is 
perhaps best to involve a combination of both concentration and time-limited reactions. For 
example, during tissue homogenisation (> 30 min) [NEM] are limited to ≤ 10 mM, whilst 
following this, [NEM] can be raised to 40 mM for a short time (< 10 min) to complete 
alkylation at low-reactivity thiols. 
Notably, extraction in the presence of NEM in the combination with low pH and protein 
denaturation – to limit any increased reactivity dictated by thiol microenvironment – will also 
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decrease side reactions leading to artefactual oxidation of thiols. Auto-oxidation (as well as 
most other reactions generating Cys PTM e.g., TDE) is not only pH dependant but also relies 
on the presence of catalytic metal ions. Thus, metal ion chelators at mM concentrations (see 
Appendix 5) are also necessary during extraction, with higher dentate chelators preferred 
(e.g., DTPA vs. EDTA) as they better restrict any catalytic abilities of the metals as well 
(e.g., in Haber-Weis / Fenton reactions). The reaction conditions described here constitute an 
improvement over current methodologies of thiol „trapping‟ during extraction, which 
frequently involve acid extraction followed by resuspension at neutral pH for alkylation. The 
improvement is two-fold as, (i) extraction and alkylation is combined in one step at below pH 
7, which will limit artefact generation from extended sample handling and during 
resuspension, and (ii) the addition of detergent increases solubility in comparison to acid 
extraction whilst still providing efficient denaturation. 
This extraction methodology has focused primarily on reducing thiol oxidation, with 
reduction of PTM being of less focus as we are essentially extracting into an oxidising 
environment. Notably, loss of thiol PTM may occur by TDE or hydrolysis during extraction, 
however the first will lead to the formation of a disulfide and will essentially preserve the 
PTM state of the Cys but will change the chemical nature of the PTM present. The advantage 
of this “all-in-one” Cys PTM analysis is that this reaction does not merit consideration. 
Hydrolysis however, will lead usually to the formation of R-SOH that may then react to be 
re-oxidised (e.g., to a disulfide), which is again of little consequence in this methodology, or 
be reduced to a thiol. This second reaction may become more relevant on heating, and thus 
the heating step was omitted from samples destined for iTRAQ analysis (heating-based 
denaturation only becomes relevant if we are seeking sub-minute timescales for our NEM 
reaction anyway). Whilst there is a chance of PTM reduction (and thus under-estimation of 
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PTM occupancy), the chances of oxidation upon extraction from the reducing environment 
present in cells into the oxidising environment of a buffer is infinitely more likely and thus 
attention was focused here. 
Once initial extraction and free thiol alkylation steps are complete, reduction of Cys PTMs 
may be undertaken. As Cys PTM are often reasonably reactive to low reducing potential 
reductants (e.g., ascorbate), several methodologies have evolved to exploit this (e.g., BST, 
SNOSID, SNORAC), however, often long reaction times and basic pH will still be necessary 
to give any appreciable global reduction of Cys PTM sites – leading to artefactual oxidation 
and TDE during reduction. The addition of modifiers such as Cu
1+
 (reduced to Cu
2+
) is in 
direct opposition to the caveats described above, which limit exposure of thiols to transition 
metals, and will also result in thiol oxidation (reactions given in Section 1.2.4). Generally 
speaking, strong reducing reagents will avoid these issues, and dithiol-based reductants (e.g., 
DTT) will be best at reducing the widest range of Cys PTMs with the smallest artefact 
generation – phosphines will reduce disulfides but not some other Cys PTM (e.g., thioesters), 
whilst borohydrides are strong enough to reduce non-sulfur groups (e.g., carbonyls). When 
dithiol-based reduction is coupled to an enrichment technique such as TDE, we observe high 
reproducibility of Cys peptide capture (Chapter 4). 
In Chapter 4, a method of TDE chromatography was described, which is robust, reproducible 
and sensitive to a wide range of Cys PTM sites. TDE chemistry was chosen for enrichment 
due to its high specificity for thiols over other nucleophiles, the commercial availability and 
low toxicity of resins, and its ease of scale-up for increased sample amount – which may be 
important for the observation of low abundance PTM sites. The major non-specific 
interactions occurring in the protocol – which would otherwise limit enrichment selectivity – 
are hydrophobic in origin, and can be reduced by the addition of detergent during binding and 
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wash. It is possible that the exact percentage of detergent necessary to prevent these 
interactions may be sample dependant – as was observed for iTRAQ-labelled peptides – but 
any decreases in binding specificity can be met with an increase in [SDS]. As detergents can 
be incompatible with down-stream analysis, we have limited [SDS] to the minimum 
necessary to reduce hydrophobic interaction, and utilise a number of aqueous wash steps to 
essentially dilute out the detergent after these initial washes. If detergent carry over is an 
issue with some samples it would be possible to increase the number of these steps. Finally, it 
was observed that elution from the resin improved with multiple rounds of elution at 10 mM, 
which both increase the total volume of elution and limit the influence of any DTT oxidation 
that may occur as beads are agitated to achieve good access. 
Whilst the chemistry of TDE has been applied previously to the isolation of Cys PTM in 
protein samples, it was observed that applying it at the peptide level has several advantages. 
Firstly, general advantages to applying peptide-centric enrichment are present including; (i) 
increased solubility in all sample steps, ii) decreased loss in sample clean-up, (iii) decreased 
influence of protein properties on chemical steps (e.g., size, hydrophobicity etc.). Peptides are 
not only easier to handle than proteins, but are a more uniform sample in terms of TDE 
reactivity, with most of the effects of protein microenvironment removed. This will lead to 
the capture of a more representative population onto TDE beads rather than a population that 
is skewed by Cys site reactivity. This will be particularly pertinent for proteins containing 
reactive dithiols (e.g., vicinal thiols), which are very reactive to TDE chemistry and will 
likely be relatively depleted in protein samples captured by this technique. The pre-digestion 
of samples will limit the occurrence of these sites, i.e., they may occur in two separate 
peptides if separated by K / R, and also reactivity of these sites (if dictated by local structure), 
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while increasing their accessibility. The technique was also utilised for label-free and label-
based (iTRAQ) quantitation (discussed below). 
One limitation to the TDE chromatography technique is that Cys PTM without TDE 
reactivity following reduction, i.e., irreversible PTM, will not be captured. As stated, Cys-
SO2H/SO3H will not be reduced by DTT to the thiol, and are not nucleophilic enough to react 
via TDE. One advantage however, is that their lowered nucleophilicity also makes them less 
reactive and relatively stable in comparison to reversible Cys PTM. It was rationalised that 
the presence of these PTM in tryptic peptides would give a unique charge distribution at 
acidic pH, when most other acidic groups (Asp, Glu and C-terminus) were protonated. In 
Chapter 5, this property was exploited to enrich for these Cys PTM utilising negative 
selection by SCX resins promoting electrostatic repulsion of these peptides and / or elution of 
hydrophobic Cys-SO2H/SO3H by organic modifiers prior to salt elution steps. HILIC 
fractionation then allowed for increased separation of Cys-SO2H/SO3H from most 
hydrophobic peptides, for example, those with N-terminal acetylation or pyroglutamate. This 
is not true however, when peptides containing excess basic groups are present, as these will 
retain equally well and are of higher abundance – thus this second level of fractionation is 
somewhat dependant on the initial enrichment by SCX. 
Unfortunately, this technique was not compatible with iTRAQ labelling as these tags add an 
extra charge for every N-terminus and Lys modified. This essentially shifts all peptide in-
solution charge states up by two for every peptide ending with Lys, and one for those ending 
in Arg. It is precisely this factor (Lys vs. Arg peptide charge) that causes co-elution of Arg 
peptides with many of those containing Cys-SO2H/SO3H (ending in Lys or containing His), 
which will have the same in-solution charge but are of vastly lower abundance. In addition, 
as iTRAQ is a multiplexing technique (i.e., MS intensities are related to abundance in all four 
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conditions), this will complicate identification of Cys-SO2H/SO3H-containing peptides, 
which may only be present in one condition (in this case IR), as their intensity will be 
relatively lower than running one sample at a time (as total peptide load is static). Finally, it 
is likely that database assignment also plays a role, as iTRAQ labelling increases FDR cut-
offs (by increasing algorithm search space and also MS/MS fragment numbers) and will 
preferentially exclude multiply modified peptides as low confidence identifications. Thus, for 
these modifications it may be best that independent sample analysis is undertaken by label 
free quantitation, e.g., spectral counting (Ch. 5 and 6), SRM or MS precursor area, or 
alternate label-based quantitation that does not alter the charge or hydrophilicity of tryptic 
peptides (e.g., stable isotopic labelling by amino acids in cell culture, SILAC). 
 
7.2. Cys PTM in the Myocardium 
The developed techniques have lead to the assignment of the largest Cys PTM databases to 
date including the; (i) largest basally (i.e., no intervention / oxidant addition) reversible Cys 
PTM peptide database (Chapter 4), (ii) largest number of irreversibly PTM Cys peptides 
identified (Chapter 5), iii) first and largest globally identified number of irreversible Cys 
PTM in biologically generated tissue (i.e., no exogenous oxidant addition; Chapters 5 and 6), 
and iv) largest database of label-quantified reversible PTM Cys in myocardial tissue (Chapter 
6). These databases have also improved overlap of previously identified Cys PTM sites 
identified by other techniques (proteomic and otherwise) in the myocardium as well as other 
tissues and species. The generation of high confidence, large datasets has allowed for their 
utilisation in the identification of over-represented functions, protein domains and linear 
sequence motifs to aid in the current knowledge of potential processes controlled by Cys 
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PTM, and in potential effectors of Cys reactivity in proteins. In addition, the coupling of 
quantitation has helped to profile changes in Cys PTM in response to ischemic stress, IR and 
antioxidant interventions, delineating potential effectors of redox signalling and oxidative 
damage under these conditions. 
Analysis of Cys PTM present basally in myocardial tissue (Chapter 4) revealed a greater 
extent of modification than previously revealed in the literature, with > 6500 Cys peptides 
observed. This dataset represents a global analysis of Cys PTM and still only represents ~ 3 - 
4 % of all Cys sites in the proteome, but increases the current observations by 3 – 10 times, 
indicating they are vast underestimates of Cys PTM in the myocardium. The first proteomic-
based identifications of many sites assigned as Cys PTM from crystallographic structural 
assignments within the dataset increases confidence that additional identified peptides are in 
fact PTM in the tissue and not captured as artefacts in the protocol. In addition, the over-
representation of proteins that are heavily associated with Cys PTM (e.g., thiol-based 
oxidoreductases, structural proteins and those containing Fe-S clusters), also increases 
confidence in these identifications. 
When sites were quantified under conditions of IR, as expected, > 50 % of sites were 
observed not to alter in Cys PTM under any intervention. These will be redox insensitive sites 
or potentially sites that are not modified under this particular stimulus, i.e., they may require 
more extended / severe oxidant stress or a different type of stimulus all together. The 
observation of a large number of unchanged sites increases confidence in the experimental 
technique, as it is known that a large number of Cys are involved in protein structural 
stability (e.g., structural disulfides), which will not change dramatically in abundance during 
mild stress. If a method were to demonstrate too high a level of „significant biological 
change‟ it may be considered that these are actually artefacts of an irreproducible method. 
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Interestingly, this is one of the few studies to examine a condition of overall reduction in the 
redox environment of the cell – i.e., following MPG treatment. This was an advantageous 
find, as it not only gives insights as to the biological affect of MPG but offers a good control 
for the methodology. Many Cys PTM methodologies have been tested following oxidising 
interventions (e.g., oxidant addition), or pathological oxidative stress, but relatively few have 
been tested following a relative reduction in the redox environment, which is much less 
common biologically. This indicates: (i) the technique can accurately measure a relative 
change in both directions from control, and (ii) redox state must at least largely be preserved 
upon extraction and sample processing as otherwise this condition would be most susceptible 
to oxidation. As stated previously however, a reduction in ratio cannot directly be assumed to 
indicate a reduction of Cys PTM, as over-oxidised Cys will also potentially decrease ratio 
values (particularly if compared to a condition that is highly oxidised itself). Thus, this 
technique is best combined with parallel assessment of Cys-SO2H/SO3H PTM to rule out this 
possibility. In this case, MPG treatment corresponded to a reduction of Cys capture, which 
was not paralleled by an increase in Cys-SO2H/SO3H (in comparison to control), and thus it 
is more likely that most sites are reduced and not over-oxidised. The only condition where 
this conclusion may not be correct is following IR, where Cys-SO2H/SO3H assignments are 
seen to increase ~ 3 fold. As the techniques for reversible and irreversible Cys PTM 
enrichment are so disparate, and the observation of Cys-SO2H/SO3H is made much harder by 
their low abundance, % assignment of oxidised : reduced : over-oxidised forms at one site 
may be best performed by techniques such as oxMRM (Held, Danielson et al., 2010), which 
specifically target a small subset of sites for label-free quantitation, but require prior 
knowledge of the modified sites. 
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Finally, access to large datasets of Cys PTM has allowed for the identification of linear 
sequence motifs (Chapters 4 and 6), which may reflect Cys PTM state and redox activity. 
Overall, motifs were fairly diverse but involved the proximity of acidic / basic, small polar 
and proximal Cys residues. In control tissue, acidic residues were most over-represented, 
often in combination with each other, as well as small polar (Gly) and aliphatic (Ile) residues. 
These motifs will constitute both redox sensitive and insensitive Cys residues. When redox 
sensitive sites are observed however, differing motifs are indicated, with vicinal thiol motifs, 
basic residues, and Pro also identified, although several motifs still contain acidic residues 
and Gly. Thus, it appears that acidic and potentially Gly residues may predicate Cys PTM in 
general, and redox sensitive Cys motifs may also contain basic residues, vicinal thiols and 
Pro. Overall, this reflects the importance of electrostatic environment to Cys reactivity, 
potentially indicating the importance of H-bond like interactions to further weaken the S-H 
bond for increased reactivity. 
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7.3. Conclusions and Future Directions 
Cys has always been known as a highly functional site in proteins, constituting structural, 
catalytic and metal-binding sites, which are often highly conserved. Since the discovery that 
biological systems not only produce ROS / RNS, but utilise them to signal, Cys in proteins is 
increasingly observed to also include redox sensing and functional regulation. Moreover, 
dysregulation of ROS / RNS generation and / or detoxification, which is found in the 
aetiology or progression of most pathologies as well as ageing and obesity, is seen to keenly 
affect Cys residues. Thus there is great interest in the development of robust, sensitive and 
reproducible methodology to profile Cys PTM during physiological functioning and disease 
states, in order to identify important proteins in redox sensing / response and oxidant damage 
in the cell. 
This thesis was concerned with the development, optimisation and application of redox 
proteomics methods to profile Cys PTM. This involved the optimisation and rationalisation 
of several protocol steps including: (i) protein extraction / alkylation to accurately capture the 
redox state of proteins (Aim 1; Chapter 3), (ii) optimisation of Cys peptide enrichment by 
TDE chemistry (Aim 2; Chapter 4), (iii) rationalisation / comparison of the technique to 
currently available technologies (Aim 3; Chapter 4), (iv) development of additional 
methodology to profile Cys PTM uncaptured by TDE (Aim 4; Chapter 5), and (v) alteration 
of the TDE technique for quantitative multiplexed analysis (Aim 5; Chapter 6). In the 
application of the developed techniques, the largest databases to date were generated for both 
reversibly and irreversibly modified Cys. These databases have not only allowed for the 
confirmation of known sites, but also the high confidence assignment of new Cys PTM sites, 
and the identification of functional processes involving Cys PTM, and linear sequence motifs 
predicating Cys PTM. Overall, > 6500 reversibly modified and > 180 irreversibly modified 
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sites were identified. Furthermore, > 1300 reversibly and > 60 irreversibly modified sites 
were altered during IR. Whilst irreversible PTMs were observed mainly following IR, 
reversible modifications were observed to change during ischemia and antioxidant 
intervention in the myocardium, as well. These techniques are broadly applicable to a wide 
range of biological samples and it would be interesting to undertake Cys PTM studies in 
other pathologies that involve redox-based stress. 
Within this system, further studies with the above methods may include the time course of 
Cys PTM during ischemia and then during reperfusion, with very early time points (< 5 min) 
in order to identify potential ROS / RNS sensors and initiators of redox and other signalling 
cascades. As Cys are highly non-enzymatically reactive with these species it is possible they 
are involved in the early initiation of signalling cascades. Furthermore, joint examination of 
alternate PTM, such as phosphorylation, in a time-dependant manner may elucidate these 
interactions („cross-talk‟) between PTM pathways. Also, the affects of other drug 
interventions, which improve myocardial functional recovery, could be examined for their 
effect on the redox environment of the cell, to observe whether the influence of MPG in the 
reduction of the cell redox environment is solely dependent on it being thiol-containing or 
whether it is a general mechanism to improve functional recovery following IR. 
Finally, the method could be adapted to observe sites targeted by differing reducing agents – 
particularly enzymes such as thioredoxin or glutaredoxin, but also non-enzymatic reducing 
reagents (e.g., ascorbate). It should be noted however, that these methods would be inherently 
prone to site-interchange and re-oxidation of Cys, ultimately leading to mis-assigning the 
PTM site or underestimating the PTM occupancy. The method presented here could thus act 
as a robust control-case for these types of studies if run in parallel. 
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